| Methotrexate in the Treatment of Distal Interphalangeal Joint Extensor Tendon Enthesopathy in Nail Psoriasis |
Completed |
Nail Psoriasis |
NCT03757364 |
| Efficiency of Methotrexate and Tofacitinib in Mild and Moderate Patients |
Recruiting |
Takayasu Arteritis|Methotrexate|Inhibition|Treatment |
NCT04299971 |
| Treatment of Rheumatoid Arthritis With Methotrexate: Predictors of Response |
Recruiting |
Rheumatoid Arthritis |
NCT03414502 |
| Individualized High Dose Methotrexate to Treat Cancer in Children Who Have a Significant Risk for Side Effects to Methotrexate |
Unknown status |
Cancer |
NCT02076997 |
| The Efficiency Of The Methotrexate At Patients Affected By Grave Pelade |
Completed |
ALOPECIA AREATA |
NCT02037191 |
| BE Study in Patients - Methotrexate Tablets |
Unknown status |
Psoriasis|Rheumatoid Arthritis |
NCT02940561 |
| Methotrexate Polyglutamate Measurements in Patients With Inflammatory Bowel Disease |
Not yet recruiting |
IBD |
NCT04205734 |
| Assessment of Safety and Pharmacokinetics of a Low Dose of Methotrexate in Healthy Adult Male Kenyan Volunteers |
Completed |
Malaria |
NCT00791531 |
| Comparison of Compliance and Evolution of Functional Capacity of Patients With Rheumatoid Arthritis Treated by Methotrexate Either by Auto-injector or by Conventional Sub-cutaneous Syringe |
Completed |
Arthritis, Rheumatoid |
NCT02553018 |
| Clinical Trial Evaluating Methotrexate + Biologic Versus Methotrexate, Salazopyrine and Hydroxychloroquine in Patients With Rheumatoid Arthritis and Insufficient Response to Methotrexate |
Unknown status |
Rheumatoid Arthritis|Insufficient Response to Methotrexate. |
NCT02714634 |
| High-dose Intravenous Methotrexate Versus Intrathecal Methotrexate for Central Nervous System Prophylaxis in DLBCL |
Not yet recruiting |
DLBCL |
NCT03123718 |
| Salvage Therapy With High/Low Methotrexate for Loss of Response to Infliximab Dose Escalation |
Completed |
Crohn's Disease |
NCT02269358 |
| A Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of Methotrexate |
Completed |
Pharmacokinetics of Isavuconazole|Pharmacokinetics of Methotrexate|Pharmacokinetics of 7-hydroxymethotrexate|Healthy Subjects |
NCT01884636 |
| Low-dose Methotrexate for Change in Global Initiative for Asthma Step 5 Medications in Chronic Severe Asthma |
Not yet recruiting |
Low Dose Methotrexate in Severe Chronic Asthma |
NCT02124226 |
| Pharmacogenomics Study on Treatment of Psoriasis Vulgaris by Methotrexate |
Unknown status |
Psoriasis Vulgaris |
NCT02715947 |
| Low Dose Oral Methotrexate in Pediatric Crohn's Disease Patients Initiating Anti-Tumor Necrosis Factor (Anti-TNF) Therapy |
Recruiting |
Pediatric Crohn's Disease |
NCT02772965 |
| Comparison of Oral Versus Subcutaneous Route of Methotrexate Administration in Moderate to Severe Psoriasis |
Unknown status |
Psoriasis Vulgaris |
NCT03408756 |
| Understanding Methotrexate Induced Gastrointestinal Intolerance in Juvenile Idiopathic Arthritis and Childhood Leukemia |
Completed |
Juvenile Idiopathic Arthritis|ALL |
NCT02528435 |
| Methotrexate Polyglutamates as a Marker of Clinical Response and Toxicity in the Treatment of Psoriasis |
Unknown status |
Psoriasis Chronic|Injury of Liver |
NCT02174354 |
| Kinetics of Elimination of Methotrexate and Its Major Metabolite 7-OH-methotrexate for Observant Patients |
Recruiting |
Rheumatoid Arthritis |
NCT03852888 |
| Methotrexate Infusion Into the Fourth Ventricle in Children With Malignant Fourth Ventricular Brain Tumors: A Pilot Study |
Completed |
Brain Tumor|Malignant Neoplasm of Fourth Ventricle of Brain |
NCT01737671 |
| Hair Fall in Patients on Low Dose Methotrexate |
Unknown status |
Alopecia|Rheumatoid Arthritis|Methotrexate Adverse Reaction |
NCT02591823 |
| Intrathecal Methotrexate for Progressive Multiple Sclerosis: An Open Label Single Arm Study |
Unknown status |
To Evaluate the Effect of Therapy With IT MTX on the Disease Course of Patients With Progressive MS |
NCT02644044 |
| Studying the Effect of Methotrexate Alone Versus Methotrexate and Vitamin D on the Cardiovascular Risk of Psoriatic Patients |
Not yet recruiting |
Psoriasis |
NCT03904680 |
| Methotrexate and Etoposide Infusions Into the Fourth Ventricle in Children With Recurrent Posterior Fossa Brain Tumors |
Recruiting |
Brain Tumor Recurrent |
NCT02905110 |
| Methotrexate-associated Anti-TNF Combination Therapy, the Neglected One ! |
Recruiting |
Chronic Inflammatory Bowel Disease |
NCT04196920 |
| Methotrexate for Central Serous Chorioretinopathy Treatment Trial |
Unknown status |
Central Serous Chorioretinopathy |
NCT01633983 |
| Safety and Efficacy of Tofacitinib vs Methotrexate in the Treatment of Psoriatic Arthritis |
Completed |
Psoriatic Arthritis |
NCT03736161 |
| Continuous Intraventricular Methotrexate in Treating Patients With Leptomeningeal Disease |
Withdrawn |
Leptomeningeal Metastases |
NCT01438021 |
| Methotrexate and Statins With Methotrexate Alone in the Treatment of Rheumatoid Arthritis |
Completed |
Arthritis, Rheumatoid |
NCT04177173 |
| Kunxian for the Treatment of Rheumatoid Arthritis |
Unknown status |
Rheumatoid Arthritis |
NCT02764515 |
| Study of ATI-450 Plus Methotrexate (MTX) vs MTX Alone in Patients With Moderate to Severe RA |
Recruiting |
Rheumatoid Arthritis |
NCT04247815 |
| A Study to Evaluate the Pharmacokinetics of ASP1707 and Methotrexate in Patients With Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT02867306 |
| Effects of Tofacitinib vs Methotrexate on Rheumatoid Arthritis Interstitial Lung Disease |
Not yet recruiting |
Rheumatoid Arthritis|Interstitial Lung Disease Due to Systemic Disease (Disorder)|RA|ILD |
NCT04311567 |
| Methotrexate in the Treatment of Advanced Knee Osteoarthritis With Effusion-synovitis |
Recruiting |
Knee Osteoarthritis|Effusion Synovial|Knee Pain |
NCT03815448 |
| Utility of Intravitreal Methotrexate in Diabetic Macular Edema Resistant to Conventional Therapies |
Terminated |
Diabetic Macular Edema |
NCT00779142 |
| Discovery Stage IND EXEMPT Clinical Study - Etoposide OS Plus Methotrexate OS and Single Nucleotide Polymorphisms |
Active, not recruiting |
Small Cell Lung Cancer |
NCT03348670 |
| Methotrexate (Rheumatrex) High Dose Special Investigation (Regulatory Post Marketing Commitment Plan) |
Completed |
Arthritis|Rheumatoid|High Dose |
NCT01414257 |
| The Effects of mETHotrexate Therapy on ST Segment Elevation MYocardial InfarctionS (TETHYS Trial) |
Unknown status |
Myocardial Infarction |
NCT01741558 |
| Effect of Omega-3 Fatty Acids on Methotrexate Induced Hepatotoxicity in Children With Acute Lymphoblastic Leukemia |
Completed |
Acute Lymphoblastic Leukemia |
NCT02373579 |
| Treatment of Early RA: Minocycline in Combination With Methotrexate vs Methotrexate Alone |
Completed |
Rheumatoid Arthritis |
NCT00579644 |
| Phase II Study of Intraventricular Methotrexate in Children With Recurrent or Progressive Malignant Brain Tumors |
Terminated |
Recurrent Childhood Medulloblastoma|Recurrent Childhood Ependymoma|Childhood Atypical Teratoid/Rhabdoid Tumor|Embryonal Tumor With Abundant Neuropil and True Rosettes|Metastatic Malignant Neoplasm to the Leptomeninges |
NCT02684071 |
| Methotrexate Treatment for Ectopic Pregnancy |
Completed |
Ectopic Pregnancy |
NCT01855568 |
| The Impact of Salpingectomy and Single Dose Systemic Methotrexate Treatments on Ovarian Reserve in Ectopic Pregnancy |
Completed |
Ectopic Pregnancy|Infertility |
NCT02714998 |
| RCT of Methotrexate Added to Treatment As Usual in Schizophrenia |
Completed |
Schizophrenia|Schizoaffective Disorder|Schizophreniform Disorder |
NCT02074319 |
| Combination of Methotrexate and Phototherapy Versus Phototherapy in Adults With Progressive Vitiligo |
Not yet recruiting |
Vitiligo |
NCT04237103 |
| VACcination In Methotrexate Treated Rheumatoid Arthritis Patients |
Active, not recruiting |
Rheumatoid Arthritis |
NCT01942174 |
| Concomitant Longitudinal Evaluation of Adalimumab With Methotrexate in the Real World: the CLEAR Study |
Completed |
Psoriasis |
NCT02196701 |
| A Study to Evaluate the Pharmacokinetics, Efficacy and Safety of Intravenous Golimumab in Pediatric Participants With Active Polyarticular Course Juvenile Idiopathic Arthritis Despite Methotrexate Therapy |
Active, not recruiting |
Arthritis, Juvenile |
NCT02277444 |
| Hand OA AND Methotrexate Use |
Not yet recruiting |
Reduction in Pain|Reduction of Inflammation|Improvement in Function |
NCT01927484 |
| Effect of Methotrexate on Inflammatory Response in Adult Atopic Dermatitis Patients |
Completed |
Atopic Dermatitis |
NCT03327116 |
| Regorafenib and Methotrexate in Treating Participants With Recurrent or Metastatic KRAS Mutated Non-Small Cell Lung Cancer |
Recruiting |
KRAS Gene Mutation|Metastatic Malignant Neoplasm in the Brain|Recurrent Non-Small Cell Lung Carcinoma|Stage IV Non-Small Cell Lung Cancer AJCC v7 |
NCT03520842 |
| Comparison of Methotrexate Versus Interferon-alfa 2b in Patients With Primary Cutaneous T-cell Lymphomas |
Unknown status |
Lymphoma, T-Cell, Cutaneous|Mycosis Fungoides |
NCT02323659 |
| Prevention of Methotrexate Induced Nephrotoxicity and Prolonged Drug Elimination Time With 12 Hours Prehydration |
Completed |
Methotrexate Induced Nephrotoxicity |
NCT00570817 |
| Low Dose Cyclosporin and Methotrexate Therapy in Diabetes |
Completed |
Type 1 Diabetes Mellitus |
NCT00905073 |
| Phase III Study of Vinflunine Plus Methotrexate Versus Methotrexate Alone in Patients With Head and Neck Cancer |
Completed |
Recurrent or Metastatic Head and Neck Carcinoma |
NCT02347332 |
| Effectiveness of Methotrexate Versus Prednisolone as First-line Therapy for Pulmonary Sarcoidosis |
Not yet recruiting |
Sarcoidosis, Pulmonary |
NCT04314193 |
| Co-Administration Of Methotrexate And CP-690,550 |
Completed |
Rheumatoid Arthritis |
NCT01745055 |
| Two-Dose Methotrexate for Ectopic Pregnancy |
Completed |
Ectopic Pregnancy |
NCT00194272 |
| A Drug Interaction Study to Evaluate the Pharmacokinetics of ASP015K and Methotrexate in Patients With Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT01754805 |
| A Study to Assess the Pharmacokinetics of Methotrexate Given With and Without AZD9056 in Rheumatoid Arthritis Patients |
Withdrawn |
Rheumatoid Arthritis |
NCT00920608 |
| Methotrexate in Symptomatic Knee Osteoarthritis |
Completed |
Osteoarthritis |
NCT01654575 |
| Ultrasound as Imaging Biomarker of Early Response to Tocilizumab and Methotrexate in Very Early Rheumatoid Arthritis |
Unknown status |
Rheumatoid Arthritis |
NCT02837146 |
| Tripterygium Wilfordii Hook F and Methotrexate for Postmenopausal Women With Rheumatoid Arthritis |
Recruiting |
Rheumatoid Arthritis |
NCT04136262 |
| A Study to Determine the Effect of Methotrexate (MTX) Dose on Clinical Outcome and Ultrasonographic Signs in Subjects With Moderately to Severely Active Rheumatoid Arthritis (RA) Treated With Adalimumab (MUSICA) |
Completed |
Rheumatoid Arthritis |
NCT01185288 |
| Add-on Methotrexate for the Treatment of Schizophrenia |
Unknown status |
Schizophrenia |
NCT03369795 |
| Study of Two Different Starting Doses of Methotrexate When Starting Treatment in Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT01404429 |
| GOLimumab and Methotrexate Versus Methotrexate in Very Early PsA (GOLMEPsA) |
Recruiting |
Psoriatic Arthritis |
NCT04108468 |
| METhotrexate Therapy Effects in the Physical Capacity of Patients With ISchemic Heart Failure (METIS Trial) |
Completed |
Heart Failure|Myocardial Ischemia |
NCT00759811 |
| Trial in Patients With Psoriasis Treated With Methotrexate Using an Optimized Treatment Schedule (METOP) |
Completed |
Psoriasis Vulgaris |
NCT02902861 |
| Treatment of Non-infectious Intermediate and Posterior Uveitis Associated Macular Edema With Intravitreal Methotrexate |
Terminated |
Non-infectious Intermediate and Posterior Uveitis |
NCT01314417 |
| Methotrexate Infusion Into Fourth Ventricle in Children With Recurrent Malignant Fourth Ventricular Brain Tumors |
Completed |
Brain Tumor, Recurrent|Malignant Neoplasm of Fourth Ventricle of Brain |
NCT02458339 |
| The Ondansetron Premedication Trial in Juvenile Idiopathic Arthritis |
Recruiting |
Juvenile Idiopathic Arthritis |
NCT04169828 |
| Methotrexate Withdrawal Study of Tofacitinib Modified Release Formulation in Subjects With Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT02831855 |
| Trial of Sirolimus and Methotrexate in Relapsed/Refractory Lymphoblastic Leukemia and Lymphoma |
Completed |
Cancer|Leukemia|Lymphoma |
NCT01162551 |
| A Study of the Use of Methotrexate in the Treatment of Chronic Idiopathic Urticaria |
Terminated |
Urticaria |
NCT00189878 |
| A Safety and Efficacy Study of Ustekinumab in Patients With Plaque Psoriasis Who Have Had an Inadequate Response to Methotrexate |
Completed |
Psoriasis |
NCT01059773 |
| Topical Steroids Alone or Associated With Methotrexate in Bullous Pemphigoid |
Unknown status |
Bullous Pemphigoid |
NCT02313870 |
| Prospective, Multicentric, Phase II Randomized Controlled Trial on Two Parallel Groups Comparing the Efficacy of Two Immunosuppressive Drugs (Methotrexate, Cyclophosphamide) in Large Granular Lymphocytes Leukemia |
Recruiting |
Large Granular Lymphocytes Leukemia |
NCT01976182 |
| SC12267 (4SC-101) in Combination With Methotrexate in Patients With Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT01010581 |
| Intravitreal Methotrexate and R2(Rituximab & Lenalidomide) Regimen in Newly-diagnosed Primary Vitreoretinal Lymphoma |
Recruiting |
Primary Intraocular Lymphoma |
NCT03746223 |
| COMMIT (Combination Of Maintenance Methotrexate-Infliximab Trial) |
Completed |
Crohn's Disease |
NCT00132899 |
| MTX-related Liver Toxicity in Psoriasis Patients, Using Ultrasound-based Techniques as a Diagnostic Tool |
Not yet recruiting |
Psoriasis|Liver Fibrosis |
NCT04168619 |
| Safety and Efficacy of Intravenous ACZ885 and Oral Methotrexate Therapy in Patients With Early Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT00487825 |
| Rheumatoid Arthritis Response to Methotrexate |
Recruiting |
Rheumatoid Arthritis |
NCT03535519 |
| Methotrexate in the Treatment of Chronic Idiopathic Urticaria |
Completed |
Chronic Urticaria |
NCT01960283 |
| Dose Ranging Study to Compare the Efficacy and Safety of Methotrexate in Plaque Type Psoriasis |
Completed |
Psoriasis |
NCT01187264 |
| Efficacy of Starting Methotrexate Early in Chikungunya Arthritis |
Completed |
Early Chikungunya Arthritis |
NCT03058471 |
| The Efficacy and Safety of Adding Methotrexate to Etanercept in Psoriasis |
Completed |
Psoriasis |
NCT01001208 |
| Methotrexate and Cytosine in Adult Langerhans Cell Histiocytosis |
Completed |
Langerhans Cell Histiocytosis |
NCT02389400 |
| Yellow Fever Vaccination Under Low Dose Methotrexate Therapy |
Unknown status |
Rheumatic|Dermatologic Disorders |
NCT02383680 |
| Remicade Study in Psoriatic Arthritis Patients Of Methotrexate-NaĂŻve Disease (RESPOND) (Study P04422) |
Completed |
Arthritis, Psoriatic |
NCT00367237 |
| Erosive Osteoarthritis of the Hands: Treatment by Methotrexate Versus Placebo |
Unknown status |
Polyarthritis |
NCT01068405 |
| Comparison Study of Psoriasis Severity Assessment Tools |
Completed |
Psoriasis |
NCT02655705 |
| A Bioavailability Study of Methotrexate 25 mg Administered by Needle Injection and a Pre Filled Needle-free Device in Healthy Volunteers. |
Completed |
Healthy |
NCT03103334 |
| ACP-196 Versus Placebo in Subjects With Rheumatoid Arthritis on Background Methotrexate |
Completed |
Rheumatoid Arthritis |
NCT02387762 |
| Effect of the Combination of Methotrexate and Adalimumab on Reduction of Immunization in Ankylosing Spondylitis (COMARIS) |
Completed |
Ankylosing Spondylitis |
NCT01895764 |
| A Study to Investigate How JNJ-38518168 May Affect the Plasma Levels of Methotrexate in Rheumatoid Arthritis Participants |
Completed |
Rheumatoid Arthritis |
NCT01450982 |
| A Pilot Study of Dextromethorphan for the Prevention and Treatment of Methotrexate Neurotoxicity |
Terminated |
Neurotoxicity Syndromes |
NCT00176553 |
| CNS Prophylaxis in Diffuse Large B-cell Lymphoma |
Unknown status |
Diffuse Large B-cell Lymphoma |
NCT02777736 |
| Etanercept Plus Methotrexate Versus Methotrexate Alone in Children With Polyarticular Course Juvenile Rheumatoid Arthritis |
Terminated |
Juvenile Rheumatoid Arthritis |
NCT03781375 |
| Efficacy Study of Methotrexate to Treat Sarcoid-associated Uveitis |
Terminated |
Sarcoid-associated Uveitis|Ocular Sarcoidosis|Macular Edema |
NCT00918554 |
| Multicenter Randomized Double Blind Controlled-study to Assess the Potential of Methotrexate Versus Placebo to Improve and Maintain Response to Anti TNF- Alpha Agents in Adult Patients With Moderate to Severe Psoriasis |
Recruiting |
Psoriasis |
NCT02829424 |
| Etanercept and Methotrexate in Combination or as Monotherapy in Psoriatic Arthritis |
Completed |
Psoriatic Arthritis |
NCT02376790 |
| Effects of Tranilast on Pharmacokinetics of Methotrexate (MTX) in Patients With Rheumatoid Arthritis (RA) |
Withdrawn |
Rheumatoid Arthritis |
NCT00717808 |
| A Study Comparing the Safety and Efficacy of Risankizumab to Methotrexate in Subjects With Moderate to Severe Plaque Psoriasis |
Active, not recruiting |
Psoriasis |
NCT03219437 |
| Effect of Methotrexate Carried by a Lipid Nanoemulsion on Left Ventricular Remodeling After STEMI |
Recruiting |
Myocardial Infarction, Anterior Wall|Myocardial Remodeling, Ventricular |
NCT03516903 |
| Leflunomide Versus Sulfasalazine/Methotrexate in Rheumatoid Arthritis:an Ultrasound/Magnetic Resonance Imaging Study |
Terminated |
Rheumatoid Arthritis |
NCT01659242 |
| Methotrexate as a Steroid-sparing Agent in Idiopathic Retroperitoneal Fibrosis: a Randomised, Multicenter Trial |
Unknown status |
Idiopathic Retroperitoneal Fibrosis|Perianeurysmal Retroperitoneal Fibrosis|Chronic Periaortitis |
NCT01240850 |
| Study of the Response and Cardiorespiratory Endurance in Early RA Patients Treated With Tocilizumab or Methotrexate |
Completed |
Rheumatoid Arthritis |
NCT01245452 |
| Will Glucarpidase After Methotrexate Treatment for Bone Sarcoma Lead to Fewer Side Effects and Reduce Chemotherapy Delays? |
Terminated |
Osteosarcoma|Spindle Cell Sarcoma of Bone |
NCT02022358 |
| RCT on the Efficacy of Methotrexate for the Prevention of GTD |
Completed |
Hydatidiform Mole |
NCT01984099 |
| Study of Etanercept Monotherapy vs Methotrexate Monotherapy for Maintenance of Rheumatoid Arthritis Remission |
Completed |
Rheumatoid Arthritis |
NCT02373813 |
| Methotrexate and Prednisolone Study in Erythema Nodosum Leprosum |
Not yet recruiting |
Erythema Nodosum Leprosum |
NCT03775460 |
| Comparison Between Cyclophosphamide and Combination of Methotrexate + Calcineurin Inhibitor for GVHD Prophylaxis |
Terminated |
Acute Myelogenous Leukemia|Acute Lymphoid Leukemia|Myeloproliferative Disease|Myelodysplastic Syndrome|Chronic Myeloid Leukemia|Chronic Myelomonocytic Leukemia |
NCT01749111 |
| Human Factors Study of Methotrexate Prefilled Pen (50 mg/mL) in Patients With Juvenile Idiopathic Arthritis |
Completed |
Juvenile Idiopathic Arthritis |
NCT02052167 |
| Targeted Treatment Early With Etanercept + Methotrexate vs.T2T Care for DMARD-naĂŻve Early RA Patients Based on naĂŻve T-cell Stratification |
Not yet recruiting |
Rheumatoid Arthritis |
NCT03813771 |
| A Canadian Study to Evaluate Early Use of Adalimumab After Methotrexate Failure in Early Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT01162421 |
| Transarterial Chemoperfusion: Cisplatin, Methotrexate, Gemcitabine for Unresectable Pleural Mesothelioma |
Recruiting |
Malignant Pleural Mesothelioma|Mesothelioma |
NCT02611037 |
| Outpatient Administration of High Dose Methotrexate (HD MTX) in Patients With Osteosarcoma |
Completed |
Osteosarcoma |
NCT01176981 |
| Clinical Trial to Evaluate Efficacy and Safety of Acellbia® (JSC "BIOCAD") With Methotrexate in First Line Biological Therapy of Patients With Active Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT02744196 |
| CAMEO: Canadian Methotrexate and Etanercept Outcome Study |
Completed |
Rheumatoid Arthritis |
NCT00654368 |
| Optimizing Psoriasis Treatment of Etanercept Combined Methotrexate |
Completed |
Psoriasis |
NCT02313922 |
| A Study to Evaluate the Efficacy and Safety of ASP5094 in Patients With Rheumatoid Arthritis on Methotrexate |
Completed |
Rheumatoid Arthritis (RA) |
NCT03257852 |
| Combination Therapy of F8IL10 and Methotrexate in Rheumatoid Arthritis Patients |
Completed |
Rheumatoid Arthritis |
NCT02076659 |
| Methotrexate or Pentostatin for Graft-versus-host Disease Prophylaxis in Risk-adapted Allogeneic Bone Marrow Transplantation for Hematologic Malignancies |
Completed |
Acute Lymphoblastic Leukemia|Acute Myelocytic Leukemia|Chronic Myelocytic Leukemia|Hodgkin's Disease|Myelodysplastic Syndrome |
NCT01188798 |
| Study Comparing Enbrel (Etanercept) Plus Methotrexate Versus Enbrel Alone in Active Rheumatoid Arthritis Despite Current Methotrexate Therapy |
Completed |
Rheumatoid Arthritis |
NCT00244556 |
| Study of Methotrexate Given to Juvenile Idiopathic Arthritis Patients Based on Pharmacogenomics and Pharmacometrics |
Recruiting |
Juvenile Idiopathic Arthritis |
NCT03006991 |
| A Study of Tocilizumab and Methotrexate Treatment Strategies (Adding Tocilizumab to Methotrexate Versus Switching to Tocilizumab) in Patients With Active Rheumatoid Arthritis With Inadequate Response to Prior Methotrexate Treatment |
Completed |
Rheumatoid Arthritis |
NCT00810199 |
| Study Evaluating the Combination of Etanercept and Methotrexate in Rheumatoid Arthritis Subjects |
Completed |
Rheumatoid Arthritis |
NCT00252668 |
| Quality of Life of Patients With Psoriasis Treated With Methotrexate: Prospective, Randomized, Double-blind, Parallel Group Study. |
Unknown status |
Severe Plaque Type Psoriasis |
NCT02248792 |
| Combined Treatment of Methotrexate + Glucocorticoids Versus Glucocorticoids Alone in Patients With PM and DM |
Completed |
Polymyositis|Dermatomyositis |
NCT00651040 |
| The Effects of Infliximab Versus Methotrexate in the Treatment of Moderate to Severe Psoriasis (Study P04271AM2)(COMPLETED) |
Completed |
Psoriasis |
NCT00251641 |
| Head and Neck Phase III Iressa Versus Methotrexate Refractory: Iressa Versus Methotrexate (IMEX) |
Completed |
Squamous Cell Carcinoma of the Head and Neck |
NCT00206219 |
| A Study to Investigate How JNJ-39758979 May Affect the Plasma Levels of Methotrexate in Rheumatoid Arthritis Participants |
Completed |
Rheumatoid Arthritis |
NCT01442545 |
| To Compare the Efficacy of the Addition of Methotrexate (MTX) to Current Standard Acute Graft-versus-host Disease (GVHD) First-line Treatment With Corticosteroids |
Recruiting |
Allogeneic Disease|GVH - Graft Versus Host Reaction|GVHD, Acute|Stem Cell Transplant Complications |
NCT03371667 |
| Methotrexate in Metastatic Colorectal Cancer With MSH2 Deficiency |
Terminated |
Advanced Colorectal Cancer |
NCT00952016 |
| Sirolimus, Tacrolimus and Short Course Methotrexate for Prevention of Acute GVHD in Recipients of Mismatched Unrelated Donor Allogeneic Stem Cell Transplantation |
Completed |
Stem Cell Transplantation |
NCT00612274 |
| Vinblastine and Methotrexate in Children With Pulmonary Vein Stenosis |
Completed |
Intraluminal Pulmonary Vein Stenosis |
NCT00215046 |
| Efficacy and Safety Study of Abatacept Subcutaneous Plus Methotrexate in Inducing Remission in Adults With Very Early Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT01142726 |
| The Influence of Methotrexate on the Metabolism and Vascular Effects of Adenosine in Humans |
Completed |
Methotrexate|Vasodilation |
NCT00184886 |
| Treatment With High Dose Methotrexate in Patients With Eosinophilic Fasciitis |
Completed |
Fasciitis |
NCT00441961 |
| Study of KRYSTEXXA® (Pegloticase) Plus Methotrexate in Patients With Uncontrolled Gout |
Recruiting |
Gout |
NCT03994731 |
| Study of Pegloticase (KRYSTEXXA®) Plus Methotrexate in Patients With Uncontrolled Gout |
Active, not recruiting |
Gout |
NCT03635957 |
| Cyclosporine Plus Methotrexate or Alemtuzumab |
Terminated |
Unrecognized Condition: Mature B or T-cell Neoplasm |
NCT02701517 |
| A Study of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate in Patients With Severe Active Rheumatoid Arthritis, Comparing Tapering Versus Maintaining the Methotrexate Dosage |
Terminated |
Rheumatoid Arthritis |
NCT01661140 |
| Exposure Study Comparing 3 Routes of Methotrexate (MTX) Administration |
Completed |
Rheumatoid Arthritis |
NCT01737944 |
| Methotrexate and Temozolomide Versus Methotrexate, Procarbazine, Vincristine and Cytarabine |
Unknown status |
Lymphoma |
NCT00503594 |
| Rapamycin vs Methotrexate in Diffuse SSc |
Completed |
Systemic Sclerosis |
NCT00241189 |
| Study Comparing Pembrolizumab With Methotrexate in Elderly, Frail or Cisplatin-ineligible Patients With Head and Neck Cancers |
Recruiting |
Cancer of Head and Neck |
NCT03193931 |
| Dose Dense Adjuvant CMF (Cyclophosphamide, Methotrexate, Fluorouracil) at 14 and 10-11 Day Intervals for Women With Early Stage Breast Cancer |
Completed |
Breast Cancer |
NCT00615901 |
| An Efficacy And Safety Study Evaluating Tofacitinib With And Without Methotrexate Compared To Adalimumab With Methotrexate |
Completed |
Rhematoid Arthritis |
NCT02187055 |
| Mechanism of Action Study for Psoriasis |
Completed |
Psoriasis |
NCT00932113 |
| Study of Insulin-like Growth Factor (IGF)-Methotrexate Conjugate in the Treatment of Advanced Tumors Expressing IGF-1R |
Completed |
Breast Cancer|Brain Cancer|Gastrointestinal Cancers|Genitourinary Cancers|Gynecologic Cancers|Head and Neck Cancers|Melanoma|Thoracic Cancers |
NCT02045368 |
| High-Dose Methotrexate in Treating Young Patients With Solid Tumors |
Completed |
Brain and Central Nervous System Tumors|Sarcoma|Unspecified Childhood Solid Tumor, Protocol Specific |
NCT00513981 |
| A Study to Evaluate the Safety and Efficacy of SM03 in Patients With Rheumatoid Arthritis Receiving Methotrexate |
Completed |
Rheumatoid Arthritis |
NCT04192617 |
| Preference Methotrexate (MTX) Pre-filled Syringe Versus Pre-filled Pen in Rheumatoid Arthritis (RA) |
Completed |
Rheumatoid Arthritis |
NCT01793259 |
| Tacrolimus/Methotrexate Versus Cyclosporine/Methotrexate for Prophylaxis of Graft Versus Host Disease |
Completed |
Graft vs Host Disease |
NCT01788501 |
| Study of LX3305 and Methotrexate in Subjects With Stable Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT00847886 |
| Initial Treatment With Golimumab in Early PsA |
Completed |
Psoriatic Arthritis |
NCT01871649 |
| A Phase III Study to Evaluate the Efficacy and Safety of ENIA11 in Combination With Methotrexate Versus Methotrexate Alone in Patients With RA |
Unknown status |
Rheumatoid Arthritis |
NCT01709760 |
| A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naĂŻve Adults With Early Active Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT01519791 |
| A Study of Tocilizumab (RoActemra/Actemra) in Monotherapy or in Combination With Methotrexate or Other Non-Biologic DMARDs in Participants With Active Rheumatoid Arthritis and an Inadequate Response to Current Non-Biologic DMARD Therapy or the First Anti-TNF Biologic Agent |
Completed |
Rheumatoid Arthritis |
NCT02046603 |
| Cardiovascular Inflammation Reduction Trial |
Completed |
Cardiovascular Disease |
NCT01594333 |
| A Phase II Trial of Ifosfamide, Etoposide, Cytarabine, and Methotrexate (IVAM) Chemotherapy for Refractory or Relapsed Diffuse Large B Cell Lymphoma |
Enrolling by invitation |
Diffuse Large B Cell Lymphoma |
NCT03383406 |
| Vinblastine and Methotrexate in Treating Children With Desmoid Tumors |
Completed |
Desmoid Tumor |
NCT00003019 |
| High-Dose Methotrexate in Treating Young Patients With Residual Ependymoma |
Unknown status |
Brain and Central Nervous System Tumors |
NCT00287924 |
| Food Effect, Oral & Intravenous Pharmacokinetics and Absolute Bioavailability of BAY1834845 Including Drug-drug Interaction With Methotrexate |
Completed |
Inflammation |
NCT03244462 |
| Methotrexate in Ankylosing Spondylitis (MTX in AS) |
Unknown status |
Ankylosing Spondylitis |
NCT00243750 |
| An Effectiveness and Safety Study of Intravenous Golimumab in Patients With Active Rheumatoid Arthritis Despite Treatment With Methotrexate Therapy |
Completed |
Arthritis, Rheumatoid |
NCT00973479 |
| A Study of RoActemra/Actemra (Tocilizumab) With or Without Methotrexate in Patients With Mild to Moderate Rheumatoid Arthritis With an Inadequate Response to Methotrexate |
Completed |
Rheumatoid Arthritis |
NCT01587989 |
| Methotrexate in the Treatment of Axial Spondyloarthritis |
Withdrawn |
Spondylarthropathies|Spondylitis, Ankylosing |
NCT00298012 |
| Dose Response and Safety Study of Topical Methotrexate for the Treatment of Fingernail Psoriasis |
Unknown status |
Fingernail Psoriasis |
NCT00666354 |
| A Study to Investigate BMS-986165 and Methotrexate in Healthy Male Patients |
Completed |
Lupus|Psoriatic Arthritis |
NCT03402087 |
| A Study With Tocilizumab [RoActemra/Actemra] Monotherapy or in Combination With Methotrexate in Patients With Rheumatoid Arthritis (PICTURE) |
Completed |
Rheumatoid Arthritis |
NCT01063062 |
| Study of Methotrexate Efficacy Versus Cyclosporine in Moderate to Severe Atopic Dermatitis Patients |
Completed |
Atopic Dermatitis |
NCT00809172 |
| Corticosteroids and Anti TNF in Methotrexate Inadequate Responder Rheumatoid Arthritis Patient |
Unknown status |
RHEUMATOID ARTHRITIS |
NCT01724268 |
| Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis |
Completed |
Ulcerative Colitis |
NCT01393405 |
| Long-term Treatment Study of Certolizumab Pegol (CDP870) as Add-on Medication to Methotrexate in Japanese Rheumatoid Arthritis (RA) Patients |
Completed |
Rheumatoid Arthritis |
NCT00851318 |
| Open-label Leucovorin Pharmacokinetic Study in Patients Receiving High Dose Methotrexate With or Without Voraxaze |
Completed |
Osteosarcoma|Leukemia|Lymphoma |
NCT00634504 |
| GLPG0259 Multiple Ascending Dose and Methotrexate Drug-drug Interaction (DDI) in Healthy Subjects |
Completed |
Healthy |
NCT00989703 |
| Methotrexate Compared With Dactinomycin in Treating Patients With Gestational Trophoblastic Neoplasia |
Completed |
Good Prognosis Metastatic Gestational Trophoblastic Tumor|Hydatidiform Mole|Non-Metastatic Gestational Trophoblastic Tumor|Uterine Corpus Choriocarcinoma |
NCT00003702 |
| Infliximab and Methotrexate in Ankylosing Spondylitis |
Completed |
Ankylosing Spondylitis |
NCT00507403 |
| Different Dose of Methotrexate for the Treatment of Meningeal Carcinomatosis |
Unknown status |
Meningeal Carcinomatosis |
NCT02590510 |
| The Effect of Methotrexate on Sperm Quality in Men With Inflammatory Bowel Disease |
Recruiting |
Inflammatory Bowel Disease (IBD) |
NCT02461784 |
| Efficacy of Methotrexate in Myasthenia Gravis |
Completed |
Myasthenia Gravis |
NCT00814138 |
| A Clinical Trial in Patients With Breast Cancer Susceptibility Gene (BRCA) Defective Tumours |
Completed |
Breast Cancer|Ovarian Cancer |
NCT01432145 |
| Multicenter Randomized Prospective Trial Comparing Methotrexate Alone or in Combination With Adalimumab in Early Arthritis |
Unknown status |
Rheumatoid Arthritis|Arthritis |
NCT00291915 |
| Pharmacologic Study of Methotrexate in Patients Undergoing Stereotactic Biopsy for Recurrent High-Grade Glioma |
Completed |
Brain and Central Nervous System Tumors |
NCT00463008 |
| Trial of Low-Dose Methotrexate and I 131 Tositumomab for Previously Untreated, Advanced-Stage, Follicular Lymphoma |
Terminated |
Follicular Lymphoma |
NCT01389076 |
| A Study of the Combination of Cetuximab and Methotrexate in Recurrent or Metastatic Cancer of the Head and Neck |
Active, not recruiting |
Squamous Cell Carcinoma of the Head and Neck |
NCT02054442 |
| A Synovial Biopsy Study of JNJ-38518168 in Participants With Active Rheumatoid Arthritis Despite Methotrexate Therapy |
Terminated |
Rheumatoid Arthritis |
NCT01862224 |
| Long-term Efficacy of Iguratimod Alone or Iguratimod in Combination With Methotrexate in Patients With Rheumatoid Arthritis |
Unknown status |
Rheumatoid Arthritis |
NCT01548001 |
| Phase III Trial Comparing Methotrexate and Cetuximab in First-line Treatment of Recurrent and/or Metastatic Squamous Cell Head and Neck Cancer |
Active, not recruiting |
Head Neck Cancer Squamous Cell Recurrent |
NCT01884623 |
| Cyclophosphamide Versus Methotrexate for Remission Maintenance in Systemic Necrotizing Vasculitides |
Unknown status |
Wegener's Granulomatosis|Churg-Strauss Syndrome|Microscopic Polyangiitis|Polyarteritis Nodosa |
NCT00751517 |
| Sirolimus/Tacrolimus Versus Tacrolimus/Methotrexate for Preventing Graft-Versus-Host Disease (GVHD) (BMT CTN 0402) |
Completed |
Leukemia, Myelocytic, Acute|Leukemia, Lymphocytic, Acute|Leukemia, Myeloid, Chronic|Myelodysplastic Syndromes |
NCT00406393 |
| FibroScan ® Study: Assessing Liver Fibrosis in Patients Using Methotrexate for Psoriasis |
Withdrawn |
Psoriasis |
NCT03820934 |
| SB-681323-Methotrexate Interaction Study |
Completed |
Arthritis, Rheumatoid |
NCT00419809 |
| Methotrexate and Metformin in Rheumatoid Arthritis Patients |
Not yet recruiting |
Arthritis, Rheumatoid |
NCT04196868 |
| Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Inadequately Responding to Methotrexate |
Completed |
Rheumatoid Arthritis |
NCT01500278 |
| A Study of Tocilizumab as Monotherapy and in Combination With Methotrexate Versus Methotrexate in Patients With Early Moderate to Severe Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT01007435 |
| Sequential Administration of Oral 6-Thioguanine (6-TG) After Methotrexate (MTX) in Patients With Relapsed Hodgkin's Disease (Phase II) |
Completed |
Hodgkin's Disease |
NCT00587873 |
| LUX-Head&Neck 3: Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy |
Active, not recruiting |
Head and Neck Neoplasms |
NCT01856478 |
| Kidney Dysfunction in Children and Young Adults Who Have Received Methotrexate for Acute Lymphoblastic Leukemia |
Completed |
Leukemia|Renal Toxicity |
NCT00993135 |
| Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological Malignancies |
Completed |
Accelerated Phase Chronic Myelogenous Leukemia|Adult Acute Myeloid Leukemia in Remission|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Del(5q)|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)|Adult Grade III Lymphomatoid Granulomatosis|B-cell Chronic Lymphocytic Leukemia|Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Chronic Myelomonocytic Leukemia|Chronic Phase Chronic Myelogenous Leukemia|Contiguous Stage II Adult Burkitt Lymphoma|Contiguous Stage II Adult Diffuse Large Cell Lymphoma|Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma|Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma|Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma|Contiguous Stage II Adult Lymphoblastic Lymphoma|Contiguous Stage II Grade 1 Follicular Lymphoma|Contiguous Stage II Grade 2 Follicular Lymphoma|Contiguous Stage II Grade 3 Follicular Lymphoma|Contiguous Stage II Mantle Cell Lymphoma|Contiguous Stage II Marginal Zone Lymphoma|Contiguous Stage II Small Lymphocytic Lymphoma|Cutaneous B-cell Non-Hodgkin Lymphoma|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue|Graft Versus Host Disease|Intraocular Lymphoma|Myelodysplastic Syndrome With Isolated Del(5q)|Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable|Nodal Marginal Zone B-cell Lymphoma|Noncontiguous Stage II Adult Burkitt Lymphoma|Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma|Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma|Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma|Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma|Noncontiguous Stage II Adult Lymphoblastic Lymphoma|Noncontiguous Stage II Grade 1 Follicular Lymphoma|Noncontiguous Stage II Grade 2 Follicular Lymphoma|Noncontiguous Stage II Grade 3 Follicular Lymphoma|Noncontiguous Stage II Mantle Cell Lymphoma|Noncontiguous Stage II Marginal Zone Lymphoma|Noncontiguous Stage II Small Lymphocytic Lymphoma|Post-transplant Lymphoproliferative Disorder|Primary Central Nervous System Hodgkin Lymphoma|Primary Central Nervous System Non-Hodgkin Lymphoma|Recurrent Adult Acute Myeloid Leukemia|Recurrent Adult Burkitt Lymphoma|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent Adult Diffuse Mixed Cell Lymphoma|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma|Recurrent Adult Grade III Lymphomatoid Granulomatosis|Recurrent Adult Hodgkin Lymphoma|Recurrent Adult Immunoblastic Large Cell Lymphoma|Recurrent Adult Lymphoblastic Lymphoma|Recurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Grade 3 Follicular Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Marginal Zone Lymphoma|Recurrent Small Lymphocytic Lymphoma|Refractory Anemia|Refractory Anemia With Excess Blasts|Refractory Anemia With Ringed Sideroblasts|Refractory Chronic Lymphocytic Leukemia|Refractory Cytopenia With Multilineage Dysplasia|Refractory Hairy Cell Leukemia|Relapsing Chronic Myelogenous Leukemia|Secondary Central Nervous System Hodgkin Lymphoma|Secondary Central Nervous System Non-Hodgkin Lymphoma|Small Intestine Lymphoma|Splenic Marginal Zone Lymphoma|Stage I Adult Burkitt Lymphoma|Stage I Adult Diffuse Large Cell Lymphoma|Stage I Adult Diffuse Mixed Cell Lymphoma|Stage I Adult Diffuse Small Cleaved Cell Lymphoma|Stage I Adult Hodgkin Lymphoma|Stage I Adult Immunoblastic Large Cell Lymphoma|Stage I Adult Lymphoblastic Lymphoma|Stage I Chronic Lymphocytic Leukemia|Stage I Grade 1 Follicular Lymphoma|Stage I Grade 2 Follicular Lymphoma|Stage I Grade 3 Follicular Lymphoma|Stage I Mantle Cell Lymphoma|Stage I Marginal Zone Lymphoma|Stage I Small Lymphocytic Lymphoma|Stage II Adult Hodgkin Lymphoma|Stage II Chronic Lymphocytic Leukemia|Stage III Adult Burkitt Lymphoma|Stage III Adult Diffuse Large Cell Lymphoma|Stage III Adult Diffuse Mixed Cell Lymphoma|Stage III Adult Diffuse Small Cleaved Cell Lymphoma|Stage III Adult Hodgkin Lymphoma|Stage III Adult Immunoblastic Large Cell Lymphoma|Stage III Adult Lymphoblastic Lymphoma|Stage III Chronic Lymphocytic Leukemia|Stage III Grade 1 Follicular Lymphoma|Stage III Grade 2 Follicular Lymphoma|Stage III Grade 3 Follicular Lymphoma|Stage III Mantle Cell Lymphoma|Stage III Marginal Zone Lymphoma|Stage IV Adult Burkitt Lymphoma|Stage IV Adult Diffuse Large Cell Lymphoma|Stage IV Adult Diffuse Mixed Cell Lymphoma|Stage IV Adult Diffuse Small Cleaved Cell Lymphoma|Stage IV Adult Hodgkin Lymphoma|Stage IV Adult Immunoblastic Large Cell Lymphoma|Stage IV Adult Lymphoblastic Lymphoma|Stage IV Chronic Lymphocytic Leukemia|Stage IV Grade 1 Follicular Lymphoma|Stage IV Grade 2 Follicular Lymphoma|Stage IV Grade 3 Follicular Lymphoma|Stage IV Mantle Cell Lymphoma|Stage IV Marginal Zone Lymphoma|Stage IV Small Lymphocytic Lymphoma|Testicular Lymphoma|Waldenström Macroglobulinemia |
NCT01789255 |
| Glucarpidase After High-Dose Methotrexate in Patients With Osteosarcoma |
Recruiting |
Osteosarcoma |
NCT03960177 |
| A Double Blind Study in Pediatric Subjects With Chronic Plaque Psoriasis, Studying Adalimumab vs. Methotrexate |
Completed |
Plaque Psoriasis |
NCT01251614 |
| A Phase III Study of Abatacept in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate |
Completed |
Rheumatoid Arthritis |
NCT00409838 |
| Study of Iguratimod Plus Methotrexate Compared to Leflunomid Plus Methotrexate in Patients With Rheumatoid Arthritis |
Unknown status |
Rheumatoid Arthritis |
NCT02275299 |
| A Study of the EP4 Antagonist CR6086 in Combination With Methotrexate, in DMARD-naĂŻve Patients With Early Rheumatoid Arthritis |
Unknown status |
Rheumatoid Arthritis, DMARD-naive and Early Disease Patients |
NCT03163966 |
| Phase II Open-Label Trial of Tacrolimus/Methotrexate and Tocilizumab for the Prevention of Acute Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation |
Completed |
Hematopoietic Stem Cell Transplantation |
NCT02206035 |
| A Study Comparing Biologics + Methotrexate With Biologics + Tacrolimus in Patients With Rheumatoid Arthritis (RA) |
Recruiting |
Rheumatoid Arthritis (RA) |
NCT03737708 |
| A Study of the Effects of RoActemra/Actemra on Vaccination in Patients With Rheumatoid Arthritis on Background Methotrexate (VISARA) |
Completed |
Rheumatoid Arthritis |
NCT01163747 |
| A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naĂŻve Adults With Early Active Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT01521923 |
| Safety and Effectiveness of Low-Dose Methotrexate for Reducing Inflammation in HIV-Infected Adults on ARV Medications |
Completed |
HIV Infections |
NCT01949116 |
| Prediction of Methotrexate Response - A Pilot Study |
Unknown status |
Rheumatoid Arthritis|Rheumatic Diseases |
NCT01726959 |
| Adnexal Mass After Methotrexate Treatment for Ectopic Pregnancies |
Unknown status |
Ectopic Pregnancies |
NCT03138694 |
| Evaluation of the Impact of 3 Methods of Communication on the Adherence of Methotrexate in Patients With Rheumatoid Arthritis |
Unknown status |
Methotrexate|Polyarthritis; Rheumatoid |
NCT03107299 |
| Effect of Food, Rabeprazole, Methotrexate and Formulation on the Pharmacokinetics (PK) of GDC-0853 and the Effect of GDC-0853 on the PK of Methotrexate in Healthy Subjects |
Completed |
Healthy Volunteer |
NCT02699710 |
| Study of Methotrexate in Lupus Erythematosus |
Completed |
Systemic Lupus Erythematosus |
NCT00470522 |
| Methotrexate, Blood Pressure and Arterial Function in Rheumatoid Arthritis |
Recruiting |
Rheumatoid Arthritis|Stiffness, Aortic|Endothelial Dysfunction|Cardiovascular Risk Factor |
NCT03254589 |
| LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy |
Completed |
Head and Neck Neoplasms|Carcinoma, Squamous Cell |
NCT01345682 |
| A Study to Compare Upadacitinib (ABT-494) Monotherapy to Methotrexate (MTX) Monotherapy in Adults With Rheumatoid Arthritis (RA) Who Have Not Previously Taken Methotrexate |
Active, not recruiting |
Rheumatoid Arthritis |
NCT02706873 |
| Ticagrelor in Methotrexate-Resistant Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT02874092 |
| The Aromatase Inhibitor and Gnrh Antagonist Versus Methotrexate for Management of Undisturbed Ectopic Pregnancy |
Not yet recruiting |
Ectopic Pregnancy |
NCT04308343 |
| Pharmacokinetic Analysis of High Dose Methotrexate in Pediatric Lymphoblastic Malignancies |
Completed |
Methotrexate Adverse Reaction |
NCT02011022 |
| Inflammation Control For Elders: ICE Study |
Withdrawn |
Inflammation|Aging |
NCT02079948 |
| Study of Different Doses of Folic Acid in Combination With Methotrexate in Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT01583959 |
| Dactinomycin or Methotrexate in Treating Patients With Low-Risk Gestational Trophoblastic Neoplasia |
Active, not recruiting |
Choriocarcinoma|FIGO Stage I Gestational Trophoblastic Tumor|FIGO Stage II Gestational Trophoblastic Tumor|FIGO Stage III Gestational Trophoblastic Tumor|Hydatidiform Mole |
NCT01535053 |
| A Study of the Safety and Efficacy of Golimumab in Subjects With Rheumatoid Arthritis That Are Methotrexate-naive |
Completed |
Rheumatoid Arthritis |
NCT00264537 |
| Study Comparing Two Treatments in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck |
Completed |
Squamous Cell Carcinoma of the Head and Neck |
NCT01528163 |
| Pharmacovigilance in Juvenile Idiopathic Arthritis Patients Treated With Biologic Agents and/or Methotrexate |
Recruiting |
Juvenile Idiopathic Arthritis |
NCT01399281 |
| Comparison of Methotrexate vs Placebo in Corticosteroid-dependent Ulcerative Colitis |
Completed |
Ulcerative Colitis |
NCT00498589 |
| MEthotrexate Versus TOcilizumab for Treatment of GIant Cell Arteritis: a Multicenter, Randomized, Controlled Trial |
Recruiting |
Giant Cell Arteritis |
NCT03892785 |
| Effectiveness Of Expectant Management In The Tubal Ectopic Pregnancy |
Completed |
Ectopic Pregnancy |
NCT01876004 |
| Study Of The Safety Of CE 224,545 And Methotrexate In Patients With Rheumatoid Arthritis |
Completed |
Arthritis, Rheumatoid |
NCT00446784 |
| Efficacy and Safety of Adalimumab and Methotrexate (MTX) Versus MTX Monotherapy in Subjects With Early Rheumatoid Arthritis |
Completed |
Early Rheumatoid Arthritis |
NCT00195663 |
| Efficacy and Safety of Fecal Microbiota Transplantation in Patients With Rheumatoid Arthritis Refractory to Methotrexate |
Recruiting |
Rheumatoid Arthritis |
NCT03944096 |
| Study to Evaluate the Efficacy and Safety of Orally Administered Rob 803 When Added to Methotrexate |
Completed |
Rheumatoid Arthritis |
NCT00525213 |
| Tacrolimus Versus Methotrexate as Rescue Therapy for Refractory Inflammatory Bowel Disease |
Unknown status |
Inflammatory Bowel Diseases |
NCT03204136 |
| Andecaliximab as Add-On Therapy to a Tumor Necrosis Factor Inhibitor and Methotrexate Regimen in Adults With Moderately to Severely Active Rheumatoid Arthritis |
Terminated |
Rheumatoid Arthritis |
NCT02862574 |
| A Study to Assess the Effect of Tocilizumab + Methotrexate on Prevention of Structural Joint Damage in Patients With Moderate to Severe Active Rheumatoid Arthritis (RA) |
Completed |
Rheumatoid Arthritis |
NCT00106535 |
| Comparing Methotrexate Followed by Misoprostol to Misoprostol Alone for Early Abortion |
Completed |
Unwanted Pregnancies |
NCT00129506 |
| Methotrexate Polyglutamate Levels as a Marker for the Clinical Outcome in the Treatment of Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT00695188 |
| A Study of Safety and Efficacy Comparing ABT-874 Versus Methotrexate in Subjects With Moderate to Severe Plaque Psoriasis |
Completed |
Psoriasis |
NCT00679731 |
| A Drug Interaction Study Between Tocilizumab, Methotrexate and Simvastatin on Patients With Rheumatoid Arthritis. |
Completed |
Rheumatoid Arthritis |
NCT00365001 |
| Bortezomib Plus Tacrolimus and Methotrexate to Prevent Graft Versus Host Disease (GVHD) After Mismatched Allogeneic Non-Myeloablative Blood Stem Cell Transplantation |
Completed |
Hematologic Malignancies |
NCT00369226 |
| Liposomal Cytarabine and High-Dose Methotrexate in Treating Patients With Central Nervous System Metastases From Breast Cancer |
Completed |
Central Nervous System Metastases|Leptomeningeal Metastases|Recurrent Breast Cancer|Stage IV Breast Cancer|Tumors Metastatic to Brain |
NCT00992602 |
| A Study of MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to Anti-TNF Therapies. |
Completed |
Rheumatoid Arthritis |
NCT00462345 |
| Sunitinib, Cyclophosphamide, and Methotrexate in Treating Patients With Metastatic Breast Cancer |
Terminated |
Breast Cancer |
NCT00616122 |
| Study Evaluating Efficacy / Safety of Etanercept + Methotrexate Compared to Usual Treatment in Moderate RA Subjects |
Terminated |
Rheumatoid Arthritis |
NCT00706797 |
| Phase 2a Study to Evaluate Suppression of Methotrexate-induced Mucositis by TK112690 |
Active, not recruiting |
Mucositis |
NCT04046250 |
| Study to Determine the Effects of Different Doses of Methotrexate (MTX) When Taken With Adalimumab in Subjects With Early Rheumatoid Arthritis (RA) |
Completed |
Early Rheumatoid Arthritis |
NCT01185301 |
| Efficacy of Golimumab in Combination With Methotrexate (Mtx) Versus Mtx Monotherapy, in Improving Dactylitis, in Mtx naĂŻve Psoriatic Arthritis Patients |
Completed |
Psoriatic Arthritis |
NCT02065713 |
| Treatment Adherence to Injectable Methotrexate in Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT02897817 |
| A Phase 3 Trial of Brentuximab Vedotin(SGN-35) Versus Physician's Choice (Methotrexate or Bexarotene) in Participants With CD30-Positive Cutaneous T-Cell Lymphoma (ALCANZA Study) |
Completed |
Primary Cutaneous Anaplastic Large Cell Lymphoma|Mycosis Fungoides|Cutaneous T-Cell Lymphoma |
NCT01578499 |
| Tacrolimus and Mycophenolate Mofetil (MMF) in GVHD Prophylactic Regimen Compared to Tacrolimus and Methotrexate (MTX |
Completed |
Mucositis|Graft-versus-host Disease |
NCT00360685 |
| Phase I/II Study of Pentostatin Combined With Tacrolimus and Mini-Methotrexate for GVHD Prevention After MUD BMT |
Completed |
Leukemia|Lymphoma |
NCT00506922 |
| Validation Study of RA-INF-Dx, a Multigene Molecular Test Used to Predict Non-Response to INfliximab Therapy |
Terminated |
Rheumatoid Arthritis |
NCT01299545 |
| An Efficacy And Safety Study of CNTO 6785 In Participants With Active Rheumatoid Arthritis Despite Methotrexate Therapy |
Completed |
Rheumatoid Arthritis |
NCT01909427 |
| Graft-Versus-Host Disease (GVHD) Prophylaxis After Allogeneic Peripheral Blood Hematopoietic Cell Transplantation |
Completed |
Acute Graft Versus Host Disease |
NCT00803010 |
| A Study of Imatinib 400 mg Once Daily in Combination With Methotrexate in the Treatment of Rheumatoid Arthritis. |
Completed |
Rheumatoid Arthritis |
NCT00154336 |
| Comparison of Single and Multiple-dose Methotrexate Therapy for Ectopic Pregnancy |
Completed |
Pregnancy, Ectopic |
NCT01662167 |
| Effects of Concomitant Administration of BMS-986195 on Methotrexate, Caffeine, Montelukast, Flurbiprofen, Omeprazole, Midazolam, Digoxin, and Pravastatin |
Completed |
Rheumatoid Arthritis |
NCT03131973 |
| An Efficacy and Safety Study of Golimumab in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy |
Completed |
Rheumatoid Arthritis |
NCT00264550 |
| Evaluate Whether Combination Therapy With Methotrexate and Raptiva in Psoriasis Patients is Safe and Increases Efficacy |
Completed |
Psoriasis |
NCT00368654 |
| Evaluation of the Effectiveness and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Have Active Disease |
Completed |
Rheumatoid Arthritis |
NCT02760368 |
| An Observational Study of Rituximab in Combination With Methotrexate in Participants With Active Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT01283399 |
| Pegaspargase and Methotrexate Based Regimens for Newly Diagnosed Extranodal NK/T Cell Lymphoma |
Completed |
Nasal Type Extranodal NK/T-Cell Lymphoma |
NCT02825147 |
| WEGENT - Comparison of Methotrexate or Azathioprine as Maintenance Therapy for ANCA-Associated Vasculitides |
Unknown status |
Systemic Wegener's Granulomatosis |
NCT00349674 |
| Applications for Methotrexate Optimization in Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT01038349 |
| A Study to Evaluate the Efficacy and Safety of Mabthera Alone and in Combination With Either Cyclophosphamide or Methotrexate in Patients With Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT02693210 |
| A Phase III Study of Abatacept (BMS-188667) in Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate |
Completed |
Rheumatoid Arthritis |
NCT00048568 |
| 2-week dc of MTX and Influenza Vaccination in RA |
Unknown status |
Rheumatoid Arthritis|Influenza|Methotrexate |
NCT02897011 |
| Phase 1b Study of PLX5622 in Rheumatoid Arthritis Patients Who Are Receiving Methotrexate |
Completed |
Rheumatoid Arthritis |
NCT01329991 |
| A Study to Evaluate the Efficacy and Safety of ASP1707 in Postmenopausal Female Patients With Rheumatoid Arthritis Taking Methotrexate |
Completed |
Rheumatoid Arthritis |
NCT02884635 |
| Tacrolimus, Sirolimus and Methotrexate as Graft Versus Host Disease Prophylaxis After Blood Stem Cell Transplantation |
Completed |
Graft Versus Host Disease|Hematologic Malignancies |
NCT00146614 |
| Combination Chemotherapy in Treating Patients With Neurofibromatosis and Progressive Plexiform Neurofibromas |
Completed |
Neurofibromatosis Type 1|Precancerous Condition |
NCT00030264 |
| A Phase 3 Study of Abatacept in Chinese Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate |
Unknown status |
Rheumatoid Arthritis (RA) |
NCT02722694 |
| A Study of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to Non-biologic DMARDs |
Completed |
Rheumatoid Arthritis |
NCT01353859 |
| A Safety and Efficacy Study of Golimumab (CNTO 148) in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy |
Completed |
Rheumatoid Arthritis |
NCT00727987 |
| Vorinostat Plus Tacrolimus & Methotrexate to Prevent Graft vs Host Disease Following Unrelated Stem Cell Transplant |
Completed |
Graft vs Host Disease|Hematologic Neoplasms|Non-Neoplastic Hematologic and Lymphocytic Disorder |
NCT01790568 |
| Study of the Optimal Protocol for Methotrexate and Adalimumab Combination Therapy in Early Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT00420927 |
| Remission and Joint Damage Progression in Early Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT00122382 |
| Multiple Ascending Dose Study of BMS-582949 in Patients With Stable Rheumatoid Arthritis on the Methotrexate Background |
Completed |
Rheumatoid Arthritis |
NCT00162292 |
| Study of Tocilizumab in Combination With Methotrexate for Treatment of Moderate to Severe Rheumatoid Arthritis Patients |
Completed |
Rheumatoid Arthritis (RA) |
NCT01258712 |
| A Study of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to Disease-Modifying Antirheumatic Drugs (DMARDs) (ALABASTER) |
Completed |
Rheumatoid Arthritis |
NCT01235507 |
| Study Comparing Etanercept and Methotrexate vs. Methotrexate Alone in Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT00195494 |
| Actual Human Use of Methotrexate (MTX) Subcutaneously Administered Via the VIBEX™ MTX Auto-Injector Device |
Completed |
Rheumatoid Arthritis (RA) |
NCT01618955 |
| A Study of Subjects With Psoriatic Arthritis to Investigate the Effectiveness of Adalimumab Introduction Compared With Methotrexate Dose Escalation (CONTROL) |
Completed |
Psoriatic Arthritis |
NCT02814175 |
| Methotrexate, Mannitol, Rituximab, and Carboplatin in Treating Patients With Newly Diagnosed Primary Central Nervous System Lymphoma |
Recruiting |
Central Nervous System Lymphoma |
NCT00293475 |
| ACTHAR for Acute Treatment of Rheumatoid Arthritis Patients With Inadequate Response to Methotrexate |
Unknown status |
Rheumatoid Arthritis |
NCT01984268 |
| A Study of Tocilizumab and Methotrexate in Combination or as Monotherapy in Treatment-NaĂŻve Patients With Early Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT01034137 |
| Comparing ATG or Post-Transplant Cyclophosphamide to Calcineurin Inhibitor-Methotrexate as GVHD Prophylaxis After Myeloablative Unrelated Donor Peripheral Blood Stem Cell Transplantation |
Not yet recruiting |
Acute Lymphoblastic Leukemia in Remission|Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome|Acute Myeloid Leukemia in Remission|Blasts 5 Percent or Less of Bone Marrow Nucleated Cells|Chronic Myelomonocytic Leukemia|Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Donor|Minimal Residual Disease|Myelodysplastic Syndrome|Myelofibrosis|Myeloproliferative Neoplasm|Recurrent Acute Myeloid Leukemia|Recurrent Hodgkin Lymphoma|Recurrent Non-Hodgkin Lymphoma|Refractory Acute Myeloid Leukemia|Therapy-Related Acute Myeloid Leukemia |
NCT03602898 |
| A Study to Assess Immune Response Following Zoster Vaccination to Subjects With Rheumatoid Arthritis Receiving Tofacitinib or Placebo With Background Methotrexate |
Completed |
Rheumatoid Arthritis |
NCT02147587 |
| Methotrexate, Vincristine, Pegylated L-Asparaginase and Dexamethasone (MOAD) in Acute Lymphoblastic Leukemia (ALL) Salvage |
Completed |
Leukemia, Lymphocytic, Acute |
NCT00905034 |
| Methotrexate With or Without Cyclophosphamide in Treating Patients With Lymphocytic Leukemia |
Terminated |
Leukemia |
NCT00003910 |
| A Pharmacokinetic Study to Determine the Oral Bioavailability of Methotrexate in Patients With Inflammatory Bowel Disease |
Completed |
Inflammatory Bowel Disease |
NCT00035074 |
| Dose-ranging Study With GLPG0634 in Methotrexate-refractory Active Rheumatoid Arthritis Patients |
Completed |
Rheumatoid Arthritis |
NCT01668641 |
| A Study to Evaluate the Effects of Rituximab on Immune Responses in Subjects With Active Rheumatoid Arthritis Receiving Background Methotrexate |
Completed |
Rheumatoid Arthritis |
NCT00282308 |
| GLPG0259 in Methotrexate-refractory Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT01211249 |
| Dose-finding Study of GLPG0634 as add-on to Methotrexate in Active Rheumatoid Arthritis Patients (DARWIN1) |
Completed |
Rheumatoid Arthritis |
NCT01888874 |
| Dose Effect Relationship of MTX and IBD |
Completed |
Inflammatory Bowel Diseases|Liver Fibroses|Methotrexate |
NCT03531593 |
| Reduced IV Fluids to Improve Clearance of HDMTX in Children w/Lymphoma or Acute Lymphoblastic Leukemia |
Recruiting |
Lymphoma|Acute Lymphoblastic Leukemia|Pediatric Cancer|Pediatric ALL|Pediatric Lymphoma |
NCT03964259 |
| Aggressive Combination Drug Therapy in Very Early Polyarticular Juvenile Idiopathic Arthritis |
Completed |
Juvenile Idiopathic Arthritis |
NCT01015547 |
| Therapeutic Strategy in Patients Treated With Methotrexate for Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT02288520 |
| Rituximab, Methotrexate, Procarbazine and Vincristine Followed by High-dose Chemotherapy With Autologous Stem-cell Rescue in Newly-diagnosed Primary CNS Lymphoma |
Active, not recruiting |
CNS Lymphoma|CNS Brain Cancer|Non-Hodgkin's Lymphoma |
NCT00596154 |
| A Study on Safety and Efficacy of Tocilizumab (RoActemra/Actemra) Alone or in Combination With Non-Biologic Antirheumatics in Participants With Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT01987479 |
| A Study to Assess the Effect of Tocilizumab Plus Methotrexate on Safety and Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT00754572 |
| Methotrexate Single-dose Treatment and Methotrexate/Actinomycin-D Single-dose Treatment in Low-Risk Gestational Trophoblastic Neoplasia |
Active, not recruiting |
Gestational Trophoblastic Disease|Gestational Trophoblastic Neoplasia|Gestational Trophoblastic Tumor|Gestational Trophoblastic Neoplasms |
NCT01823315 |
| Triple Combination Therapy in High Risk Crohn's Disease (CD) |
Recruiting |
Crohn Disease |
NCT02764762 |
| Efficacy and Safety of TAK-783 in Subjects With Rheumatoid Arthritis |
Completed |
Arthritis, Rheumatoid |
NCT00760968 |
| A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate |
Completed |
Rheumatoid Arthritis |
NCT00934648 |
| Methotrexate Plus Dipyridamole in Treating Patients With Advanced Ovarian Cancer |
Unknown status |
Ovarian Cancer |
NCT00002487 |
| High-Dose Methotrexate and Leucovorin in Treating Patients With Newly Diagnosed Glioblastoma Multiforme |
Completed |
Brain and Central Nervous System Tumors |
NCT00082797 |
| The Effect of Low Dose Aspirin on the Pharmacokinetics of Methotrexate |
Unknown status |
Rheumatoid Arthritis |
NCT00464997 |
| A Study to Evaluate Rituximab in Combination With Methotrexate in Methotrexate-Naive Patients With Active Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT00299104 |
| Triple III Comparison of Leflunomide Alone Versus Two DMARD Combinations in the Treatment of Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT00579878 |
| Steroids and Methotrexate to Treat Systemic Vasculitis |
Completed |
Inflammation|Vasculitis|Wegener's Granulomatosis |
NCT00001256 |
| Cardiac Sarcoidosis Randomized Trial |
Recruiting |
Cardiac Sarcoidosis|Sarcoidosis |
NCT03593759 |
| Pharmacokinetics of Adalimumab With Methotrexate for Treatment of Patients With Ulcerative Colitis (UC) |
Active, not recruiting |
Ulcerative Colitis |
NCT01716039 |
| Evaluation of Pharmacokinetics and Safety of GSK3196165 in Combination With Methotrexate in Japanese Subjects With Rheumatoid Arthritis |
Completed |
Arthritis, Rheumatoid |
NCT03028467 |
| Comparison of Combination Disease Modifying Antirheumatic Drugs With Methotrexate Therapy in Early Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT02644499 |
| A Study of Certolizumab Pegol as Additional Therapy in Chinese Patients With Active Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT02151851 |
| Dose Finding Study of Namilumab in Combination With Methotrexate in Participants With Moderate to Severe Rheumatoid Arthritis (RA) |
Completed |
Rheumatoid Arthritis |
NCT02379091 |
| Study to Investigate the Effect of BMS-986142 on the Pharmacokinetics (PK) of Methotrexate and Probe Substrate Cocktail in Healthy Patients |
Completed |
Rheumatoid Arthritis |
NCT02456844 |
| A Study of CDP870 as Add-on Meditation to Methotrexate (MTX) in Patients With Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT00993317 |
| Study of the Safety of MDX-1342 in Combination With Methotrexate in Patients With Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT00639834 |
| Study of 6-Thioguanine in Combination With 6-Mercaptopurine During Maintenance Therapy of Childhood Lymphoma |
Withdrawn |
Non-Hodgkin Lymphoma |
NCT02141100 |
| A Dose Range Finding Study of JNJ-38518168 in Patients With Active Rheumatoid Arthritis in Spite of Treatment With Methotrexate |
Terminated |
Rheumatoid Arthritis |
NCT01679951 |
| A Study of Safety and Effectiveness of Golimumab in Participants With Active Rheumatoid Arthritis Despite Methotrexate Therapy |
Completed |
Rheumatoid Arthritis |
NCT00361335 |
| A Study of MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to Anti-TNF Agents. |
Completed |
Rheumatoid Arthritis |
NCT00504777 |
| A Study to Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid Arthritis Subjects Who Have Had an Inadequate Response to Methotrexate |
Completed |
Arthritis, Rheumatoid |
NCT01554696 |
| Study Evaluating Etanercept and Methotrexate in Plaque Psoriasis |
Completed |
Psoriasis|Arthritis, Psoriatic |
NCT00161655 |
| Study to Assess Efficacy of Tacrolimus + Methotrexate Versus Placebo + Methotrexate in Treatment of Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT00036153 |
| Assessment of Clinical Effectiveness and Safety of Adalimumab and High Dose Methotrexate in Routine Clinical Practice |
Completed |
Rheumatoid Arthritis |
NCT01736189 |
| Adalimumab in Combination With Methotrexate vs Methotrexate Alone in Early Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT00234845 |
| Evaluation of the Effectiveness and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo and Adalimumab, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Have Active Disease |
Recruiting |
Rheumatoid Arthritis |
NCT02760407 |
| Safety and Efficacy Study of Adalimumab in Adult Chinese Rheumatoid Arthritis Subjects Treated With Methotrexate |
Completed |
Rheumatoid Arthritis |
NCT00538902 |
| Tac, Mini-MTX, MMF Versus Tac, MTX for GVHD Prevention |
Recruiting |
Chronic Myelogenous Leukemia|Acute Lymphoblastic Leukemia|Acute Myeloid Leukemia|Acute Biphenotypic Leukemia|Myelodysplastic Syndrome|Myeloproliferative Neoplasm|Non-Hodgkin Lymphoma|Hodgkins Disease|Chronic Lymphocytic Leukemia|Multiple Myeloma |
NCT01951885 |
| Adalimumab Administered in Korean Rheumatoid Arthritis Subjects Treated With Methotrexate |
Completed |
Rheumatoid Arthritis |
NCT00235859 |
| Tacrolimus/Sirolimus/Methotrexate vs Tacrolimus/Methotrexate or Cyclosporine/Mycophenolate Mofetil for GVHD Prophylaxis After Reduced Intensity Allogeneic Stem Cell Transplantation for Patients With Lymphoma |
Completed |
Non-hodgkin Lymphoma|Hodgkin Lymphoma |
NCT00928018 |
| Efficacy and Safety of Etanercept in Active RA Despite Methotrexate Therapy in Japan |
Completed |
Rheumatoid Arthritis |
NCT00688103 |
| Study To Evaluate The Pharmacokinetic Interaction Between PLA-695 And Methotrexate In Adults With Rheumatoid Arthritis |
Completed |
Arthritis, Rheumatoid |
NCT00440492 |
| Methotrexate Compared With Paclitaxel in Treating Patients With Advanced Head and Neck Cancer |
Completed |
Head and Neck Cancer |
NCT00003592 |
| A Study of Retreatment With Rituximab in Patients With Rheumatoid Arthritis Receiving Background Methotrexate |
Completed |
Rheumatoid Arthritis |
NCT00266227 |
| Study of Sequential Administration of Oral 6-Thioguanine After Methotrexate in Patients With LCH |
Completed |
Langerhans Cell Histiocytosis |
NCT00588536 |
| Study Evaluating ERB-041 With Methotrexate in Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT00141830 |
| Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis |
Recruiting |
Metastatic Breast Cancer|Leptomeningeal Disease |
NCT02422641 |
| Medroxyprogesterone +/- Cyclophosphamide & Methotrexate in Hormone Receptor-Negative Recurrent/Metastatic Breast Cancer |
Completed |
Estrogen Receptor-negative Breast Cancer|Progesterone Receptor-negative Breast Cancer|Recurrent Breast Cancer|Stage IV Breast Cancer |
NCT00577122 |
| Comparative Clinical Trial of Efficacy and Safety of BCD-055 and Remicade® in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT02762838 |
| Study of the Efficacy and Safety of BCD-089 in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis |
Recruiting |
Rheumatoid Arthritis |
NCT04227366 |
| Methotrexate Followed by Fludarabine in Patients With T-Cell Large Granular Lymphocytic Leukemia |
Terminated |
T-Cell Large Granular Lymphocytic Leukemia |
NCT00278265 |
| Association Between Methotrexate Erythrocyte Polyglutamate Concentration and Clinical Response in Rheumatoid Arthritis Patients Treated With Subcutaneous Injectable Methotrexate |
Recruiting |
Rheumatoid Arthritis |
NCT03445871 |
| Impact of Concomitant MTX on Efficacy, Safety and Adherence of Ustekinumab-treatment in Patients With Active PsA |
Recruiting |
Psoriatic Arthritis |
NCT03148860 |
| A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ASP5094 Following Multiple Intravenous Doses in Subjects With Rheumatoid Arthritis on Methotrexate |
Completed |
Rheumatoid Arthritis (RA) |
NCT02698657 |
| A Pharmacokinetic and Pharmacodynamic Study of MabThera (Rituximab) Plus Methotrexate in Patients With Rheumatoid Arthritis (RA) |
Terminated |
Rheumatoid Arthritis |
NCT00422942 |
| A Study of Effectiveness and Safety of CNTO 136 in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy |
Completed |
Arthritis, Rheumatoid |
NCT00718718 |
| Comparison of Disease Modifying Antirheumatic Drugs Therapy in Patients With RA Failing Methotrexate Monotherapy |
Completed |
Rheumatoid Arthritis |
NCT02930343 |
| A Study Comparing Upadacitinib (ABT-494) Monotherapy to Methotrexate (MTX) Monotherapy in Adults With Rheumatoid Arthritis (RA) Who Have an Inadequate Response to MTX (SELECT-MONOTHERAPY) |
Active, not recruiting |
Rheumatoid Arthritis |
NCT02706951 |
| Methotrexate and Mycophenolate Mofetil for UVEITIS |
Completed |
Uveitis |
NCT01829295 |
| PET/CT Imaging Companion Study To ACTG A5314 |
Completed |
HIV|Inflammation|Atherosclerosis |
NCT02312219 |
| A Study of MabThera/Rituxan (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis and Inadequate Response to DMARD Therapy |
Completed |
Rheumatoid Arthritis |
NCT02006706 |
| A Trial of Anti-TNF Chimeric Monoclonal Antibody (cA2) in Korean Patients With Active Rheumatoid Arthritis Despite Methorexate (Extension Part)(Study P05645)(COMPLETED) |
Completed |
Arthritis, Rheumatoid |
NCT00732875 |
| Combination Therapy With Avonex and BiMonthly High Dose Intravenous Methotrexate in Multiple Sclerosis |
Completed |
Multiple Sclerosis |
NCT00037102 |
| Surgery Plus Single Agent Chemotherapy Versus Primary Chemotherapy for Gestational Trophoblastic Neoplasms |
Unknown status |
Gestational Trophoblastic Neoplasms |
NCT02606539 |
| A Multicenter Study to Compare the Efficacy and Safety of the Combination of Etanercept and Methotrexate in Treatment of Rheumatoid Arthritis |
Withdrawn |
Rheumatoid Arthritis |
NCT00783536 |
| Efficacy and Safety Study of KN019 in Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate |
Recruiting |
Rheumatoid Arthritis |
NCT04038970 |
| Safety and Efficacy of MK-8457 and Methotrexate (MTX) in Participants With Active Rheumatoid Arthritis Despite MTX Therapy (P08683, MK-8457-008) |
Terminated |
Rheumatoid Arthritis (RA) |
NCT01569152 |
| A Comparison of Methotrexate Alone or Combined to Infliximab or to Pulse Methylprednisolone in Early Rheumatoid Arthritis: A Magnetic Resonance Imaging Study |
Completed |
Rheumatoid Arthritis |
NCT00396747 |
| MAP Study: Methotrexate and Adalimumab in Psoriasis |
Completed |
Psoriasis |
NCT03217734 |
| Resistance to Methotrexate in Patients With Acute Lymphoblastic Leukemia in Relapse or Remission |
Completed |
Leukemia |
NCT00899899 |
| A Dose Escalation Study to Assess Safety, Tolerability and Pharmacokinetics of ASP2409 Following a Single Intravenous Dose in Patients With Rheumatoid Arthritis on Methotrexate |
Completed |
Rheumatoid Arthritis|Pharmacokinetics of ASP2409 |
NCT02171143 |
| Efficacy and Safety Study of MP-435 in Combination With Methotrexate (MTX) in Patients With Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT01143337 |
| Study Comparing Etanercept Plus Methotrexate to Either Etanercept or Methotrexate Alone in Rheumatoid Arthritis. |
Completed |
Active Rheumatoid Arthritis |
NCT00393471 |
| Safety and Tolerability Study of MBS2320 in Healthy Subjects and Subjects With Rheumatoid Arthritis |
Completed |
Arthritis, Rheumatoid |
NCT02480946 |
| Efficacy and Safety Study of BG00012 With Methotrexate in Patients With Active Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT00810836 |
| Juanbi Pill for Rheumatoid Arthritis |
Recruiting |
Juanbi Pill|Rheumatoid Arthritis |
NCT02885597 |
| Comparison of High-Dose Methotrexate (HDM) Plus Doxorubicin to HDM Plus Etoposide-Ifosfamide in Osteosarcoma Children |
Completed |
Osteosarcoma|Localised High Grade Osteosarcoma of the Limbs |
NCT00180908 |
| A Study To Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of ASP2408 After Multiple Dose Subcutaneous Injections in Patients With Rheumatoid Arthritis on Methotrexate |
Completed |
Rheumatoid Arthritis|Pharmacokinetics of ASP2408 |
NCT02052375 |
| A Phase I Study of Methotrexate for HIV Infection |
Completed |
HIV Infections |
NCT00000834 |
| Methotrexate, Trimetrexate Glucuronate, and Leucovorin in Treating Patients With Refractory or Recurrent Osteosarcoma |
Completed |
Sarcoma |
NCT00119301 |
| Abatacept Post-marketing Clinical Study in Japan |
Completed |
Rheumatoid Arthritis |
NCT01758198 |
| A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate |
Terminated |
Rheumatoid Arthritis |
NCT01198002 |
| 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours |
or speak with your personal physician. |
India|For additional information regarding investigative sites for this trial |
contact 1-877-CTLILLY (1-877-285-4559 |
| Methotrexate and Glucocorticoids in Treating Patients With Newly Diagnosed Acute Graft-Versus-Host Disease After Donor Stem Cell Transplant |
Completed |
Cancer |
NCT00357084 |
| Effect of Vitamin D Diffiency on Oral Mucosa in Patients Recieving Methotrexate Chemotherapy |
Not yet recruiting |
Acute Lymphoblastic Leukemia |
NCT04096846 |
| A Study To Evaluate The Safety And Pharmacokinetic Profile Of A P38 Inhibitor (PH-797804) In Subjects With Rheumatoid Arthritis Who Are Also Taking Methotrexate |
Completed |
Arthritis, Rheumatoid |
NCT00620685 |
| Methotrexate Alone Versus Combination of Methotrexate and Subcutaneous Fludarabine for Severe Rheumatoid Arthritis: Safety, Tolerance and Efficacy |
Completed |
Arthritis, Rheumatoid|Synovitis |
NCT00001677 |
| Study of Subcutaneous Golimumab in Chinese Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy |
Completed |
Rheumatoid Arthritis |
NCT01248780 |
| Namilumab vs Adalimumab in Participants With Moderate to Severe Early Rheumatoid Arthritis Inadequately Responding to Methotrexate |
Terminated |
Rheumatoid Arthritis |
NCT02393378 |
| Doxorubicin With Cisplatin, High-Dose Methotrexate, and Additional Risk-Adapted Outpatient Chemotherapy |
Terminated |
Osteosarcoma |
NCT00673179 |
| A Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate |
Completed |
Rheumatoid Arthritis |
NCT02141997 |
| A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate |
Completed |
Rheumatoid Arthritis |
NCT01000610 |
| Combination of Methotrexate(MTX) and Actinomycin(ACTD) in the Low Risk Gestational Trophoblastic Neoplasma ďĽGTN） Patients With Score of 5-6 |
Recruiting |
Gestational Trophoblastic Tumor|Effects of Chemotherapy|Drug Toxicity |
NCT03885388 |
| Methotrexate and Thiotepa in Treating Patients With Newly Diagnosed Primary CNS Lymphoma |
Completed |
Lymphoma |
NCT00045539 |
| Randomized Trial Comparing Sirolimus and Tacrolimus Versus Cyclosporine and Methotrexate as Graft-versus-host Disease (GVHD) Prophylaxis After Allogeneic Stem Cell Transplantation |
Completed |
Graft-versus-host Disease|Survival |
NCT00993343 |
| A Study of Ocrelizumab in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Are Naive to Methotrexate (FILM) |
Terminated |
Rheumatoid Arthritis |
NCT00485589 |
| Masitinib in Combination With Methotrexate, in Treatment of Patients With Active Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT00913432 |
| Evaluation of the Optimal MTX Dose as an Add-on Therapy to Adalimumab for RA Patients in Japan, South Korea and Taiwan |
Recruiting |
Rheumatoid Arthritis |
NCT03505008 |
| A Study to Evaluate Ocrelizumab Compared With Placebo in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate Therapy |
Terminated |
Rheumatoid Arthritis |
NCT00673920 |
| Study to Assess the Safety and Efficacy of Tacrolimus (Prograf Capsule/Injection) and Methotrexate (MTX) Combination Therapy for Prevention of Graft Versus Host Disease (GVHD) in Patients Who Received Peripheral Hematopoietic Stem Cell Transplantation From a Sibling Donor |
Completed |
Graft Versus Host Disease |
NCT02660684 |
| Study Evaluating the Efficacy and Safety of Etanercept and Methotrexate in Japanese Subjects With Rheumatoid Arthritis |
Completed |
Arthritis, Rheumatoid |
NCT00445770 |
| Study to Assess Changes in the Immune Profile in Adults With Early Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT02557100 |
| Methotrexate, Glucarpidase, and Leucovorin in Treating Patients With Newly Diagnosed Primary Central Nervous System Lymphoma |
Completed |
Chemotherapeutic Agent Toxicity|Lymphoma|Mucositis|Neurotoxicity |
NCT00727831 |
| Response or Resistance to Chemotherapy in Young Patients With Acute Lymphoblastic Leukemia Treated With Methotrexate |
Completed |
B-cell Childhood Acute Lymphoblastic Leukemia|Childhood Acute Lymphoblastic Leukemia in Remission|Recurrent Childhood Acute Lymphoblastic Leukemia|T-cell Childhood Acute Lymphoblastic Leukemia |
NCT00898404 |
| Single Ascending Dose Study of Safety and Tolerability of Sarilumab and Methotrexate in Japanese Patients With Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT01850680 |
| Etanercept and Methotrexate in Patients to Induce Remission in Early Arthritis (EMPIRE) |
Completed |
Rheumatoid Arthritis|Inflammatory Arthritis |
NCT01303874 |
| Methotrexate and Cyclosporine in Treatment of Early Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT00209859 |
| Metronomic Chemotherapy in Patients With Advanced Solid Tumor With Bone Metastasis and Advanced Pretreated Osteosarcoma |
Recruiting |
Solid Tumor|Osteosarcoma |
NCT02517918 |
| Study Evaluating Etanercept Plus Methotrexate in Early Rheumatoid Arthritis |
Completed |
Active Rheumatoid Arthritis|Arthritis, Rheumatoid|Rheumatoid Arthritis |
NCT00913458 |
| A Study to Evaluate the Safety and Efficacy of MabThera (Rituximab) in Combination With Methotrexate (MTX) in Participants With Active Rheumatoid Arthritis Who Failed on Anti-Tumor Necrosis Factor Alpha Therapy |
Completed |
Rheumatoid Arthritis |
NCT00468546 |
| Efficacy of Chinese Herbal Medicine Qing Re Huo Xue in Patients With Rheumatoid Arthritis |
Not yet recruiting |
Rheumatoid Arthritis |
NCT04170504 |
| Methotrexate-based Chemo-immunotherapy Followed by Maintenance Therapy for Patients > 65 Years With Central Nervous System (CNS)-Lymphoma |
Unknown status |
Primary Non Hodgkin Lymphoma of the Central Nervous System |
NCT00989352 |
| A Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Combination Therapy of T-614 and Methotrexate in Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate |
Completed |
"Rheumatoid Arthritis" |
NCT00965757 |
| A Study to Evaluate the Safety and Efficacy of CCX354-C in Subjects With Rheumatoid Arthritis Partially Responsive to Methotrexate Therapy |
Completed |
Rheumatoid Arthritis |
NCT01242917 |
| Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate |
Recruiting |
Arthritis, Rheumatoid |
NCT03980483 |
| Phase IIIB Subcutaneous Abatacept Monotherapy Study |
Completed |
Rheumatoid Arthritis (RA) |
NCT00547521 |
| Oral Baricitinib (LY3009104)Treatment in Japanese Participants With Active Rheumatoid Arthritis on Background Methotrexate Therapy |
Completed |
Arthritis, Rheumatoid |
NCT01469013 |
| Rheumatoid Arthritis: Comparison of Active Therapies in Patients With Active Disease Despite Methotrexate Therapy |
Completed |
Rheumatoid Arthritis |
NCT00405275 |
| A Study to Evaluate Efficacy of Tocilizumab Administered as Monotherapy or in Combination With Methotrexate and/or Other Disease Modifying Antirheumatic Drugs (DMARDs) in Rheumatoid Arthritis (RA) Participants |
Completed |
Rheumatoid Arthritis |
NCT01941940 |
| AMG 827 in Rheumatoid Arthritis Subjects With Inadequate Response to Methotrexate |
Completed |
Rheumatoid Arthritis |
NCT00950989 |
| Hydroxytriptolide in Active Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate |
Completed |
Rheumatoid Arthritis |
NCT02202395 |
| The Infliximab Rheumatoid Arthritis Methotrexate Tapering (iRAMT) Protocol |
Completed |
Arthritis, Rheumatoid |
NCT00246064 |
| A Phase IIIb Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate |
Completed |
Active Rheumatoid Arthritis |
NCT00420199 |
| The Influence of Thiopurine Methyltransferase Activity on Toxicity After High-dose Methotrexate in Childhood Acute Lymphoblastic Leukemia |
Completed |
Acute Lymphoblastic Leukemia |
NCT01886651 |
| Phase IIB Rheumatoid Arthritis Dose Ranging Study for BMS-945429 in Subjects Who Are Not Responding to Methotrexate |
Completed |
Rheumatoid Arthritis |
NCT01373151 |
| Study Comparing Etanercept in Combination With Methotrexate in Subjects With Rheumatoid Arthritis |
Completed |
Arthritis, Rheumatoid |
NCT00565409 |
| Masitinib in Refractory Active Rheumatoid Arthritis |
Terminated |
Rheumatoid Arthritis (RA) |
NCT01410695 |
| The Efficacy of the Traditional Chinese Medicine Niubang Pill Combined With Methotrexate on Active Rheumatoid Arthritis |
Recruiting |
Niu Bang Zi Pill|Rheumatoid Arthritis |
NCT03173040 |
| Reduce Risk for Crohn's Disease Patients |
Recruiting |
Crohn's Disease |
NCT02852694 |
| Safety, Pharmacokinetic (PK), Pharmcodynamic (PD), and Drug-Drug Interaction of PLX3397 in Patients With Rheumatoid Arthritis Who Are Receiving Methotrexate |
Withdrawn |
Rheumatoid Arthritis |
NCT01090570 |
| Thiopurine EnhAnced Maintenance Therapy |
Unknown status |
Acute Lymphoblastic Leukemia|Lymphoblastic Lymphoma |
NCT02912676 |
| A Study of Subcutaneous RoActemra/Actemra (Tocilizumab) as Monotherapy or in Combination With Methotrexate or Other Non-Biologic DMARDs in Patients With Active Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT01995201 |
| A Dose Range Finding Study of JNJ-39758979 in Patients With Active Rheumatoid Arthritis Currently Treated With Methotrexate |
Withdrawn |
Active Rheumatoid Arthritis; Rheumatoid Arthritis |
NCT01480388 |
| MTX Discontinuation and Vaccine Response |
Completed |
Arthritis, Rheumatoid |
NCT02748785 |
| Study of Two Doses of ABX464 in Participants With Moderate to Severe Rheumatoid Arthritis |
Recruiting |
Rheumatoid Arthritis |
NCT03813199 |
| A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT00106548 |
| Fludarabine Phosphate, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Peripheral Blood Stem Cell Transplant, Tacrolimus, and Methotrexate in Treating Patients With Myeloid Malignancies |
Completed |
Accelerated Phase Chronic Myelogenous Leukemia|Adult Acute Myeloid Leukemia in Remission|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Del(5q)|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)|Blastic Phase Chronic Myelogenous Leukemia|Childhood Acute Myeloid Leukemia in Remission|Childhood Chronic Myelogenous Leukemia|Childhood Myelodysplastic Syndromes|Chronic Phase Chronic Myelogenous Leukemia|de Novo Myelodysplastic Syndromes|Hematopoietic/Lymphoid Cancer|Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable|Previously Treated Myelodysplastic Syndromes|Recurrent Adult Acute Myeloid Leukemia|Recurrent Childhood Acute Myeloid Leukemia|Relapsing Chronic Myelogenous Leukemia |
NCT01056614 |
| IGF-MTX Conjugate in the Treatment of Myelodysplastic Syndrome |
Recruiting |
Myelodysplastic Syndromes|Leukemia, Myelomonocytic, Chronic|Anemia, Refractory, With Excess of Blasts |
NCT03175978 |
| Rituximab-HyperCVAD (R-HCVAD) Alternating With Rituximab-Methotrexate-Cytarabine- (R-MC) in Newly Diagnosed Patients With Diffuse Large B-Cell Lymphoma With MYC-Rearrangement. |
Withdrawn |
Newly Diagnosed Diffuse Large B-Cell Lymphoma|Intermediate (Burkitt-Like) Lymphoma |
NCT01854372 |
| Efficacy, Safety and Immunogenicity of Enerceptan Compared to Enbrel in Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT03332719 |
| Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma |
Active, not recruiting |
Chemotherapeutic Agent Toxicity|Cognitive/Functional Effects|Lymphoma|Neurotoxicity|Radiation Toxicity |
NCT01399372 |
| A Study of Ocrelizumab Compared to Placebo in Patients With Active Rheumatoid Arthritis Continuing Methotrexate Treatment (STAGE) |
Terminated |
Rheumatoid Arthritis |
NCT00406419 |
| Comparing The Effectiveness And Safety Of 2 Doses Of An Experimental Drug, CP-690,550, To Methotrexate (MTX) In Patients With Rheumatoid Arthritis Who Have Not Previously Received MTX |
Completed |
Arthritis, Rheumatoid |
NCT01039688 |
| Low-Dose Oral Methotrexate Versus Colchicine for Primary Biliary Cirrhosis |
Completed |
Liver Cirrhosis, Biliary |
NCT00004748 |
| A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy |
Completed |
Rheumatoid Arthritis |
NCT00106522 |
| Ofatumumab in Combination With Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine Sulfate, and Dexamethasone Alternating With Ofatumumab in Combination With Cytarabine and Methotrexate in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma |
Active, not recruiting |
Stage I Mantle Cell Lymphoma|Stage II Contiguous Mantle Cell Lymphoma|Stage II Non-Contiguous Mantle Cell Lymphoma|Stage III Mantle Cell Lymphoma|Stage IV Mantle Cell Lymphoma |
NCT01527149 |
| PAZOPANIB Efficacy and Tolerance in Desmoids Tumors |
Completed |
Progressive Desmoids Tumors |
NCT01876082 |
| Sirolimus, Tacrolimus, and Methotrexate in Preventing Acute Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation |
Completed |
Chronic Myeloproliferative Disorders|Graft Versus Host Disease|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Myelodysplastic/Myeloproliferative Diseases |
NCT00089037 |
| Abatacept and Infliximab in Combination With Methotrexate in Subjects With Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT00095147 |
| A Study of the Safety and Efficacy of Rituximab in Patients With Moderate to Severe Rheumatoid Arthritis Receiving Methotrexate |
Completed |
Rheumatoid Arthritis |
NCT00243412 |
| A Study of CNTO 136 (Sirukumab) Administered Subcutaneously in Japanese Patients With Active Rheumatoid Arthritis Unresponsive to Methotrexate or Sulfasalazine |
Completed |
Arthritis, Rheumatoid |
NCT01689532 |
| A Study of Rituximab (MabThera®/Rituxan®) in Patients With Rheumatoid Arthritis and Inadequate Response to Methotrexate |
Completed |
Rheumatoid Arthritis |
NCT00578305 |
| Characterization of Adalimumab Concentrations in Pediatric Patients With Inflammatory Rheumatic Disease With and Without Methotrexate |
Recruiting |
Rheumatic Diseases |
NCT04042792 |
| Ursodiol-Methotrexate for Primary Biliary Cirrhosis |
Completed |
Liver Cirrhosis, Biliary |
NCT00006168 |
| Chemotherapy and HAART to Treat AIDS-related Primary Brain Lymphoma |
Completed |
Lymphoma-AIDS-Related|Brain Neoplasm |
NCT00267865 |
| Safety Study of PRTX-100 With Methotrexate or Leflunomide to Treat Active Rheumatoid Arthritis |
Completed |
Arthritis, Rheumatoid |
NCT01749787 |
| Induction Therapy With a Single High Dose Bolus of Intravenous Methotrexate With Leucovorin Rescue, Prior to Initiation of AVONEX® Treatment, in Patients Presenting With a First Acute Demyelinating Event. |
Withdrawn |
Demyelinating Disorders|Multiple Sclerosis|Optic Neuritis|Myelitis|Neuritis |
NCT00037115 |
| Efficacy and Safety Study of BMS-986142 in Patients With Moderate to Severe Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT02638948 |
| Abatacept to Silence Anti-citrullinated Protein Antibody-expressing B Cells in Rheumatoid Arthritis (ASCARA) |
Recruiting |
Rheumatoid Arthritis|Rheumatic Diseases |
NCT03492658 |
| Phase III Randomized Clinical Trial Comparing Post-Transplant Cyclophosphamide (PTCy) to Standard Care (SoC) for Acute Leukemia |
Recruiting |
Acute Leukemia in Remission|Post-Transplant Cyclophosphamide |
NCT04314219 |
| A Study of RoActemra/Actemra (Tocilizumab) Versus Adalimumab in Combination With Methotrexate (MTX) in Patients With Moderate to Severe Active Rheumatoid Arthritis And an Inadequate Response to Treatment With Only One Tumor Necrosis Factor (TNF)-Inhibitor |
Terminated |
Rheumatoid Arthritis |
NCT01283971 |
| Infliximab Plus Methotrexate for the Treatment of Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT00269867 |
| Longterm Followup of Patients With Rheumatoid Arthritis Treated With Methotrexate |
Completed |
External Causes of Morbidity and Mortality |
NCT02641977 |
| A Study of the Safety and Efficacy of CNTO 148 (Golimumab) in Children With Juvenile Idiopathic Arthritis (JIA) and Multiple Joint Involvement Who Have Poor Response to Methotrexate (GO KIDS) |
Terminated |
Juvenile Idiopathic Arthritis |
NCT01230827 |
| Low Dose Chemotherapy With Aspirin in Patients With Breast Cancer After Neoadjuvant Chemotherapy |
Unknown status |
Breast Cancer |
NCT01612247 |
| Study of Glucarpidase (CPG2) for the Management of Patients With Delayed Methotrexate Clearance |
Completed |
Neoplasms |
NCT00219791 |
| Prospective Evaluation of FibroScan in Patients Treated With Methotrexate |
Completed |
Liver Fibrosis |
NCT00673101 |
| BBBD Followed By Methotrexate and Carboplatin With or Without Trastuzumab in Treating Women With Breast Cancer That Has Spread to the Brain |
Withdrawn |
Brain and Central Nervous System Tumors|Breast Cancer|Cognitive/Functional Effects|Drug/Agent Toxicity by Tissue/Organ|Psychosocial Effects of Cancer and Its Treatment |
NCT00397501 |
| Open Randomized Prospective Clinical Study of R-FPD Versus R-MAD Regimen in the Treatment of Primary Central Nervous System Lymphoma |
Recruiting |
Primary Central Nervous System Lymphoma |
NCT04083066 |
| Long-term Outcome of AIDS-related Primary Central Nervous System Lymphoma Treated With High Dose Methotrexate and Combined Antiretroviral Therapy |
Completed |
Central Nervous System Lymphoma|AIDS Related Lymphoma |
NCT03690895 |
| Tocilizumab REMission in Early RA |
Completed |
Rheumatoid Arthritis |
NCT04157010 |
| A Study Evaluating the Efficacy and Safety of CKD-506 in Adult Subjects With Moderate-to-Severe Rheumatoid Arthritis and Inadequate Response to Methotrexate |
Completed |
Rheumatoid Arthritis |
NCT04204603 |
| A Pilot Study of the Feasibility of Discontinuation of Adalimumab in Stable Rheumatoid Arthritis Patients in Clinical Remission |
Completed |
Arthritis, Rheumatoid |
NCT00808509 |
| Impact and Use of Abatacept IV for Rheumatoid Arthritis in Real Life Setting |
Completed |
Rheumatoid Arthritis |
NCT02037737 |
| A Retrospective, Observational Chart Review of Biologics in Monotherapy Versus the Combination Biologic Plus Methotrexate in Patients With Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT01866150 |
| Treatment Protocol of Voraxaze for Patients Experiencing or at Risk of Methotrexate Toxicity |
Approved for marketing |
Neoplasms |
NCT00481559 |
| Study of CE-224,535 A Twice Daily Pill To Control Rheumatoid Arthritis In Patients Who Have Not Totally Improved With Methotrexate |
Completed |
Arthritis, Rheumatoid |
NCT00628095 |
| I-MVAC +/- Panitumumab as First-line Treatment of Advanced Urothelial Carcinoma Without H-Ras Nor K-Ras Mutations |
Unknown status |
Infiltrating Urothelial Carcinoma|KRAS Gene Mutation |
NCT02818725 |
| A Study of the Effectiveness and Safety of Ustekinumab (STELARA) and CNTO 1959 Administered Under the Skin of Patients With Active Rheumatoid Arthritis, Despite Existing Methotrexate Therapy |
Completed |
Arthritis, Rheumatoid |
NCT01645280 |
| Safety and Tolerability of Rituxan With Methotrexate and Etanercept or Methotrexate and Adalimumab in Patients With Active Rheumatoid Arthritis |
Terminated |
Rheumatoid Arthritis |
NCT00298272 |
| Dose Ranging Study of ART621 in Subjects Diagnosed With Rheumatoid Arthritis Taking Methotrexate |
Terminated |
Rheumatoid Arthritis |
NCT00928317 |
| Study To Assess The Efficacy And Safety Of Pf-06651600 In Subjects With Rheumatoid Arthritis With An Inadequate Response To Methotrexate |
Completed |
Rheumatoid Arthritis |
NCT02969044 |
| Evaluation of Patient Performance Using the Metoject Device for Subcutaneous Injection in Rheumatoid Arthritis (RA)Patient |
Completed |
Rheumatoid Arthritis (RA) |
NCT01871961 |
| A Clinical Trial Using Metronomic Oral Low-dose Cyclophosphamide Alternating With Low-dose Oral Methotrexate With Continuous Celecoxib and Weekly Vinblastine in Children and Adolescents With Relapsed or Progressing soliD Tumours. |
Unknown status |
Solid Tumours. |
NCT01285817 |
| Filgotinib Alone and in Combination With Methotrexate (MTX) in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Are Naive to MTX Therapy |
Completed |
Rheumatoid Arthritis |
NCT02886728 |
| A Comparative Study Between PF-06410293 and Humira® in Combination With Methotrexate in Participants With Active Rheumatoid Arthritis |
Recruiting |
Rheumatoid Arthritis |
NCT04230213 |
| Endothelial Function, Inflammatory Disease Activity, and Bone and Cartilage Markers in Rheumatic Patients: The Influence of Antirheumatic Treatment |
Completed |
Rheumatoid Arthritis|Psoriatic Arthritis|Ankylosing Spondylitis|Endothelial Dysfunction|Inflammatory Disease Activity |
NCT00902005 |
| An Observational Study of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (ACTIVATE) |
Completed |
Rheumatoid Arthritis |
NCT01384461 |
| Combination Methotrexate and Infliximab |
Completed |
Ankylosing Spondylitis |
NCT00432432 |
| Study of Hysteroscopic Repeat Curettage as the First-line Treatment in Low-risk Postmolar Gestational Trophoblastic Neoplasia |
Recruiting |
Gestational Trophoblastic Neoplasia |
NCT03703271 |
| Comparison of Three Different Treatment Regimes in Early Rheumatoid Arthritis: A Randomized Open-labelled Trial |
Completed |
Rheumatoid Arthritis |
NCT01870128 |
| A Rheumatoid Arthritis Study to Assess Early Response to Abatacept+MTX as Defined by Improvement of Synovitis Measures by Power Doppler Ultrasonography |
Completed |
Rheumatoid Arthritis |
NCT00767325 |
| 24-week Study With Open Label Extension of VX-509, an Oral JAK3 Inhibitor, in Subjects Taking Methotrexate |
Completed |
Rheumatoid Arthritis |
NCT01590459 |
| Metronomic Low-Dose Cyclophosphamide and Methotrexate With or Without Bevacizumab in Treating Women With Metastatic Breast Cancer |
Completed |
Breast Cancer |
NCT00083031 |
| [CREMA]Combination of R-M Followed by R-A in Elderly Patients With Primary CNS Lymphoma |
Recruiting |
Primary CNS Lymphoma |
NCT03569995 |
| A Study of the Impact of Methotrexate (MTX) Discontinuation on the Efficacy of Subcutaneous (SC) Tocilizumab (TCZ) With MTX |
Completed |
Rheumatoid Arthritis |
NCT01855789 |
| A Study in Participants With Rheumatoid Arthritis on Background Methotrexate Therapy |
Completed |
Arthritis, Rheumatoid |
NCT01185353 |
| Comparison of Creatinine Clearance Calculation for Estimation of GFR in Patients Receiving HD Methotrexate |
Completed |
CNS Lymphoma|CNS Involvement of Systemic Lymphoma |
NCT01319591 |
| Methotrexate-Inadequate Response Study |
Completed |
Rheumatoid Arthritis (RA) |
NCT00559585 |
| A Double-Blind Study Evaluating Duvelisib in Subjects With Moderate to Severe Rheumatoid Arthritis and an Inadequate Response to Methotrexate Alone |
Completed |
Rheumatoid Arthritis |
NCT01851707 |
| Efficacy and Safety Study of CC-292 Versus Placebo as Co-therapy With Methotrexate in Active Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT01975610 |
| A Study to Assess CH1504 in Patients With Active Rheumatoid Arthritis |
Completed |
Arthritis, Rheumatoid |
NCT00658047 |
| Renal and Hepatic Clearance Following High-Dose Methotrexate in Childhood ALL |
Completed |
Lymphoblastic Leukemia, Acute, Childhood |
NCT01896752 |
| A Dose Response Study of E6011 in Subjects With Rheumatoid Arthritis Inadequately Responding to Methotrexate |
Completed |
Rheumatoid Arthritis |
NCT02960438 |
| PoC in Rheumatoid Arthritis With Methotrexate |
Completed |
Rheumatoid Arthritis, NOS |
NCT00605735 |
| A Dose-Range Finding Study for ALX-0061 Combination Therapy in Subjects With Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT02309359 |
| Abatacept With Methotrexate- Phase IIB |
Completed |
Rheumatoid Arthritis |
NCT00162266 |
| Methotrexate With or Without Antineoplaston Therapy in Treating Postmenopausal Women With Advanced Refractory Breast Cancer |
Withdrawn |
Stage IV Breast Cancer|Recurrent Breast Cancer |
NCT00003536 |
| Coproporphyrine Isomers and Methotrexate Elimination |
Completed |
Central Nervous System Neoplasms|Lymphoma, Large B-Cell, Diffuse|Precursor B-Cell Lymphoblastic Leukemia-Lymphoma|Burkitt Lymphoma |
NCT00822432 |
| Filgotinib in Combination With Methotrexate in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate |
Completed |
Rheumatoid Arthritis |
NCT02889796 |
| An Evaluation of Sarilumab Plus Methotrexate Compared to Etanercept Plus Methotrexate in RA Patients Not Responding to Adalimumab Plus Methotrexate |
Terminated |
Rheumatoid Arthritis |
NCT01764997 |
| Association of L-asparaginase-Methotrexate-Dexamethasone for Nasal and Nasal-type Natural Killer (NK)-T-cell Lymphoma |
Completed |
Lymphoma, Non-Hodgkin |
NCT00283985 |
| A Study Comparing LBAL to Humira® in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy |
Unknown status |
Arthritis, Rheumatoid |
NCT02746380 |
| Bioavailability in Patient With Psoriasis: Metoject Prefilled Pen |
Completed |
Psoriasis |
NCT02097173 |
| Study of LX3305 in Subjects With Active Rheumatoid Arthritis on Stable Methotrexate |
Completed |
Rheumatoid Arthritis |
NCT00903383 |
| High-Dose (HD) Methotrexate (MTX) Induction Chemotherapy Followed by Alternative HD MTX-based and HD Cytarabine-based Combination Consolidation Chemotherapy for Newly Diagnosed Primary CNS Lymphoma; CISL 10-01 Study |
Completed |
CNS Lymphoma |
NCT01083342 |
| Tretinoin, Cytarabine, and Daunorubicin Hydrochloride With or Without Arsenic Trioxide Followed by Tretinoin With or Without Mercaptopurine and Methotrexate in Treating Patients With Acute Promyelocytic Leukemia |
Completed |
Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)|Adult Acute Promyelocytic Leukemia (M3)|Childhood Acute Promyelocytic Leukemia (M3)|Untreated Adult Acute Myeloid Leukemia|Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies |
NCT00003934 |
| Safety Study of SCIO-469 to Treat Patients With Active Rheumatoid Arthritis Receiving Methotrexate |
Completed |
Rheumatoid Arthritis |
NCT00043732 |
| Effects of Tofacitinib (CP-690,550) on Magnetic Resonance Imaging (MRI)- Assessed Joint Structure In Early Rheumatoid Arthritis (RA) |
Completed |
Rheumatoid Arthritis |
NCT01164579 |
| Prediction of Excretion and Toxicity of High Dose Methotrexate in Children and Adolescents With ALL |
Active, not recruiting |
ALL |
NCT02133599 |
| Success of Tocilizumab in RA Patients With Remission Induction and Sustained Efficacy After Discontinuation |
Completed |
Rheumatoid Arthritis |
NCT01120366 |
| A Study of PF-06438179 (Infliximab-Pfizer) and Infliximab in Combination With Methotrexate in Subjects With Active Rheumatoid Arthritis (REFLECTIONS B537-02). |
Completed |
Rheumatoid Arthritis |
NCT02222493 |
| A Study of P38 Inhibitor (4) in Patients With Active Rheumatoid Arthritis (RA) on Stable Methotrexate Therapy |
Completed |
Rheumatoid Arthritis |
NCT00316771 |
| Efficacy and Safety of Adalimumab in Patients With Active Rheumatoid Arthritis Treated Concomitantly With Methotrexate. |
Completed |
Rheumatoid Arthritis |
NCT00195702 |
| Oral CF101 Tablets and Methotrexate Treatment in Rheumatoid Arthritis Patients |
Completed |
Rheumatoid Arthritis |
NCT00556894 |
| Maintenance Treatment for Ovarian Carcinoma in Remission by an Antiangiogenic Treatment Strategy |
Terminated |
Ovarian Carcinoma |
NCT01175772 |
| A Study Comparing SB2 to Remicade® in Subjects With Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy |
Completed |
Rheumatoid Arthritis |
NCT01936181 |
| A Trial of NNC0109-0012, an Anti-IL-20 Biologic, in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to Methotrexate |
Terminated |
Inflammation|Rheumatoid Arthritis |
NCT01636843 |
| Bucillamine Study of Holding Remission After Infliximab Dose-off |
Unknown status |
Rheumatoid Arthritis |
NCT00716248 |
| A Trial of Carboxypeptidase-G2 (CPDG2) and Thymidine for the Management of Patients With Methotrexate Toxicity and Renal Dysfunction |
Completed |
Kidney Diseases |
NCT00001298 |
| Antifolate Effectiveness in Arthritis |
Completed |
Rheumatoid Arthritis|Adjuvant Arthritis |
NCT00000395 |
| High-Dose Methotrexate (MTX) for Adult Acute Lymphoblastic Leukemia (ALL) |
Unknown status |
Lymphoblastic Leukemia, Acute |
NCT00131027 |
| Oral CF101 and Methotrexate Treatment in Rheumatoid Arthritis Patients |
Completed |
Rheumatoid Arthritis |
NCT00280917 |
| Rituxan With or Without Methotrexate in Psoriatic Arthritis |
Completed |
Psoriatic Arthritis |
NCT00509678 |
| A Study Investigating the Efficacy and Safety of Upadacitinib (ABT-494) Given With Methotrexate (MTX) in Adults With Rheumatoid Arthritis Who Have Had an Inadequate Response to MTX Alone |
Completed |
Rheumatoid Arthritis |
NCT02066389 |
| Study to Evaluate the Efficacy of Tacrolimus in Rheumatoid Arthritis Patients Shown Unsuccessful Response to Methotrexate |
Completed |
Rheumatoid Arthritis |
NCT01224041 |
| Low-dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor-negative Early Breast Cancer |
Completed |
Breast Cancer |
NCT00022516 |
| Dose-Escalating Multiple Dose Study of PD-0360324 in Combination With Methotrexate in Patients With Rheumatoid Arthritis |
Completed |
Arthritis, Rheumatoid |
NCT00550355 |
| A Study to Evaluate the Efficacy of Tacrolimus in Rheumatoid Arthritis Patients Shown Unsuccessful Response to Methotrexate |
Completed |
Rheumatoid Arthritis |
NCT01224418 |
| Safety and Effectiveness Study of RWJ-445380 Cathepsin-S Inhibitor in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy |
Completed |
Rheumatoid Arthritis |
NCT00425321 |
| A Study Of PF-06410293 (Adalimumab-Pfizer) And Adalimumab (Humira®) In Combination With Methotrexate In Subjects With Active Rheumatoid Arthritis (REFLECTIONS B538-02). |
Completed |
Rheumatoid Arthritis |
NCT02480153 |
| Study of Etanercept in Subjects With Rheumatoid Arthritis Who Have Had an Inadequate Response to Adalimumab or Infliximab Plus Methotrexate |
Terminated |
Rheumatoid Arthritis |
NCT01783015 |
| A Study to Evaluate the Safety and Efficacy of Rituximab in Combination With Methotrexate Compared to Methotrexate Alone in Patients With Active Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT00299130 |
| BIANCA-SC: A Study of the Efficacy, Safety, and Tolerability of Blisibimod in Addition to Methotrexate During Induction of Remission in Subjects With ANCA-Associated Small Vessel Vasculitis |
Withdrawn |
Granulomatosis With Polyangiitis|Microscopic Polyangiitis |
NCT01598857 |
| Alemtuzumab With or Without Methotrexate and Mercaptopurine in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia |
Completed |
Recurrent Childhood Acute Lymphoblastic Leukemia |
NCT00089349 |
| Efficacy of Remicade in the Treatment of Active Rheumatoid Arthritis Despite Methotrexate (Study P03027) |
Completed |
Arthritis, Rheumatoid |
NCT00794898 |
| Safety, Tolerability, and Efficacy of GS-9876 in Participants With Active Rheumatoid Arthritis on Background Therapy With Methotrexate |
Completed |
Rheumatoid Arthritis |
NCT02885181 |
| Efficacy, Safety and Tolerability of Secukinumab in Patients With Rheumatoid Arthritis Taking Methotrexate |
Completed |
Rheumatoid Arthritis |
NCT01359943 |
| A 2-Year Phase 3 Study Of CP-690,550 In Patients With Active Rheumatoid Arthritis On Background Methotrexate |
Completed |
Arthritis, Rheumatoid |
NCT00847613 |
| TAC/MTX vs. TAC/MMF/PTCY for Prevention of Graft-versus-Host Disease and Microbiome and Immune Reconstitution Study (BMT CTN 1703/1801) |
Active, not recruiting |
Acute Leukemia|Chronic Myelogenous Leukemia (CML)|Myelodysplasia|Lymphoma |
NCT03959241 |
| A Study of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque Psoriasis Naive to Systemic Treatment |
Completed |
Plaque Psoriasis |
NCT02634801 |
| A Study of Tocilizumab With or Without Methotrexate in Patients With Rheumatoid Arthritis. |
Completed |
Rheumatoid Arthritis |
NCT01010503 |
| CF101 Therapy Compared to Methotrexate Therapy for Active Rheumatoid Arthritis |
Active, not recruiting |
Rheumatoid Arthritis |
NCT02647762 |
| To Compare the Efficacy, Pharmacokinetics and Safety Between CT-P13 and China Approved Remicade When Co-administered With Methotrexate in Patients With Active Rheumatoid Arthritis |
Recruiting |
Rheumatoid Arthritis |
NCT03707535 |
| Phase II Trial of Combined Modality Treatment in Primary Central Nervous System Lymphoma |
Completed |
Lymphoma, B Cell |
NCT00210314 |
| A Trial Investigating the Mechanism of Action of NNC0109-0012 (Anti-IL-20 mAb) Through Synovial Biopsies in Subjects With Rheumatoid Arthritis and an Inadequate Response to Methotrexate |
Withdrawn |
Inflammation|Rheumatoid Arthritis |
NCT02097264 |
| A Study Comparing LBEC0101 to Enbrel® in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy |
Unknown status |
Arthritis, Rheumatoid |
NCT02357069 |
| A Study Comparing SB4 to Enbrel® in Subjects With Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy |
Completed |
Rheumatoid Arthritis |
NCT01895309 |
| Preventing Nephrotoxicity and Ototoxicity From Osteosarcoma Therapy |
Completed |
Osteosarcoma|Nephrotoxicity|Ototoxicity |
NCT01848457 |
| Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Effects of Multiple Rising Subcutaneous Doses of BI 655064 in Healthy Volunteers and in Rheumatoid Arthritis Patients With Prior Inadequate Response to Methotrexate Therapy |
Completed |
Arthritis, Rheumatoid|Healthy |
NCT01751776 |
| Study of CP-690,550 Versus Placebo In Rheumatoid Arthritis Patients On Background Methotrexate With Inadequate Response To Tumor Necrosis Factor (TNF) Inhibitors |
Completed |
Arthritis, Rheumatoid |
NCT00960440 |
| Safety and Preliminary Efficacy of GLPG0634 in Methotrexate-refractory Active Rheumatoid Arthritis Patients |
Completed |
Rheumatoid Arthritis |
NCT01384422 |
| Methotrexate, Procarbazine, Lomustine, Dexamethasone, and Cytarabine in Treating Patients With Primary CNS Lymphoma |
Completed |
Lymphoma |
NCT00074191 |
| A Study of The Effect of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate on Articular Damage in The Hand in Patients With Moderate to Severe Rheumatoid Arthritis Who Have an Inadequate Response to Non-Biological DMARDs |
Withdrawn |
Rheumatoid Arthritis |
NCT01878318 |
| A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Adults With Rheumatoid Arthritis Who Are on a Stable Dose of Methotrexate and Who Have an Inadequate Response to Methotrexate |
Active, not recruiting |
Rheumatoid Arthritis |
NCT02629159 |
| A Study of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate Versus RoActemra/Actemra Monotherapy in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate |
Completed |
Rheumatoid Arthritis |
NCT01399697 |
| Evaluation of Effectiveness of Two Dosing Regimens of Fostamatinib Compared to Placebo in Patients With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Not Responding. |
Completed |
Rheumatoid Arthritis |
NCT01197521 |
| High Dose Methotrexate With Leucovorin Rescue With or Without Glucarpidase in Osteosarcoma |
Terminated |
Osteosarcoma |
NCT00634322 |
| A Study to Evaluate the Safety and Tolerability of Multiple Doses of Gerilimzumab in Rheumatoid Arthritis Patients |
Recruiting |
Rheumatoid Arthritis |
NCT04179513 |
| Early Systemic Central Nervous System Prophylaxis in Diffuse Large B-cell Lymphoma |
Not yet recruiting |
Diffuse Large B Cell Lymphoma |
NCT03719560 |
| A Phase 2 Study to Investigate the Safety, Tolerability and Efficacy of ABT-122 in Subjects With Active Psoriatic Arthritis (PsA) Who Have an Inadequate Response to Methotrexate (MTX) |
Completed |
Psoriatic Arthritis |
NCT02349451 |
| Study of Docetaxel in Breast Cancer Patients |
Completed |
Breast Neoplasms |
NCT00174707 |
| MEDA Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation for Stage IV Natural Killer/T-cell Lymphoma |
Recruiting |
Extranodal NK-T-Cell Lymphoma, Nasal Type |
NCT02764281 |
| Long-term Treatment Study of Certolizumab Pegol Without Coadministration of Methotrexate in Japanese Rheumatoid Arthritis (RA) Patients |
Completed |
Rheumatoid Arthritis |
NCT00850343 |
| Trial With HuMax-CD4 in Patients With Rheumatoid Arthritis Failing Treatment With Methotrexate and a TNF-alpha Blocker |
Terminated |
Rheumatoid Arthritis |
NCT00042406 |
| BHCG Level in Day 4,7, in Comparison to Day 10 as an Indicator for Treatment Success |
Unknown status |
Ectopic Pregnancy |
NCT01860690 |
| Safety and Efficacy of Adalimumab to Methotrexate and Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis |
Completed |
Psoriasis |
NCT00235820 |
| Methotrexate, Cyclophosphamide, and Etoposide Phosphate Given With Osmotic Blood-Brain Barrier Disruption Plus Dexamethasone and Cytarabine in Treating Patients With Primary CNS Lymphoma |
Completed |
Lymphoma |
NCT00074178 |
| A Study of Abatacept in Japanese Patients With Active Rheumatoid Arthritis While Receiving Methotrexate |
Completed |
Rheumatoid Arthritis |
NCT00345748 |
| Blinatumomab, Methotrexate, Cytarabine, and Ponatinib in Treating Patients With Philadelphia Chromosome-Positive, or BCR-ABL Positive, or Relapsed/Refractory, Acute Lymphoblastic Leukemia |
Recruiting |
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Acute Lymphoblastic Leukemia|BCR-ABL1 Fusion Protein Expression|Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Philadelphia Chromosome Positive|Recurrent Acute Lymphoblastic Leukemia|Refractory Acute Lymphoblastic Leukemia|t(9;22) |
NCT03263572 |
| Remission Induction in Very Early Rheumatoid Arthritis |
Unknown status |
Rheumatoid Arthritis |
NCT00523692 |
| Optimized Treatment Algorithm for Patients With Early Rheumatoid Arthritis (RA) |
Completed |
Arthritis, Rheumatoid |
NCT00660647 |
| Efficacy and Safety of Tripterygium Wilfordii in Patients With Rheumatoid Arthritis |
Completed |
Arthritis, Rheumatoid |
NCT01613079 |
| Study to Evaluate the Efficacy and Safety of GSK3196165 Plus Methotrexate in Subjects With Active Moderate-Severe Rheumatoid Arthritis |
Completed |
Arthritis, Rheumatoid |
NCT02504671 |
| Carboxypeptidase-G2 in Treating Nervous System Toxic Effects in Patients Given an Overdose of Intrathecal Methotrexate |
Completed |
Neurotoxicity|Unspecified Adult Solid Tumor, Protocol Specific|Unspecified Childhood Solid Tumor, Protocol Specific |
NCT00018967 |
| Cyclophosphamide and Prednisone Followed by Methotrexate To Treat Vasculitides |
Completed |
Vasculitis|Wegener's Granulomatosis |
NCT00001473 |
| Dose-Escalating Study of BG9924 in Combination With Methotrexate in Active Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT00292422 |
| Fludarabine and Busulfan Followed by Donor Peripheral Stem Cell Transplant and Antithymocyte Globulin, Tacrolimus, and Methotrexate in Treating Patients With Myeloid Cancer |
Completed |
Chronic Myeloproliferative Disorders|Graft Versus Host Disease|Leukemia|Myelodysplastic Syndromes|Myelodysplastic/Myeloproliferative Diseases |
NCT00346359 |
| A Study of Subcutaneous (SC) Tocilizumab (RoActemra/Actemra) in Participants With Active Rheumatoid Arthritis (RA) and Inadequate Response to Disease-Modifying Anti-Rheumatic Drugs (DMARDs) |
Completed |
Rheumatoid Arthritis |
NCT02046616 |
| A Study of Retreatment With MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA) |
Completed |
Rheumatoid Arthritis |
NCT00422383 |
| An Efficacy and Safety Study of Infliximab in Participants With Rheumatoid Arthritis |
Completed |
Arthritis, Rheumatoid |
NCT00896168 |
| Comparison Of 4 CP-690,550 Doses Vs. Placebo, Each Combined With Methotrexate, For The Treatment Of Rheumatoid Arthritis in Japan |
Completed |
Arthritis, Rheumatoid |
NCT00603512 |
| Comparison Of 6 CP-690,550 Doses Vs.Placebo, Each Combined With Methotrexate, For The Treatment Of Rheumatoid Arthritis |
Completed |
Arthritis, Rheumatoid |
NCT00413660 |
| Natalizumab in the Treatment of Rheumatoid Arthritis in Subjects Receiving Methotrexate |
Terminated |
Rheumatoid Arthritis |
NCT00083759 |
| Study of MDX-1100 (Anti-CXCL10 Human Monoclonal Antibody) in Combination With Methotrexate in Subjects With Active Rheumatoid Arthritis (RA) |
Completed |
Rheumatoid Arthritis |
NCT01017367 |
| Comparison of Methotrexate (MTX) and the VIBEX™ MTX Device |
Completed |
Rheumatoid Arthritis (RA) |
NCT01618968 |
| A Study of Combination Treatment With MabThera (Rituximab) and RoActemra (Tocilizumab) Versus RoActemra in Patients With Rheumatoid Arthritis With an Incomplete Response to Methotrexate |
Terminated |
Rheumatoid Arthritis |
NCT00845832 |
| An Extension Study to Demonstrate Long-Term Efficacy and Safety of CT-P13 When Co-administered With Methotrexate in Patient With Rheumatoid Arthritis Who Were Treated With Infliximab (Remicade or CT-P13) in Study CT-P13 3.1 |
Completed |
Rheumatoid Arthritis |
NCT01571219 |
| A Study to Assess the Safety and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT00109408 |
| A Placebo-Controlled, Double-Blinded, Randomized Trial of Remicade in Korean Patients With Rheumatoid Arthritis Despite Methotrexate (Study P04280)(COMPLETED) |
Completed |
Arthritis, Rheumatoid |
NCT00202852 |
| Study Evaluating CCI-779 in Active Rheumatoid Arthritis on Concomitant Methotrexate Therapy |
Terminated |
Rheumatoid Arthritis |
NCT00076206 |
| Long Term Efficacy, Safety and Immunogenicity of Enerceptan in Rheumatoid Arthritis ( GEMENE002 ) |
Unknown status |
Rheumatoid Arthritis |
NCT03403140 |
| Phase II Randomized Study of Glucocorticoids With or Without Methotrexate for Treatment of Giant Cell Arteritis |
Completed |
Giant Cell Arteritis |
NCT00004686 |
| Study of Rituximab-HCVAD Alternating With Rituximab-Methotrexate-Cytarabine Versus Standard Rituximab-CHOP Every 21 Days for Patients With Newly Diagnosed High Risk Aggressive B-Cell Non-Hodgkin's Lymphomas in Patients 60 Years Old or Younger |
Completed |
Lymphoma |
NCT00290498 |
| GAD-M Regimen As First-Line Treatment in Untreated Extranodal NK/T Cell Lymphoma |
Active, not recruiting |
Extranodal NK/T-cell Lymphoma, Nasal Type |
NCT01991158 |
| Trial of Early Aggressive Drug Therapy in Juvenile Idiopathic Arthritis |
Completed |
Juvenile Chronic Polyarthritis|Juvenile Idiopathic Arthritis|Juvenile Rheumatoid Arthritis |
NCT00443430 |
| Evaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients |
Completed |
Rheumatoid Arthritis |
NCT01061736 |
| BG9924 in Combination With Methotrexate Extension of Study 104RA203 (NCT 00458861) |
Terminated |
Rheumatoid Arthritis |
NCT00523328 |
| Methotrexate Use Improvement in Rheumatoid Arthritis Using Biomarker Feedback |
Recruiting |
Rheumatoid Arthritis |
NCT03913728 |
| Maintenance Treatment Versus Observation in Elderly Patients With PCNS Lymphoma |
Recruiting |
Primary Central Nervous System Lymphoma |
NCT02313389 |
| A Study Of CP-195543 And Celecoxib Dual Therapy In Subjects With Rheumatoid Arthritis |
Terminated |
Arthritis, Rheumatoid |
NCT00424294 |
| A Study Assessing the Efficacy and Safety of SM03 in Patients With Active Rheumatoid Arthritis Receiving MTX |
Recruiting |
Rheumatoid Arthritis(RA) |
NCT04312815 |
| Mechanistic Study of GSK3196165 Plus Methotrexate (MTX) in Subjects With Active Rheumatoid Arthritis |
Completed |
Arthritis, Rheumatoid |
NCT02799472 |
| A Study To Assess the Immune Response Following Administration Of Influenza and Pneumococcal Vaccines To Subjects With Rheumatoid Arthritis Receiving CP-690,550 Or Placebo |
Completed |
Rheumatoid Arthritis |
NCT01359150 |
| Abatacept as GVHD Prophylaxis Phase 2 |
Active, not recruiting |
Graft vs Host Disease|Malignancy |
NCT01743131 |
| Study Conducted in Subjects With Rheumatoid Arthritis Who Have Moderate to Severe Disease Activity Despite Methotrexate Therapy With or Without Other Non Biologic Disease Modifying Antirheumatic Drugs (DMARDs)for at Least 12 Weeks Prior to Screening |
Completed |
Rheumatoid Arthritis |
NCT01578850 |
| The Chinese University of Hong Kong Early Arthritis Study |
Completed |
Rheumatoid Arthritis |
NCT00901550 |
| Voraxaze for Delayed Methotrexate Clearance |
Terminated |
Hematologic Malignancy|Solid Tumor |
NCT00424645 |
| Whole Brain Irradiation in Primary Central Nervous System (CNS) Lymphoma (PCNSL) |
Completed |
Central Nervous System Lymphoma |
NCT00153530 |
| Combination Chemotherapy in Treating Children With Astrocytomas and Primitive Neuroectodermal Tumors |
Completed |
Brain and Central Nervous System Tumors |
NCT00002463 |
| PROACTIVE: Preventing Acute/Chronic GVHD With TocIlizumab Combined With GVHD Prophylaxis Post allogEneic Transplant |
Recruiting |
Hematologic Malignancy |
NCT03699631 |
| Thyroid Treatment Trial |
Completed |
Graves Ophthalmopathy |
NCT00348413 |
| S0521, Combination Chemotherapy With or Without Gemtuzumab Followed By Tretinoin, Mercaptopurine, and Methotrexate or Observation in Treating Patients With Acute Promyelocytic Leukemia |
Completed |
Leukemia |
NCT00492856 |
| Etanercept: Single Blind Control Study in Ocular Manifestations of Behcet's Disease |
Unknown status |
Behcet Syndrome|Uveal Disease |
NCT00931957 |
| To Evaluate the Blood Levels and Safety of IV and Subcutaneous CDP6038 in Subjects With Rheumatoid Arthritis Using Methotrexate |
Completed |
Arthritis|Rheumatoid Arthritis |
NCT01009242 |
| Phase III Randomized Study of Ursodiol With Vs Without Methotrexate for Primary Biliary Cirrhosis |
Completed |
Liver Cirrhosis, Biliary |
NCT00004784 |
| Study Evaluating The Efficacy And Safety Of SBI-087 In Seropositive Subjects With Active Rheumatoid Arthritis |
Completed |
Active Rheumatoid Arthritis |
NCT01008852 |
| A Study to Evaluate Potential Cytochrome P450 and Transporter Protein Interactions With CC-99677 |
Not yet recruiting |
Healthy Volunteer |
NCT04268394 |
| First-line Antimetabolites as Steroid-sparing Treatment Uveitis Pilot Trial |
Completed |
Uveitis |
NCT01232920 |
| A Randomized Controlled Study of Postoperative Adjuvant Therapy of Uracil-tegafur (UFT) Compared With Cyclophosphamide/Methotrexate/5-fluorouracil (CMF) in Breast Cancer (NSAS-BC) |
Completed |
Breast Cancer |
NCT00152191 |
| Study of Safety and Efficacy of HLX01+MTX in Patients With Rheumatoid Arthritis |
Recruiting |
Moderately to Severely Active Rheumatoid Arthritis |
NCT03522415 |
| Cyclophosphamide, Methotrexate, and Prednisolone With or Without Aromatase Inhibitor Therapy in Treating Postmenopausal Women With Metastatic Breast Cancer |
Unknown status |
Breast Cancer |
NCT00687648 |
| Safety and Efficacy of UC-MSCs in Patients With Plaque Psoriasis |
Unknown status |
Moderate and Severe Plaque Psoriasis |
NCT03424629 |
| ADalimumab in Persistent Early Oligoarthrits Study (ADEOS) |
Completed |
Oligoarthritis |
NCT04154852 |
| Combination Disease-Modifying Antirheumatic Drugs (DMARDs) Versus Sulfasalazine in Inflammatory Back Pain |
Completed |
Seronegative Spondyloarthropathies |
NCT01040195 |
| Clinical Study of Autologous Erythrocytes Derived MPs Packaging MTX Peritoneal Perfusion to Treat Malignant Ascites |
Unknown status |
Malignant Ascites |
NCT03230708 |
| AVONEX® Combination Trial - "ACT" |
Completed |
Multiple Sclerosis, Relapsing-Remitting |
NCT00112034 |
| Neoadjuvant Chemotherapy With Methotrexate, Vinblastine, Adriamycin and Cisplatin (M-VAC) Plus Avastin in Patients With Urothelial Cancer |
Completed |
Bladder Cancer |
NCT00506155 |
| Safety and Feasibility Study of Combination of State of Art Chemoimmunotherapy, Intensive Central Nervous System Prophylaxis and Scrotal Irradiation to Treat Primary Diffuse Large B-cell Lymphoma of Testis |
Active, not recruiting |
Large B-cell Diffuse Lymphoma of Testis |
NCT00945724 |
| A Study to Evaluate Efficacy and Safety of ASP015K in Patients With Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate (MTX) Treatment |
Completed |
Rheumatoid Arthritis |
NCT02305849 |
| Chidamide Combined With PECM in Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL) |
Recruiting |
Peripheral T-cell Lymphoma |
NCT03321890 |
| Clinical Trial Evaluating Metronomic Chemotherapy in Patients With Metastatic Osteosarcoma |
Recruiting |
Osteosarcoma |
NCT03063983 |
| Effects of Abatacept in Patients With Early Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT02504268 |
| Juvenile Idiopathic Arthritis (JIA) Registry |
Active, not recruiting |
Juvenile Idiopathic Arthritis|JIA |
NCT00783510 |
| Efficacy and Safety of CDP870 and Methotrexate Compared to Methotrexate Alone in Subjects With Rheumatoid Arthritis |
Completed |
Arthritis, Rheumatoid |
NCT00544154 |
| Clinical Research on Treatment of Psoriasis by Human Umbilical Cord-derived Mesenchymal Stem Cells |
Not yet recruiting |
Psoriasis |
NCT03765957 |
| A Retrospective Cohort Study: The Influence of MTHFR C677T and A1298C on the High-dose Methotrexate-Related Toxicities in Pediatric Patients With Non-Hodgkin Lymphoma |
Completed |
Pediatric NHL |
NCT04283955 |
| Comparative Study of BAT1806 to RoActemra® in Rheumatoid Arthritis Patients With Inadequate Response to Methotrexate |
Recruiting |
Rheumatoid Arthritis |
NCT03830203 |
| National Psoriasis Foundation - Dendritic Cell-Specific Transmembrane Protein (DC-Stamp) Biomarker Study |
Completed |
Psoriatic Arthritis |
NCT01123265 |
| Nausea and Vomiting in Children Receiving Chemotherapeautic Monotherapy |
Completed |
Acute Leukemia |
NCT01661413 |
| Study Evaluating Gerilimzumab´s Safety/Efficacy for Patients MTX or TNFα Antagonist Failed in Rheumatoid Arthritis |
Withdrawn |
Rheumatoid Arthritis |
NCT02795299 |
| Leflunomide + Methotrexate in Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT00563849 |
| Interleukin-2 Gene or Methotrexate in Treating Patients With Recurrent or Refractory Stage III or Stage IV Head and Neck Cancer |
Completed |
Head and Neck Cancer |
NCT00006033 |
| Liposomal Doxorubicin Compared With Observation or Cyclophosphamide and Methotrexate in Treating Older Women Who Have Undergone Surgery for Breast Cancer |
Terminated |
Breast Cancer |
NCT00296010 |
| Methotrexate, Vinblastine, Doxorubicin and Cisplatin (MVAC) Followed by Gemcitabine Plus Cisplatin (GEM+CDDP) in Locally Advanced or Metastatic Bladder Cancer |
Terminated |
Bladder Cancer |
NCT00635726 |
| A Study in Moderate to Severe Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT01710358 |
| or speak with your personal physician. |
Portugal|Ramon L. Ortega Colon |
Puerto Rico|Office of Dr. Ramon Toro |
EST) |
| Childhood Acute Lymphoblastic Leukemia Treatment Protocol Moscow-Berlin 2008 |
Active, not recruiting |
Childhood Acute Lymphoblastic Leukemia |
NCT01953770 |
| Folic Acid in Pediatric Inflammatory Bowel Disease |
Recruiting |
Inflammatory Bowel Diseases |
NCT03860012 |
| Methotrexate-Inadequate Response Autoinjector Device Sub Study |
Completed |
Rheumatoid Arthritis |
NCT01844895 |
| A Study of Subcutaneous Tocilizumab as Monotherapy and/or in Combination With Non-Biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs) in Participants With Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT01941095 |
| Efficacy and Safety Study of Tacrobell to Treat Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT01746680 |
| Lenalidomide, MTX, Ara-C and Rituximab in Relapsed Aggressive B-cell Lymphomas |
Completed |
B-cell Lymphoma |
NCT01788189 |
| A Safety Study of Rituximab Plus MTX Injected Into the Cerebrospinal Fluid in the Treatment of Brain Lymphoma |
Completed |
Central Nervous System Lymphoma|Intraocular Lymphoma |
NCT00221325 |
| Efficacy and Safety Study of TAS5315 Compared With Placebo in Participants With Rheumatoid Arthritis. |
Active, not recruiting |
Rheumatoid Arthritis |
NCT03605251 |
| A Placebo-controlled Study With an Extension Examining the Safety and Efficacy of Alefacept in Psoriatic Arthritis |
Completed |
Psoriatic Arthritis |
NCT00659412 |
| Methotrexate - Inadequate Response Device Sub-Study |
Completed |
Rheumatoid Arthritis (RA) |
NCT01173120 |
| Registry of Etanercept (Enbrel®) In Children With Juvenile Rheumatoid Arthritis |
Completed |
Juvenile Rheumatoid Arthritis |
NCT00078793 |
| Good EULAR Response In Patients With Early Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT01558089 |
| An Efficacy and Safety Study of Subcutaneous Tocilizumab in Combination With Methotrexate (MTX) and as Monotherapy Versus MTX in Participants With Moderate to Severe Rheumatoid Arthritis With Inadequate Response to Current Disease-Modifying Antirheumatic Drug (DMARD) Therapy |
Recruiting |
Rheumatoid Arthritis |
NCT03155347 |
| Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission |
Completed |
B-cell Childhood Acute Lymphoblastic Leukemia|Childhood Acute Lymphoblastic Leukemia in Remission|Graft Versus Host Disease|L1 Childhood Acute Lymphoblastic Leukemia|L2 Childhood Acute Lymphoblastic Leukemia|T-cell Childhood Acute Lymphoblastic Leukemia |
NCT00382109 |
| A Study To Evaluate The Mechanism Of Action Of CP-690,550 In Patients With Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT00976599 |
| A Trial to Compare Ibrutinib Versus Lenalidomide in Combination With MRE-chemotherapy for Adult Patients With Recurrent/Refractory Primary Central Nervous System Lymphoma (PCNSL) |
Recruiting |
Recurrent/RefractoryPrimary Central Nervous System Lymphoma (PCNSL) |
NCT04129710 |
| B-MAD Chemotherapy in Newly-diagnosed Extranodal NK/ T-cell Lymphoma |
Recruiting |
Extranodal NK/T-cell Lymphoma |
NCT03246750 |
| Neoadjuvant Doxorubicin, Polyglutamate Paclitaxel, Capecitabine and Metronomic Chemotherapy in Breast Cancer |
Withdrawn |
Breast Cancer |
NCT01227408 |
| Aminopterin Dose Finding Treatment for Methotrexate-NaĂŻve Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT01724931 |
| Graft-Versus-Host Disease Prevention in Treating Patients Who Are Undergoing Bone Marrow Transplantation |
Completed |
Graft Versus Host Disease|Leukemia|Lymphoma |
NCT00002456 |
| A Study of MabThera (Rituximab) in Primary Central Nervous System Lymphoma. |
Terminated |
Lymphoma |
NCT00517699 |
| Safety and Efficacy of Pf-06650833 In Subjects With Rheumatoid Arthritis, With An Inadequate Response To Methotrexate |
Completed |
Rheumatoid Arthritis |
NCT02996500 |
| A Study to Evaluate the Long-term Safety and Efficacy of LBEC0101 in Subjects With Active RA Despite Methotrexate (MTX) |
Completed |
Rheumatoid Arthritis |
NCT02715908 |
| The GUARD Trial - Part 1: A Phase 3 Clinical Trial for Prevention of Proliferative Vitreoretinopathy |
Recruiting |
Proliferative Vitreoretinopathy |
NCT04136366 |
| Multicentre ObservatioNal Initiative in Treat to Target Outcomes in Psoriatic Arthritis |
Recruiting |
Psoriatic Arthritis |
NCT03531073 |
| Methorexate and Knee Osteoarthritis |
Completed |
Pain Reduction|Physical Function Improvement |
NCT04326894 |
| Dose Optimisation Study of ART621 in Subjects Diagnosed With Rheumatoid Arthritis Taking Methotrexate |
Completed |
Rheumatoid Arthritis |
NCT00854685 |
| Investigation of [6R] 5,10-methylenetetrahydrofolate as Rescue Therapy for Osteosarcoma Patients Treated With HDMTX. |
Completed |
Osteosarcoma |
NCT01987102 |
| Changes in Ultrasonographic Assessment of Inflammation Upon Initiation of Adalimumab Combination Therapy in Chinese Rheumatoid Arthritis (RA) Patients With Inadequate Response to Methotrexate |
Withdrawn |
Rheumatoid Arthritis (RA) |
NCT02786563 |
| Cyclophosphamide and Anti-thymocyte Globulin Followed By Methotrexate and Cyclosporine in Preventing Chronic Graft-Versus-Host Disease in Patients With Severe Aplastic Anemia Undergoing Donor Bone Marrow Transplant |
Completed |
Aplastic Anemia |
NCT00343785 |
| Evaluation of 2 Oral Doses of PG-760564 in Rheumatoid Arthritis (RA) Patients Receiving Methotrexate |
Completed |
Rheumatoid Arthritis |
NCT00369928 |
| A Study to Evaluate Ocrelizumab in Combination With Methotrexate Compared With Infliximab Plus Methotrexate in Patients With Active Rheumatoid Arthritis Currently Responding Inadequately to Etanercept or Adalimumab |
Terminated |
Rheumatoid Arthritis |
NCT00808210 |
| Perioperative Chemotherapy for Patients With Locally Advanced Bladder Cancer |
Active, not recruiting |
Bladder Cancer |
NCT01812369 |
| Efficacy Study of MM-093 in Rheumatoid Arthritis Patients on Methotrexate (MTX) |
Completed |
Rheumatoid Arthritis |
NCT00105976 |
| Efficacy Confirmation Study of CDP870 in Early Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT01451203 |
| Prevention of Graft-Versus-Host Disease in Patients With Advanced Leukemia or Lymphoma Who Are Eligible for Peripheral Stem Cell Transplantation |
Terminated |
Leukemia|Lymphoma|Graft Versus Host Disease |
NCT00003056 |
| The Effect of Corticotrophin (ACTH) in Combination With Methotrexate in Newly Diagnosed Rheumatoid Arthritis Patients |
Completed |
Rheumatoid Arthritis |
NCT01948388 |
| S0501 Fludarabine, Melphalan, and Donor Stem Cell Transplant Followed By Tacrolimus and Methotrexate in Treating Patients for Relapsed Lymphoma |
Terminated |
Lymphoma |
NCT00121186 |
| A Study for Patients With Active Rheumatoid Arthritis Despite Ongoing Methotrexate Therapy |
Completed |
Rheumatoid Arthritis |
NCT00785928 |
| Combination Chemotherapy, Monoclonal Antibody, and Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma |
Completed |
Brain and Central Nervous System Tumors|Lymphoma |
NCT00068250 |
| A Study Investigating the Efficacy and Safety of ABT-494 Given With Methotrexate in Subjects With Rheumatoid Arthritis Who Failed Anti-Tumor Necrosis Factor (TNF) Biologic Therapy |
Completed |
Rheumatoid Arthritis |
NCT01960855 |
| NOPHO ALL-2008 Pilot Study on Consolidation Therapy for Children and Adolescents With Acute Lymphoblastic Leukemia |
Completed |
Leukemia, Lymphocytic, Acute |
NCT00548431 |
| A Study for Patients With Rheumatoid Arthritis on Methotrexate (MTX) With an Inadequate Response to TNFα Inhibitor Therapy |
Completed |
Arthritis, Rheumatoid |
NCT00689728 |
| Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma |
Active, not recruiting |
T Acute Lymphoblastic Leukemia|T Lymphoblastic Lymphoma |
NCT00408005 |
| Rescue Regimen and High Dose Methotrexate in Management of Presistent Gestational Trophoplastic Neoplasia |
Unknown status |
Gestational Trophoblastic Disease |
NCT03280979 |
| Concomitant Use of Apremilast for the Treatment of Active RA Despite TNF-Inhibition and Methotrexate- CATARA |
Withdrawn |
Arthritis, Rheumatoid |
NCT01204138 |
| Efficacy, Safety and Tolerability of AIN457 in Patients With Rheumatoid Arthritis (RA) Taking Methotrexate (MTX) |
Completed |
Rheumatoid Arthritis |
NCT00928512 |
| Effects of MEDI-522 On Disease Activity and Progression of Joint Damage in Patients With Active Rheumatoid Arthritis Suboptimally Responding to Methotrexate |
Completed |
Rheumatoid Arthritis |
NCT00069017 |
| A Study in Rheumatoid Arthritis With an Investigational Oral p38 MAP Kinase Inhibitor VX-702 |
Completed |
Rheumatoid Arthritis |
NCT00395577 |
| A Study of Subcutaneously Administered Tocilizumab in Patients With Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT00965653 |
| A Rheumatoid Arthritis (RA) Study Treating Signs and Symptoms of RA in People With RA & Receiving Methotrexate |
Completed |
Rheumatoid Arthritis |
NCT00038298 |
| MESA Versus ESA in the Treatment of Early Stage NK/T-cell Lymphoma |
Recruiting |
Extranodal NK/T-cell Lymphoma, Nasal Type |
NCT02631239 |
| A Safety and Efficacy Study for Infliximab (Remicade) With Methotrexate in Patients With Early Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT00236028 |
| A Study of Tocilizumab (RoActemra) in Tocilizumab-Naive Participants With Rheumatoid Arthritis and Inadequate Response to Non-Biologic Disease-Modifying Antirheumatic Drugs (DMARDs) and/or Biologic Therapy |
Completed |
Rheumatoid Arthritis |
NCT02001987 |
| a Phase II Study in Primary Central Nervous System Lymphoma |
Unknown status |
Primary Central Nervous System Lymphoma |
NCT00455286 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACZ885 in Patients With Rheumatoid Arthritis With Ongoing Treatment With Methotrexate |
Completed |
Rheumatoid Arthritis |
NCT00619905 |
| Gemcitabine Hydrochloride and Cisplatin or High-Dose Methotrexate, Vinblastine, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Urothelial Cancer |
Withdrawn |
Anterior Urethral Cancer|Localized Transitional Cell Cancer of the Renal Pelvis and Ureter|Posterior Urethral Cancer|Recurrent Bladder Cancer|Recurrent Urethral Cancer|Regional Transitional Cell Cancer of the Renal Pelvis and Ureter|Stage III Bladder Cancer|Transitional Cell Carcinoma of the Bladder|Ureter Cancer|Urethral Cancer Associated With Invasive Bladder Cancer |
NCT01639521 |
| Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed Primary CNS Lymphoma |
Completed |
Brain and Central Nervous System Tumors|Lymphoma |
NCT00416819 |
| Inflammation and Coronary Endothelial Function |
Active, not recruiting |
Coronary Artery Disease |
NCT02366091 |
| A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis (RA) |
Completed |
Rheumatoid Arthritis |
NCT02265705 |
| Five-year Actively Controlled Clinical Trial in New Onset Juvenile Dermatomyositis |
Unknown status |
Juvenile Dermatomyositis |
NCT00323960 |
| Study to Investigate the Safety and Efficacy of Tregalizumab in Subjects (MTX-IR) With Active Rheumatoid Arthritis |
Terminated |
Rheumatoid Arthritis |
NCT01999192 |
| CMAB008 With MTX Therapy in Adult Patients With Moderately to Severely Active Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT03478111 |
| A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Trial to Evaluate the Safety, Tolerability, and Efficacy of MK-8457 in Participants With Rheumatoid Arthritis (MK-8457-010) |
Terminated |
Rheumatoid Arthritis |
NCT01651936 |
| Prevention of Graft-Versus-Host Disease in Patients With Hematologic Malignancies Who Are Receiving a Bone Marrow Transplant |
Withdrawn |
Graft Versus Host Disease|Leukemia|Myelodysplastic Syndromes |
NCT00002790 |
| A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Juvenile Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis, Juvenile |
NCT00036374 |
| A Study of Liquid Certolizumab Pegol as Additional Medication to Methotrexate in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT00160602 |
| Study to Assess the Efficacy and Safety of Rituximab in Patients With Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT00074438 |
| Cardiovascular Inflammation Reduction Trial - Inflammation Imaging Study |
Completed |
Vascular Inflammation|Atherosclerotic Cardiovascular Disease |
NCT02576067 |
| The Effect of Folinic Acid Rescue Following MTX GVHD Prophylaxis on Regimen Related Toxicity and Transplantation Outcome |
Unknown status |
Graft vs Host Disease|Allogeneic Hematopoietic Cell Transplantation|Mucositis |
NCT02506231 |
| A Non-Comparative Study to Assess the Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis. |
Completed |
Rheumatoid Arthritis |
NCT00502996 |
| Open-Label Steroid Reduction Study of Adalimumab With Methotrexate in Patients With Active Rheumatoid Arthritis |
Terminated |
Rheumatoid Arthritis |
NCT00233558 |
| Comparison of Mycophenolate Mofetil and Cyclophosphamide for Active Takayasu's Arteritis |
Unknown status |
Takayasu Arteritis |
NCT03096275 |
| Combination Chemotherapy and Radiation Therapy With or Without Methotrexate in Treating Young Patients With Newly Diagnosed Gliomas |
Unknown status |
Brain and Central Nervous System Tumors |
NCT00278278 |
| Hepatitis A Vaccine in Patients With Immunomodulating Drugs |
Completed |
Response to Hepatitis A Vaccine |
NCT01360970 |
| Efficacy, Safety and Tolerability of ACZ885 in Patients With Active Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT00424346 |
| Prospective Clinical Trial Evaluating Metronomic Chemotherapy in Patients With High-grade, Operable, Non-metastatic Osteosarcoma of the Extremity |
Unknown status |
High Grade Osteosarcoma |
NCT02273583 |
| Study To Evaluate The Safety And Efficacy Of ILV-094 In Subjects With Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT00883896 |
| Atorvastatin as GVHD Prophylaxis for Allogeneic Hematopoietic Cell Transplantation |
Active, not recruiting |
Graft vs Host Disease |
NCT01665677 |
| Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in Treating Older Patients With Acute Lymphoblastic Leukemia |
Recruiting |
Acute Lymphoblastic Leukemia|B Acute Lymphoblastic Leukemia|B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1|Recurrent Acute Lymphoblastic Leukemia|Refractory Acute Lymphoblastic Leukemia |
NCT02143414 |
| Three Doses of Hepatitis A Vaccine in Patients With Immunomodulating Drugs |
Unknown status |
Vaccine Response Impaired |
NCT01446978 |
| LTA Pilot Study of Glucarpidase in Patients With Central Nervous System Lymphoma - ARM A |
Recruiting |
Central Nervous System Lymphoma |
NCT03684980 |
| Extended Use of Cannabidiol for the Prevention of Graft-versus-host-disease |
Unknown status |
Graft vs Host Disease |
NCT02478424 |
| Acute Graft-Versus-Host Disease (aGvHD) Prophylaxis With ATG-Fresenius in Matched Unrelated Donor-Stem Cell Transplantation (MUD-SCT) |
Completed |
Graft vs Host Disease |
NCT00655343 |
| A Study Assessing the Efficacy and Safety of Sarilumab Added to MTX in Japanese Patients With Moderately to Severely Active Rheumatoid Arthritis (SARIL-RA-KAKEHASI) |
Completed |
Rheumatoid Arthritis |
NCT02293902 |
| Safety and Efficacy of TAK-715 in Subjects With Rheumatoid Arthritis |
Completed |
Arthritis, Rheumatoid |
NCT00760864 |
| Safety Study to Evaluate Induction and Consolidation Treatment in Patients With Mantle Cell Lymphoma (LCM-04-02) |
Completed |
Mantle Cell Lymphoma |
NCT00505232 |
| Disease-Modifying Antirheumatic Drugs Cycle Combination Therapy Research |
Unknown status |
Rheumatoid Arthritis |
NCT01617590 |
| Community-Based Interventions for Infant Health in Nepal |
Unknown status |
Child Mortality |
NCT00656591 |
| Phase II Study Evaluating a Combination of Pegylated Liposomal Doxorubicin and Dexamethasone for the Treatment of Immunocompetent Patients With Cerebral Lymphoma Relapsed or Refractory to First-line Chemotherapy With High Dose Methotrexate (MTXHD) and / or High-dose Cytarabine. |
Terminated |
Cerebral Lymphoma B Cell Refractory |
NCT01848652 |
| A Pharmacokinetic/Pharmacodynamic Study Comparing PF-05280586 To Rituximab In Subjects With Active Rheumatoid Arthritis With An Inadequate Response To TNF Inhibitors (REFLECTIONS B328-01) |
Completed |
Rheumatoid Arthritis |
NCT01526057 |
| Chemotherapy and Radiation Therapy in Treating Patients With HIV-Related Primary Central Nervous System Lymphoma |
Unknown status |
Lymphoma |
NCT00003261 |
| Observation on the Treg in the Uveitis Patients |
Completed |
Uveitis |
NCT01306474 |
| Evaluating Etanercept Use in Patients With Moderate to Severe Rheumatoid Arthritis Who Have Lost Response to Adalimumab |
Terminated |
Moderate to Severe Rheumatoid Arthritis |
NCT01927757 |
| A Study to Evaluate the Efficacy, Safety and Pharmacokinetics/Pharmacodynamics (PK/PD) of Ocrelizumab in Patients With Rheumatoid Arthritis |
Terminated |
Rheumatoid Arthritis |
NCT00779220 |
| Cyclophosphamide, Methotrexate, and Fluorouracil, With or Without Epirubicin Hydrochloride, in Treating Women Who Have Undergone Surgery for Breast Cancer (Group III Closed to New Patients as of 12/7/2009) |
Unknown status |
Breast Cancer |
NCT01031030 |
| Study in Patients With Primary Breast Diffuse Large B-cell Lymphoma |
Completed |
Large B Cell Diffuse Lymphoma |
NCT01448096 |
| Bortezomib, Rituximab and Combination Chemotherapy in Treating Participants With Mantle Cell Lymphoma |
Active, not recruiting |
Mantle Cell Lymphoma |
NCT00477412 |
| Cesarean Scar Pregnancy Managed by Dilatation and Evacuation (D&E) Versus Hysteroscopic Surgery |
Recruiting |
Scar; Previous Cesarean Section |
NCT04205292 |
| REMission INDuction in Very Early Rheumatoid Arthritis |
Terminated |
Arthritis, Rheumatoid |
NCT02935387 |
| Bevacizumab With or Without Cyclophosphamide and Methotrexate: A Pilot Study in Women With Operable Breast Cancer |
Completed |
Breast Cancer |
NCT00121134 |
| A Randomized Trial of Chemotherapy in Surgical Patients With Infiltrating Ductal Carcinoma of Breast |
Recruiting |
Breast Cancer |
NCT02897700 |
| A Retrospective Non-intervention Study to Characterize FOlate Rescue Treatment in Osteosarcoma Patients Treated With HDMTX |
Completed |
Osteosarcoma |
NCT02383901 |
| S9716: Combination Chemotherapy in Treating Patients With Merkel Cell Cancer |
Completed |
Neuroendocrine Carcinoma of the Skin |
NCT00003549 |
| Randomized Study Comparing CMF and Goserelin + Tamoxifen in Premenopausal Receptor-Positive Patients |
Completed |
Early-Stage Breast Cancer |
NCT00309478 |
| Study Evaluating Multiple Doses Of ATN-103 In Subjects With Active Rheumatoid Arthritis |
Completed |
Active Rheumatoid Arthritis |
NCT00959036 |
| CD24Fc for the Prevention of Acute GVHD Following Myeloablative HSCT |
Not yet recruiting |
Hematopoietic Stem Cell Transplantation|Acute Graft Versus Host Disease|Acute Myeloid Leukemia|Acute Lymphoblastic Leukemia|Myelodysplastic Syndromes |
NCT04095858 |
| Study Comparing Etanercept With Usual DMARD Therapy in Subjects With Rheumatoid Arthritis in the Asia Pacific Region |
Completed |
Rheumatoid Arthritis |
NCT00422227 |
| A Randomized, Placebo-controlled Phase II Clinical Trial to Evaluate the Safety and Efficacy of F8IL10 (Dekavil) in Patients With Active RA Receiving MTX |
Unknown status |
Rheumatoid Arthritis |
NCT02270632 |
| Randomized, Controlled Trial to Test the Efficacy of Interferon Beta in the Treatment of Intermediate Uveitis |
Completed |
Uveitis, Intermediate|Macular Edema|Multiple Sclerosis |
NCT00344253 |
| Study Comparing The Effect On Disease Activity When Reducing Or Discontinuing Etanercept In Subjects With RA |
Completed |
Rheumatoid Arthritis |
NCT00858780 |
| Fenretinide in Children With Recurrent/Resistant ALL, AML, and NHL |
Completed |
Acute Myelogenous Leukemia|Acute Lymphoblastic Leukemia|Non-Hodgkin's Lymphoma |
NCT01187810 |
| Intrathecal DepoCyte and Lineage-targeted Minimal Residual Disease-oriented Therapy of Acute Lymphoblastic Leukemia |
Completed |
Acute Lymphoblastic Leukemia |
NCT00795756 |
| Phase II Study Evaluating Busulfan and Fludarabine as Preparative Therapy in Adults With Hematopoietic Disorders Undergoing MUD SCT |
Completed |
Chronic Myeloid Leukemia|Acute Myelogenous Leukemia|Myelodysplasia|Acute Lymphocytic Leukemia|Severe Aplastic Anemia|Non-Hodgkin's Lymphoma|Lymphoproliferative Disease|Multiple Myeloma|Advanced Myeloproliferative Disease |
NCT00516152 |
| Bevacizumab With Etoposide and Cisplatin in Breast Cancer Patients With Brain and/or Leptomeningeal Metastasis |
Completed |
Breast Neoplasms|Leptomeningeal Metastasis|Brain Metastases |
NCT01281696 |
| Melphalan and Busulfan Followed By Donor Peripheral Stem Cell Transplant, Tacrolimus, and Methotrexate in Treating Patients With Multiple Myeloma |
Completed |
Multiple Myeloma and Plasma Cell Neoplasm |
NCT00313625 |
| Effect of SAR153191 (REGN88) With Methotrexate in Patients With Active Rheumatoid Arthritis Who Failed TNF-α Blockers |
Terminated |
Rheumatoid Arthritis |
NCT01217814 |
| Gene Expression Profiling in Patients With Invasive Bladder Cancer Receiving Methotrexate, Vinblastine, Doxorubicin, and Cisplatin |
Terminated |
Bladder Cancer |
NCT00516750 |
| Maintenance Metronomic Chemotherapy for Metastatic Colorectal Carcinoma |
Terminated |
Colorectal Cancer Metastatic |
NCT01668680 |
| A Study of the Effect of Tocilizumab on Markers of Atherogenic Risk in Patients With Moderate to Severe Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT00535782 |
| A Study of Oral SCIO-469 Pharmacokinetics (Study of a Drug in the Body to Watch How the Drug is Absorbed, Distributed, Metabolized and Eliminated Over a Period of Time) in the Body of Female Patients With Active Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT00508768 |
| Trial for Patients With Newly Diagnosed Primary Central Nervous System (CNS) Lymphoma |
Completed |
Central Nervous System Lymphoma |
NCT01011920 |
| Standard Maintenance POMP/D Plus Ixazomib Maintenance Therapy in Adult Patients With Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma or Mixed Phenotype Acute Leukemia in Complete Remission (CR) |
Withdrawn |
Acute Lymphoblastic Leukemia in Complete Remission|Lymphoblastic Lymphoma in Complete Remission|Mixed Phenotype Acute Leukemia in Complete Remission |
NCT02578511 |
| The Effect of Some Drugs Used in Treatment of Vasculitis on the Complement System in Children |
Recruiting |
Vasculitis |
NCT03692416 |
| Dose Optimization of Infliximab in Moderate to Severe Plaque Psoriasis (Study P05315) |
Terminated |
Psoriasis |
NCT00833053 |
| Combination Chemotherapy Followed By Peripheral Stem Cell Transplant in Treating Young Patients With Newly Diagnosed Supratentorial Primitive Neuroectodermal Tumors or High-Risk Medulloblastoma |
Active, not recruiting |
Untreated Childhood Medulloblastoma|Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor |
NCT00336024 |
| Pilot Study of MGd + High-dose MTX-Based Chemoimmunotherapy + RT for Newly Dx PCNSL |
Withdrawn |
Brain and Central Nervous System Tumors|Lymphoma|Neurotoxicity |
NCT00734773 |
| Temozolomide in Treatment of Patients With Primary Central Nervous System Lymphoma |
Unknown status |
Primary CNS Lymphoma |
NCT02934204 |
| Optimizing 6-mercaptopurine Therapy in Pediatric Acute Lymphoblastic Leukemia by Using Allopurinol |
Unknown status |
Lymphoblastic Leukemia, Acute, Childhood |
NCT03022747 |
| Severe Psoriatic Arthritis - Early intervEntion to Control Disease: the SPEED Trial |
Recruiting |
Psoriatic Arthritis |
NCT03739853 |
| Comparing Cyclophosphamide and Abatacept With Standard of Care Treatment Following Stem Cell Transplantation in Patients With Hematologic Malignancy |
Recruiting |
GVHD|Hematologic Neoplasms |
NCT03680092 |
| Visilizumab for the Prevention of Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation |
Terminated |
Graft Versus Host Disease |
NCT00720629 |
| S1314, Co-expression Extrapolation (COXEN) Program to Predict Chemotherapy Response in Patients With Bladder Cancer |
Active, not recruiting |
Bladder Cancer |
NCT02177695 |
| Pennsylvania |
Washington |
United States|Geisinger Wyoming Valley/Henry Cancer Center |
Uniontown |
| Effectiveness and Safety of Yisaipu Combined With Tripterygium Wilfordii for Active RA |
Recruiting |
Arthritis, Rheumatoid |
NCT03589833 |
| Combination Chemotherapy and Alemtuzumab in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia |
Terminated |
Recurrent Adult Acute Lymphoblastic Leukemia |
NCT00262925 |
| Skin Disease and Pulmonary Mortality After Transplantation |
Completed |
Pulmonary Mortality|Acute GVH Disease |
NCT03320928 |
| Chemotherapy for Relapsed Epstein Barr Virus Associated Lymphoma |
Terminated |
Epstein Barr Virus Associated Non Hodgkin's Lymphoma|Epstein Barr Virus Associated Hodgkin's Lymphoma|Post-Transplant Lymphoproliferative Disease |
NCT01964755 |
| Evaluation of the Long Term Safety, Tolerability and Efficacy of Two Dosing Regimens of Olokizumab (OKZ), in Subjects With Rheumatoid Arthritis (RA) Who Previously Completed 24 Weeks of Blinded Treatment in One of the Core Studies - CREDO 1, 2 or 3. |
Recruiting |
Rheumatoid Arthritis |
NCT03120949 |
| Safety, Tolerance, Pharmacokinetics and Activity of HE3286 in Patients With Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT00712114 |
| RABIOPRED - a Validation Study of Theranostic Test to PREDict Treatment Response of Anti-TNFα BIologicals in Rheumatoid Arthritis |
Terminated |
RheumatoId Arthritis |
NCT03016260 |
| Extension Study of Tocilizumab Long Term Treatment of Moderate to Severe Rheumatoid Arthritis Patients |
Completed |
Rheumatoid Arthritis |
NCT01347983 |
| Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia |
Completed |
Leukemia|Lymphoma |
NCT00005977 |
| Autoimmunity in Inner Ear Disease |
Terminated |
Hearing Loss, Sensorineural |
NCT00000361 |
| R2-MTX With Lenalidomide Maintenance in Newly-diagnosed PCNSL：a Multicenter Phase Ib/II Stuty |
Recruiting |
Primary Central Nervous System Lymphoma |
NCT04120350 |
| Idarubicin Based Combined Modality Therapy in Primary CNS Lymphoma |
Completed |
Primary Central Nervous System Lymphoma |
NCT00193973 |
| A Clinical Research on the Relation of Blood Drug Concentration and Calcium Folinate Rescued in High-dose MTX Therapy |
Unknown status |
Osteosarcoma |
NCT01758666 |
| Optimal Treatment for Women With a Persisting Pregnancy of Unknown Location |
Active, not recruiting |
Persistent Pregnancy of Unknown Location|Ectopic Pregnancy |
NCT02152696 |
| BG9924 in Combination With Methotrexate for Participants With Active Rheumatoid Arthritis |
Terminated |
Rheumatoid Arthritis |
NCT00458861 |
| 23-valent Polysaccharide Pneumococcal Vaccine in Juvenile Idiopathic Arthritis Patients Under Anti-TNF Therapy |
Completed |
Juvenile Idiopathic Arthritis |
NCT02196480 |
| R-MACLO-IVAM and Thalidomide in Untreated Mantle Cell Lymphoma |
Completed |
Lymphoma |
NCT00450801 |
| RCT for Women With a Persisting Pregnancy of Unknown Location |
Terminated |
Persistent Pregnancy of Unknown Location|Ectopic Pregnancy |
NCT01800162 |
| Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis |
Completed |
Arthritis, Psoriatic |
NCT01976364 |
| Preemptive HLA Genotyping for the Safe Use of Infliximab-combination Therapy in Inflammatory Bowel Disease |
Not yet recruiting |
Inflammatory Bowel Diseases|Ulcerative Colitis|Crohn Disease |
NCT04109300 |
| HIgh Dose Thymoglobulin Instead of Cyclosporine With a Low Dose of Thymoglobulin for GVHD Prophylaxis |
Not yet recruiting |
Graft-versus-host-disease|Relapse |
NCT03456817 |
| Phase IIb Study of Evobrutinib in Subjects With Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT03233230 |
| Efficacy and Safety of Fecal Microbiota Transplantation in Peripheral Psoriatic Arthritis |
Active, not recruiting |
Psoriatic Arthritis |
NCT03058900 |
| Safety and Preliminary Efficacy Study of V404 PDS in Uveitis |
Terminated |
Uveitis, Posterior|Uveitis, Intermediate |
NCT02125266 |
| Low-dose Recombinant Human IL-2 for the Treatment of Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT02467504 |
| An Efficacy and Safety Study of CNTO 148 Subcutaneous Injection Compared With Placebo in Patients With Active Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT00207714 |
| Safety and Effectiveness of MPCD Therapy on the Treatment of Malignant Pleural Effusion |
Not yet recruiting |
Lung Cancer|Breast Cancer|Malignant Pleural Effusion |
NCT04131231 |
| Low Dose Metronomic Poly-chemotherapy for Metastatic CRC |
Completed |
Colorectal Cancer |
NCT02280694 |
| Glucarpidase Effect on Severe Delayed HDM-clearance in Children Treated With High-dose Mtx in ALL |
Completed |
Acute Lymphoblastic Leukemia (ALL) |
NCT01305655 |
| Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia |
Completed |
Childhood B Acute Lymphoblastic Leukemia|Childhood T Acute Lymphoblastic Leukemia|Cognitive Side Effects of Cancer Therapy|Long-Term Effects Secondary to Cancer Therapy in Children|Neurotoxicity Syndrome|Psychological Impact of Cancer|Untreated Childhood Acute Lymphoblastic Leukemia |
NCT00437060 |
| Calcineurin Inhibitor-Free Interventions for Prevention of Graft-versus-Host Disease (BMT CTN 1301) |
Active, not recruiting |
Acute Leukemia|Myelodysplasia |
NCT02345850 |
| Macular Edema Ranibizumab v. Intravitreal Anti-inflammatory Therapy Trial |
Recruiting |
Uveitis|Macular Edema |
NCT02623426 |
| New Combination of Chemoimmunotherapy for Systemic B-cell Lymphoma With Central Nervous System Involvement |
Active, not recruiting |
Diffuse Large B-cell Lymphoma |
NCT02329080 |
| A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to a Single Anti-TNF Inhibitor. |
Completed |
Rheumatoid Arthritis |
NCT00576433 |
| SPRiNG: SCIO-469 Patients With Rheumatoid Arthritis Not Receiving Methotrexate |
Completed |
Arthritis, Rheumatoid |
NCT00089921 |
| Treatment of Refractory Adult-onset Still's Disease With Anakinra: a Randomized Study |
Completed |
Adult-Onset Still's Disease |
NCT01033656 |
| European Study in Bone Sarcoma Patients Over 40 Years |
Completed |
Spindle Cell Sarcoma of Bone|Osteosarcoma |
NCT02986503 |
| A Study of the Efficacy and Safety of Re-treatments With Rituximab in Patients With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Anti-tnfa Therapies |
Completed |
Rheumatoid Arthritis |
NCT02097745 |
| TNF-blocking Therapy in Combination With Disease-modifying Antirheumatic Drugs in Early Rheumatoid Arthritis |
Unknown status |
Rheumatoid Arthritis |
NCT00908089 |
| A Pilot Study of MabThera (Rituximab) Evaluated by MRI in Patients With Rheumatoid Arthritis. |
Completed |
Rheumatoid Arthritis |
NCT00502853 |
| Pharmacogenomic in Colombian Patients With Rheumatoid Arthritis |
Recruiting |
Pharmacological Action |
NCT03352622 |
| Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia |
Recruiting |
Acute Biphenotypic Leukemia|Acute Leukemia of Ambiguous Lineage|Acute Lymphoblastic Leukemia|Acute Myeloid Leukemia|Acute Undifferentiated Leukemia|Blastic Plasmacytoid Dendritic Cell Neoplasm|Lymphoblastic Lymphoma|Mixed Phenotype Acute Leukemia |
NCT03970096 |
| A Study of the Efficacy and Safety of TACI-antibody Fusion Protein Injection (RC18) in Subjects With Inadequate Response to MTX Due to Treat Moderate and Severe Rheumatoid Arthritis. |
Recruiting |
Moderate and Severe RheumatoId Arthritis |
NCT03016013 |
| Treatments Against RA and Effect on FDG-PET/CT |
Recruiting |
Arthritis, Rheumatoid |
NCT02374021 |
| Microbial Dysbiosis in Rheumatoid Arthritis |
Enrolling by invitation |
Rheumatoid Arthritis |
NCT03802890 |
| Quality of Life Study With Adalimumab in Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT00234936 |
| The Effect of Adalimumab Plus Methotrexate (MTX) Versus Placebo Plus MTX on Cartilage in (RA) Patients |
Terminated |
Rheumatoid Arthritis |
NCT02150473 |
| Study to Describe Real World Drug Retention Rate of the Tocilizumab at One Year |
Completed |
Rheumatoid Arthritis |
NCT02608112 |
| Combination Chemotherapy in Treating Patients With Stage IV Locally Advanced or Metastatic Bladder Cancer |
Completed |
Bladder Cancer |
NCT00005086 |
| Combination Chemotherapy in Treating Children With Stage III or Stage IV Non-Hodgkin's Lymphoma or Acute Lymphoblastic Leukemia |
Completed |
Leukemia|Lymphoma |
NCT00003217 |
| A Study of RO7123520 to Evaluate the Safety and Efficacy in Participants With Moderately To Severely Active Rheumatoid Arthritis (RA) Who Are Inadequately Responding to Anti-Tumor Necrosis Factor (TNF)-Alpha Therapy |
Terminated |
Rheumatoid Arthritis |
NCT03001219 |
| Discovery Stage IND EXEMPT NDA Clinical Research - Etoposide OS and Single Nucleotide Polymorphisms |
Active, not recruiting |
Small Cell Lung Cancer |
NCT03305341 |
| Dose-finding of Multiple Dose of BT061 in Patients With Active Rheumatoid Arthritis Incompletely Controlled on Stable Methotrexate (MTX) |
Completed |
Rheumatoid Arthritis |
NCT01481493 |
| A Study of Cyclophosphamide/Methotrexate/5-Fluorouracil (CMF) With Pegfilgrastim in Subjects With Breast Cancer |
Completed |
Breast Cancer |
NCT00124111 |
| Study Medication Adherence and Its Determinants in Chronic Disease Through the Example of Methotrexate in Chronic Inflammatory Rheumatism |
Completed |
Rheumatic Diseases |
NCT02926560 |
| Randomized Study: Standard of Care With or Without Atorvastatin for Prevention of GVHD for Matched Unrelated Donor BMT |
Recruiting |
Acute Myeloid Leukemia|Acute Lymphocytic Leukemia|Myelodysplastic Syndrome |
NCT03066466 |
| Study of Adalimumab Administered as Subcutaneous Injections in Adult Chinese Rheumatoid Arthritis Subjects Treated With Methotrexate |
Completed |
Rheumatoid Arthritis |
NCT00647920 |
| Rituximab and Combination Chemotherapy in Treating Patients With Previously Untreated Mantle Cell Lymphoma |
Active, not recruiting |
Mantle-Cell Lymphoma |
NCT00878254 |
| Safety Study of a Single Dose of REGN88(SAR153191)in Patients With Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT01055899 |
| Maraviroc-Based GVHD Prophylaxis in HLA-Unrelated and HLA-Mismatched Related Transplantation |
Unknown status |
Graft-versus-host Disease|Hematopoietic Stem Cell Transplantation |
NCT02799888 |
| A Study of Bevacizumab in Combination With Chemotherapy for Treatment of Osteosarcoma |
Completed |
Osteosarcoma|Malignant Fibrous Histiocytoma (MFH) of Bone |
NCT00667342 |
| U-Act-After: An Observational Study on Long-Term Efficacy of Tight Control RoActemra/Actemra (Tocilizumab) and/or Methotrexate in Patients With Early Rheumatoid Arthritis Who Have Participated in the U-Act-Early Study (ML22497) |
Completed |
Rheumatoid Arthritis |
NCT01918267 |
| The Clinical Efficacy and Safety of Iguratimod in RA and Early RA Patients for 6 Months Treatment |
Recruiting |
Arthritis, Rheumatoid |
NCT03855007 |
| MRD/Risk-oriented Therapy of Adult Ph- ALL Including Pegylated Asparaginase and Lineage-targeted Methotrexate |
Unknown status |
Untreated Philadelphia Positive Acute Lymphoblastic Leukemia|De Novo|Secondary|Low-dose Corticosteroids Pretreatment |
NCT02067143 |
| A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to a TNF-Blocker. |
Completed |
Rheumatoid Arthritis |
NCT00424502 |
| Study of Two Schedules of Infliximab Maintenance Therapy in Ankylosing Spondylitis |
Completed |
Ankylosing Spondylitis |
NCT00439283 |
| Efficacy and Safety of Adalimumab 80 mg Every Other Week With Methotrexate |
Unknown status |
Rheumatoid Arthritis |
NCT01270035 |
| A Study To Evaluate The Safety And Efficacy Of Tofacitinib Modified Release Tablets Compared To Tofacitinib Immediate Release Tablets In Adult Patients With Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT02281552 |
| Combination Chemotherapy in Patients With Newly Diagnosed BPDCN |
Recruiting |
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) |
NCT03599960 |
| Safety, Tolerability, Pharmacodynamics and Efficacy Study of TAB08 in Patients With Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT01990157 |
| Prospective Study on Intensive Early Rheumatoid Arthritis Treatment |
Completed |
Rheumatoid Arthritis |
NCT00480272 |
| LAMPP Trial for Peripheral and Cutaneous T-Cell Lymphoma |
Terminated |
T-Cell Lymphoma |
NCT00161239 |
| Treatment Outcome in Early Diffuse Cutaneous Systemic Sclerosis |
Completed |
Early Diffuse Cutaneous Systemic Sclerosis |
NCT02339441 |
| S0213 Chemotherapy Plus Rituximab in Treating Patients With Mantle Cell Lymphoma |
Completed |
Lymphoma |
NCT00041132 |
| Study to Demonstrate Non-Inferiority Efficacy and Safety of CinnoRA® Produced by CinnaGen Company Versus Humira® for Treatment of Active Rheumatoid Arthritis |
Completed |
Active Rheumatoid Arthritis |
NCT03172325 |
| COBRA-Slim With or Without Fast Access to TNF Blockade for Remission Induction in Early RA |
Recruiting |
Arthritis, Rheumatoid |
NCT03649061 |
| Evaluation of Effectiveness of Two Dosing Regimens of Fostamatinib Compared to Placebo in Patients With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate and Have Had Inadequate Response to Single TNF-alpha Antagonist |
Completed |
Rheumatoid Arthritis |
NCT01197755 |
| Phase II Study of Combined Modality Treatment in Primary Testicular Non-Hodgkin's Lymphoma |
Completed |
Lymphoma, B Cell |
NCT00210379 |
| BOW015 (Infliximab-EPIRUS) and Infliximab in Patients With Active Rheumatoid Arthritis: The UNIFORM Study |
Unknown status |
Rheumatoid Arthritis |
NCT02683564 |
| Safety & Efficacy of Atorvastatin for Prophylaxis of Acute Graft Versus Host Disease in Patients With Hematological Malignancies HLA- Donor Hematopoietic Stem Cell Transplantation |
Completed |
Acute Myelogenous Leukemia|Acute Lymphocytic Leukemia|Myelodysplastic Syndrome |
NCT01491958 |
| Early Immunosuppressants in Crohn's Disease |
Completed |
Crohn's Disease |
NCT00546546 |
| A Placebo Controlled Study to Assess Efficacy and Safety of Certolizumab Pegol in the Treatment of Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT00152386 |
| A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients |
Completed |
Arthritis, Rheumatoid |
NCT02260791 |
| Comparison of 2 Immunomodulator Withdrawal Schemes for Infliximab Monotherapy in Active Pediatric Crohn's Disease After Thiopurine Failure |
Terminated |
Crohn's Disease |
NCT01802593 |
| A Study to Compare FKB327 Long-term Safety, Efficacy and Immunogenicity With Humira® in Rheumatoid Arthritis Patients |
Completed |
Arthritis, Rheumatoid |
NCT02405780 |
| Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia |
Completed |
Leukemia |
NCT00003700 |
| Extension Study to Assess the Efficacy and Safety of Repeat Treatment With Rituximab (MabThera) in Participants With Active Rheumatoid Arthritis (RA) |
Completed |
Rheumatoid Arthritis |
NCT02093026 |
| Ketogenic Diet Adjunctive to HD-MTX Chemotherapy for Primary Central Nervous System Lymphoma |
Unknown status |
Primary Central Nervous System Lymphoma |
NCT02983942 |
| A Study of P38 Inhibitor (4) Monotherapy in Patients With Active Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT00303563 |
| A Phase 3 Study Comparing 2 Doses Of CP-690,550 And The Active Comparator, Humira (Adalimumab) Vs. Placebo For Treatment Of Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT00853385 |
| Tepotinib Phase II in Non-small Cell Lung Cancer (NSCLC) Harboring MET Alterations |
Recruiting |
Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer With MET Exon 14 (METex14) Skipping Alterations or MET Amplification |
NCT02864992 |
| A Phase 2 Study to Evaluate the Safety and Efficacy of YRA-1909 in Patients With Rheumatoid Arthritis |
Recruiting |
Rheumatoid Arthritis |
NCT03275025 |
| A Study of Tocilizumab in Patients With Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT01187563 |
| Brain Function in Children Previously Treated on Clinical Trials POG-9605 and POG-9201 |
Completed |
Long-term Effects Secondary to Cancer Therapy in Children|Neurotoxicity |
NCT00028509 |
| Open Label Study to Assess the Predictability of Early Response to Certolizumab Pegol in Patients With Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT01443364 |
| Donor Lymphocyte Infusion After Alternative Donor Transplantation |
Terminated |
Immunodeficiency |
NCT01027702 |
| Bortezomib-based GVHD Prophylaxis After Allogeneic Transplant for Patients Without Matched Related Donors |
Completed |
Leukemia|Lymphoma|Myelodysplastic Syndrome |
NCT01323920 |
| Randomized Double-blind Parallel Trial to Evaluate Equivalence in Efficacy and Safety of HD203 and Enbrel in RA Patients |
Completed |
Rheumatoid Arthritis |
NCT01270997 |
| Proof-of-Concept Study With BMS-817399 to Treat Moderate to Severe Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT01404585 |
| Clinical Study Comparing the New Immunosuppressive Drug Gusperimus With the Conventional Treatment in Wegener's Granulomatosis |
Terminated |
Wegeners Granulomatosis |
NCT01446211 |
| A Multiple-dose Study of the Safety and Tolerability of REGN88(SAR153191) in Rheumatoid Arthritis Subjects |
Completed |
Rheumatoid Arthritis |
NCT01011959 |
| Safety and Efficacy Study of Tranilast in Patients With Active Rheumatoid Arthritis (RA) |
Completed |
Active Rheumatoid Arthritis |
NCT00882024 |
| Study of NI-071 in Comparison With Remicade in Patients With Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT01567358 |
| Infliximab and Classic DMARDs in the Rheumatoid Arthritis Patients |
Unknown status |
Rheumatoid ArthritisďĽRA） |
NCT01915537 |
| Open Label Extension for Patients Coming From the Dosing Flexibility Study in Patients With Rheumatoid Arthritis (RA) |
Completed |
Rheumatoid Arthritis |
NCT00753454 |
| Safety and Efficacy Study of M2951 in Participants With Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT02784106 |
| Risk-Adapted Therapy for Young Children With Embryonal Brain Tumors, Choroid Plexus Carcinoma, High Grade Glioma or Ependymoma |
Active, not recruiting |
Brain and Central Nervous System Tumors |
NCT00602667 |
| Very Early Versus Delayed Etanercept in Patients With RA |
Completed |
Rheumatoid Arthritis |
NCT02433184 |
| Safety, Efficacy and Pharmacokinetics Study of ALD518 in Patients With Active Rheumatoid Arthritis |
Completed |
Arthritis, Rheumatoid |
NCT00867516 |
| Sequential Application of Yisaipu® and DMARDs in Treating Mild-to-Moderate AS |
Completed |
Ankylosing Spondylitis |
NCT03411798 |
| Efficacy, Safety, Pharmacokinetics and Immunogenicity Study of Abatacept Administered Intravenously to Treat Active Polyarticular-course Juvenile Idiopathic Arthritis in Japan |
Completed |
Juvenile Idiopathic Arthritis |
NCT01835470 |
| Study to Compare the Overall Survival of Patients Receiving INGN 201 (Study Drug) With Patients Receiving Methotrexate |
Unknown status |
Carcinoma, Squamous Cell |
NCT00041613 |
| Open-label, Extension Study of CDP870 in Patients With Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT01197066 |
| Chemotherapy Before Surgery in Treating Patients With High Grade Upper Urinary Tract Cancer |
Active, not recruiting |
Localized Urothelial Carcinoma of the Renal Pelvis and Ureter|Recurrent Urothelial Carcinoma of the Renal Pelvis and Ureter|Regional Urothelial Carcinoma of the Renal Pelvis and Ureter |
NCT02412670 |
| Study Evaluating 2 Dosing Regimens Of TRU-015 In Rheumatoid Arthritis |
Terminated |
Arthritis, Rheumatoid |
NCT00634933 |
| Maraviroc in Rheumatoid Arthritis |
Terminated |
Arthritis, Rheumatoid |
NCT00427934 |
| Safety, Tolerability and Efficacy of MBS2320 in Patients With Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT03139136 |
| An Efficacy and Safety Study of JNJ-38518168 in Adult Participants With Rheumatoid Arthritis |
Terminated |
Rheumatoid Arthritis |
NCT00941707 |
| Efficacy and Safety Study of R935788 Tablets to Treat Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT00665925 |
| Safety and Efficacy Study of GDC-0853 Compared With Placebo and Adalimumab in Participants With Rheumatoid Arthritis (RA) |
Completed |
Rheumatoid Arthritis |
NCT02833350 |
| Infliximab as Induction Therapy in Early Rheumatoid Arthritis (IDEA) |
Completed |
Rheumatoid Arthritis |
NCT01308255 |
| Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis |
Terminated |
Rheumatoid Arthritis |
NCT01285310 |
| Study to Evaluate SC Route of Administration of Ofatumumab in RA Patients |
Completed |
Arthritis, Rheumatoid |
NCT00686868 |
| Atacicept in Anti-Tumor Necrosis Factor Alpha-naĂŻve Subjects With Rheumatoid Arthritis (AUGUST II) |
Completed |
Rheumatoid Arthritis |
NCT00595413 |
| A Clinical Trial to Study the Effects of Revamilast in Patients With Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT01430507 |
| Alemtuzumab and Cyclosporine for the Prevention of Graft vs Host Disease After Stem Cell Transplants |
Completed |
Graft Versus Host Disease|Bone Marrow Transplantation |
NCT00775632 |
| Evaluation of Safety and Effectiveness of Fostamatinib Compared to Placebo in Patients in Asia With Rheumatoid Arthritis |
Terminated |
Rheumatoid Arthritis |
NCT01569074 |
| Adjuvant Chemotherapy for Elderly Non Frail Patients With an Increased Risk for Relapse of a Primary Carcinoma of the Breast |
Completed |
Breast Cancer |
NCT01204437 |
| My-HyperCVAD in the Treatment of Relapsed Refractory Adult Acute Lymphoid Leukemia |
Unknown status |
Lymphoid Leukemia |
NCT00801580 |
| Efficacy, Pharmacokinetics, Safety, and Immunogenicity Study of Abatacept Administered Subcutaneously to Treat Rheumatoid Arthritis in Japanese Patients |
Completed |
Rheumatoid Arthritis |
NCT01001832 |
| Study Evaluating TMI-005 in Active Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT00095342 |
| A Safety and Tolerability Study of REGN88(SAR153191) in Subjects With Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT01026519 |
| Optimal MTX Dose With Folic Acid Randomized Case-control Trial |
Recruiting |
Rheumatoid Arthritis |
NCT04066803 |
| Treatment of Newly Diagnosed High Risk Acute Lymphoblastic Leukemia in Children |
Recruiting |
Acute Lymphoblastic Leukemia|Child |
NCT02339350 |
| Study of Camrelizumab in Combination With Neoadjuvant Chemotherapy in the Treatment of Osteosarcoma |
Recruiting |
Osteosarcoma |
NCT04294511 |
| The GD-2008 ALL Protocol for Childhood Acute Lymphoblastic Leukemia |
Unknown status |
Acute Lymphoblastic Leukemia |
NCT00846703 |
| Comparison of Treatments to Maintain Disease Remission in Patients With Wegener's Granulomatosis and Related Vasculitis Syndromes |
Completed |
Vasculitis|Wegener's Granulomatosis |
NCT00004567 |
| PRINTO (the Paediatric Rheumatology International Trials Organisation) |
Unknown status |
Juvenile Idiopathic Arthritis |
NCT00415935 |
| Dose-Dense MVAC With Pegfilgrastim Support in Subjects With Muscle-Invasive Urothelial Carcinoma |
Completed |
Bladder Cancer|Muscle-invasive Bladder Cancer |
NCT00808639 |
| A Study of Ocrelizumab in Participants With Moderate to Severe Rheumatoid Arthritis (RA) |
Terminated |
Rheumatoid Arthritis |
NCT02720120 |
| Open-Label Study Comparing Etanercept to Conventional Disease Modifying Antirheumatic Drug (DMARD) Therapy |
Completed |
Rheumatoid Arthritis |
NCT00848354 |
| A Study of the Pharmacokinetics and Safety of MK-8808 (MK-8808-002) |
Terminated |
Rheumatoid Arthritis |
NCT01390441 |
| 4B951, Combination Chemotherapy in Treating Patients With Bladder Cancer |
Terminated |
Bladder Cancer |
NCT00005047 |
| Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA) |
Completed |
Rheumatoid Arthritis |
NCT02115750 |
| Study Evaluating Multiple Ascending Doses Of ATN-103 In Japanese Subjects With Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT01007175 |
| Combination Chemotherapy in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma |
Completed |
Lymphoma |
NCT00003311 |
| A Study of Efalizumab in Participants With Moderate to Severe Chronic Psoriasis Who Have Failed, Have a Contraindication to, or Are Intolerant of Other Systemic Therapies |
Completed |
Psoriasis |
NCT00249808 |
| The Comparative Trial of UFT + TAM With CMF + TAM in Adjuvant Therapy for Breast Cancer (CUBC) |
Completed |
Breast Cancer |
NCT00152178 |
| A Multi-Site Study to Evaluate the Safety and Effect of Study Drug on Participants With Rheumatoid Arthritis |
Completed |
Arthritis, Rheumatoid |
NCT00308282 |
| Dose-finding Study of GLPG0634 as Monotherapy in Active Rheumatoid Arthritis (RA) Patients (DARWIN2) |
Completed |
Rheumatoid Arthritis |
NCT01894516 |
| Discovery Stage IND EXEMPT SNP Clinical Study - Etoposide and Single Nucleotide Polymorphisms |
Active, not recruiting |
Small Cell Lung Cancer |
NCT01064466 |
| A Study to Assess Safety and Efficacy of ASP015K in Patients With Rheumatoid Arthritis (RA) Who Had an Inadequate Response or Intolerance to Methotrexate (MTX) |
Recruiting |
Rheumatoid Arthritis (RA) |
NCT03660059 |
| Standard of Care vs. Bortezomib in Graft-Versus Host Disease After Hematopoietic Stem Cell Transplant |
Completed |
Graft Versus Host Disease |
NCT01754389 |
| A Proof of Concept and Dose Ranging Study in Patients With Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT00713544 |
| Freiburg ZNS-NHL Study |
Unknown status |
Primary Non Hodgkin Lymphoma of the Central Nervous System |
NCT00647049 |
| QUILT-3.036: AMG 337 in Subjects With Advanced or Metastatic Solid Tumors |
Withdrawn |
Solid Tumor |
NCT03147976 |
| Clinical Efficacy of TNF-Kinoid in Patients With Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT01911234 |
| Study Evaluating the Efficacy and Safety of Etanercept in Chinese Subjects With Rheumatoid Arthritis |
Completed |
Arthritis, Rheumatoid |
NCT00443950 |
| Combination Chemotherapy in Treating Patients With Transitional Cell Cancer of the Urothelium |
Completed |
Bladder Cancer|Transitional Cell Cancer of the Renal Pelvis and Ureter|Urethral Cancer |
NCT00014274 |
| Treatment of Arthritis With Syk Kinase Inhibition (TASKI-1) |
Completed |
Rheumatoid Arthritis |
NCT00326339 |
| Long-term Treatment Study of CDP870 Self-injection in Patients With Active Rheumatoid Arthritis Who Are Participating in the Long-term Treatment Studies (Study 275-08-002 or Study 275-08-004) of CDP870 |
Completed |
Active Rheumatoid Arthritis |
NCT02586246 |
| A 6-month Randomised, Double-blind, Open Arm Comparator, Phase IIb, With AZD9056, in Patients With Rheumatoid Arthritis (RA) |
Completed |
Rheumatoid Arthritis |
NCT00520572 |
| Study to Investigate Safety, Tolerability, Pharmacokinetics, and Drug-drug Interaction of Multiple Oral Doses of BAY1830839 in Healthy Male Participants |
Recruiting |
Healthy Volunteers |
NCT03965728 |
| Evaluation of Therapeutic Strategies for Treatment of Ectopic Pregnancies (EP) and Evaluation of Subsequent Fertility |
Unknown status |
Tubal Pregnancy |
NCT00137982 |
| Pembrolizumab (MK-3475) Versus Standard Treatment for Recurrent or Metastatic Head and Neck Cancer (MK-3475-040/KEYNOTE-040) |
Active, not recruiting |
Head and Neck Squamous Cell Cancer |
NCT02252042 |
| Uncontrolled Study to Evaluate Efficacy of Tocilizumab in Patients With Moderate or Severe Rheumatoid Arthritis |
Unknown status |
Arthritis, Rheumatoid |
NCT02087696 |
| VELVET, a Dose Range Finding Trial of Veltuzumab in Subjects With Moderate to Severe Rheumatoid Arthritis |
Terminated |
Rheumatoid Arthritis |
NCT01390545 |
| Assessment of Safety, Pharmacokinetics and Efficacy in a Combination Treatment With SMP-114 |
Terminated |
Rheumatoid Arthritis (RA) |
NCT00296257 |
| Ofatumumab With IVAC Salvage Chemotherapy in Diffuse Large B Cell Lymphoma Patients |
Completed |
Diffuse Large B Cell Lymphoma |
NCT01481272 |
| A Study of CH-4051 in Patients With Rheumatoid Arthritis (RA) |
Completed |
Rheumatoid Arthritis |
NCT01116141 |
| Treatment of Early Aggressive Rheumatoid Arthritis (TEAR) |
Completed |
Rheumatoid Arthritis |
NCT00259610 |
| High-dose Chemotherapy and ASCT or Consolidating Conventional Chemotherapy in Primary CNS Lymphoma |
Unknown status |
Diffuse Large B-cell-lymphoma |
NCT02531841 |
| A Multicentre Trial to Determine the Efficacy of AD 452 in RA Subjects. |
Completed |
Rheumatoid Arthritis |
NCT00141934 |
| Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults Undergoing Allogeneic Blood and Marrow Transplantation |
Recruiting |
Hematologic Diseases|Acute Myeloid Leukemia in Remission|Acute Lymphoblastic Leukemia in Remission|Chronic Myelogenous Leukemia - Chronic Phase|Chronic Myelogenous Leukemia, Accelerated Phase|Chronic Myelogenous Leukemia, Blastic Phase|Myelodysplastic Syndromes|Mantle Cell Lymphoma|Follicular Lymphoma|Diffuse Large B Cell Lymphoma|Non Hodgkin Lymphoma|Graft Vs Host Disease|Graft-versus-host-disease |
NCT03842696 |
| Low-Dose/Metronomic(LDM)Chemotherapy for Metastatic Breast Cancer |
Terminated |
Chemotherapy|Breast Cancer, Metastatic |
NCT01067989 |
| Abatacept for GVHD Prophylaxis After Hematopoietic Stem Cell Transplantation for Pediatric Sickle Cell Disease |
Recruiting |
Sickle Cell Disease|Graft Versus Host Disease |
NCT02867800 |
| An Observational Study of Infliximab Injection in Ankylosing Spondylitis, Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis Participants |
Completed |
Spondylitis, Ankylosing|Arthritis, Rheumatoid|Psoriasis|Arthritis, Psoriatic |
NCT00760669 |
| Bruton's Tyrosine Kinase (BTK) Inhibitor, Ibrutinib, in Patients With Refractory/Recurrent Primary Central Nervous System Lymphoma (PCNSL) and Refractory/Recurrent Secondary Central Nervous System Lymphoma (SCNSL) |
Active, not recruiting |
Refractory/Recurrent Primary Central Nervous System Lymphoma (PCNSL)|Refractory/Recurrent Secondary Central Nervous System Lymphoma (SCNSL) |
NCT02315326 |
| High-Dose Sequential Chemoimmunotherapy for B-Cell Lymphomas With Central Nervous System Involvement |
Unknown status |
B-Cell Lymphomas |
NCT00801216 |
| R-MPV Followed by Nivolumab in Older (≥65) Pts With Previously Untreated Primary CNS Lymphoma |
Recruiting |
Brain and Nervous System|Eye and Orbit |
NCT04022980 |
| Outcome After MTX & Transvaginal Surgery or UAE & Uterine Curettage in Patients With Cesarean Scar Pregnancy |
Unknown status |
Cesarean Scar Pregnancy|Menstruation |
NCT03218059 |
| A Study in Participants With Moderate to Severe Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT01711359 |
| 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours |
or speak with your personal physician. |
Korea |
contact 1-877-CTLILLY (1-877-285-4559 |
| Efficacy of Novel Drug-combinations for Relief of Psoriasis |
Suspended |
Psoriasis |
NCT02394301 |
| A Study to Investigate the Use of Golimumab (Simponi®) in Participants With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis (P06554) |
Completed |
Arthritis, Rheumatoid|Arthritis, Psoriatic|Spondylitis, Ankylosing |
NCT01313858 |
| Effectiveness in Daily Practice of Different Treatment Strategies for Early Rheumatoid Arthritis. |
Completed |
Rheumatoid Arthritis |
NCT01172639 |
| Intercontinental Multidisciplinary Registry and Treatment Optimization Study for Choroid Plexus Tumors |
Terminated |
Brain Cancer|Choroid Plexus Tumors |
NCT01014767 |
| Bevacizumab, Metronomic Chemotherapy (CM), Diet and Exercise After Preoperative Chemotherapy for Breast Cancer |
Active, not recruiting |
Breast Cancer |
NCT00925652 |
| Dose Dense MVAC for Muscle Invasive Bladder Cancer |
Completed |
Muscle Invasive Bladder Cancer|High Risk Urothelial Carcinoma of the Upper Urinary Tracts |
NCT01031420 |
| ABCB1/P-glycoprotein Expression as Biologic Stratification Factor for Patients With Non Metastatic Osteosarcoma |
Active, not recruiting |
Osteosarcoma |
NCT01459484 |
| Modified Stem Cell Transplant Procedure to Treat Patients With Blood and Immune System Cancers |
Completed |
Hematologic Neoplasms |
NCT00051311 |
| Clofarabine With Cytarabine for Patients With Minimal Residual Disease Positive Leukemia |
Terminated |
Minimal Residual Disease|Leukemia, Lymphoblastic, Acute|Leukemia, Myelogenous, Acute |
NCT01158885 |
| A Novel Single Arm Phase II Study for Relapsed Germ Cell Tumours With Poor Prognosis |
Recruiting |
Germ Cell Tumour |
NCT01782339 |
| Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Primary CNS Lymphoma |
Completed |
Lymphoma |
NCT00003061 |
| A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Rheumatoid Arthritis. |
Completed |
Arthritis, Rheumatoid |
NCT00036387 |
| A Study on The Safety of Administering Rituximab at A More Rapid Rate in Patients With Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT01382940 |
| Radiotherapy Alone Versus Concurrent Chemoradiation in Low Risk NK/T-cell Lymphoma |
Terminated |
Extranodal NK/T-cell Lymphoma, Nasal Type |
NCT01667289 |
| An Exploratory Study of the Safety and Efficacy of Prophylactic Immunomodulatory Treatment in Myozyme-naive Cross-Reacting Immunologic Material (CRIM[-]) Patients With Infantile-Onset Pompe Disease |
Completed |
Pompe Disease|Glycogen Storage Disease Type II |
NCT00701129 |
| Golimumab in Rheumatoid Arthritis Participants With an Inadequate Response to Etanercept (ENBREL) or Adalimumab (HUMIRA) |
Completed |
Arthritis|Arthritis, Rheumatoid|Autoimmune Diseases |
NCT01004432 |
| The Clinical Efficacy and Safety of Tacrolimus in Refractory Rheumatoid Arthritis Patients for 6 Months Treatment |
Recruiting |
Arthritis, Rheumatoid |
NCT02837978 |
| Trial of Nivolumab vs Therapy of Investigator's Choice in Recurrent or Metastatic Head and Neck Carcinoma (CheckMate 141) |
Active, not recruiting |
Squamous Cell Carcinoma of the Head and Neck |
NCT02105636 |
| Efficacy and Safety of TwHF and MTX in Patients With Rheumatoid Arthritis |
Unknown status |
Rheumatoid Arthritis |
NCT03324412 |
| Chemoresistance of Trophoblastic Tumors |
Unknown status |
Trophoblastic Tumor |
NCT03488901 |
| A Specification Clinical Application Research of Tripterygium Wilfordii Treating Rheumatoid Arthritis |
Unknown status |
Rheumatoid Arthritis |
NCT03337815 |
| A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNFα Inhibitor |
Completed |
Rheumatoid Arthritis |
NCT01851070 |
| Phase II Trial of CD24Fc for the Prevention of Acute GVHD Following Myeloablative Allogeneic HSCT |
Active, not recruiting |
Graft Versus Host Disease|Hematopoietic Stem Cell Transplantation|Leukemia |
NCT02663622 |
| Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult T-LBL/ALL |
Recruiting |
Leukemia|Leukemia, Acute|Adult Lymphoblastic Lymphoma|Leukemia, Lymphoblastic|Leukemia, T Cell|Adult Acute Lymphoblastic Leukemia|Lymphoblastic Lymphoma|Lymphoblastic Leukemia |
NCT03564704 |
| Liposomal Cytarabine for Central Nervous System (CNS)-Treatment in High-risk Acute Lymphoblastic Leukemia (ALL) |
Suspended |
Acute Lymphoblastic Leukemia |
NCT00991744 |
| Assessing the Long Term Effectiveness and Safety of Biotherapies in the Treatment of Cutaneous Psoriasis |
Recruiting |
Psoriasis |
NCT01617018 |
| Rituximab (RTX) Therapy in Patients With Active TAO |
Recruiting |
Ophthalmopathy, Thyroid-Associated |
NCT02378298 |
| Study on Tailored Treatment in Elderly Patients With Newly Diagnosed Primary Lymphoma of Central Nervous System |
Recruiting |
Primary Central Nervous System Lymphoma |
NCT03495960 |
| ZD6474 (Zactima) and Metronomic Chemotherapy in Advanced Breast Cancer |
Completed |
Metastatic Breast Cancer |
NCT00496665 |
| Protocol For the Treatment Acute Lymphoblastic Leukemia With Ph 'Negative in Elderly Patients (> 55 Years) |
Recruiting |
Acute Lymphoblastic Leukemia |
NCT01366898 |
| Clinical Guidelines for APL Treatment |
Recruiting |
APL |
NCT02020161 |
| A Pilot Study of Allopurinol As A Modifier of 6-MP Metabolism in Pediatric ALL |
Recruiting |
Acute Lymphoblastic Leukemia (ALL) |
NCT02046694 |
| Defining the Molecular Profile of Breast Cancer in Uganda and Its Clinical Implications |
Suspended |
Breast Cancer Female |
NCT03518242 |
| CINJALL: Treatment for Children With Acute Lymphocytic Leukemia |
Completed |
Acute Lymphocytic Leukemia |
NCT00176462 |
| MT-R Followed by Autologous Stem Cells Transplantation in Newly-diagnosed Primary Central Nervous System Lymphoma |
Unknown status |
Primary Central Nervous System Lymphoma |
NCT02399189 |
| H-9926-LCH III: Treatment Protocol of the Third International Study for Langerhans Cell Histiocytosis |
Completed |
Leukemia |
NCT00488605 |
| Total Therapy Study XVI for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia |
Active, not recruiting |
Acute Lymphoblastic Leukemia |
NCT00549848 |
| ANG1005 in Leptomeningeal Disease From Breast Cancer |
Not yet recruiting |
Leptomeningeal Carcinomatosis|Leptomeningeal Metastases|Brain Metastases|HER2-negative Breast Cancer |
NCT03613181 |
| Understanding the Pathogenesis and Treatment of Childhood Onset Dermatomyositis |
Terminated |
Dermatomyositis |
NCT00035958 |
| Phase II Study of Chemotherapy and Pamidronate for the Treatment of Newly Diagnosed Osteosarcoma |
Completed |
Osteosarcoma |
NCT00586846 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), Proof of Mechanism of GSK2618960 in Primary Sjögren's Syndrome (pSS) |
Withdrawn |
Autoimmune Diseases |
NCT03239600 |
| Open-label, Pilot Protocol of Patients With Rheumatoid Arthritis Who Switch to Infliximab After Incomplete Response to Etanercept |
Completed |
Rheumatoid Arthritis |
NCT00317538 |
| Ibrutinib, Rituximab, and Consolidation Chemotherapy in Treating Young Patients With Newly Diagnosed Mantle Cell Lymphoma |
Active, not recruiting |
Blastoid Variant Mantle Cell Lymphoma|CD20 Positive|Mantle Cell Lymphoma|Pleomorphic Variant Mantle Cell Lymphoma |
NCT02427620 |
| A Clinical Study of a Natural Remedy for Rheumatoid Arthritis vs. Commonly Used Conventional Medications |
Completed |
Rheumatoid Arthritis |
NCT01600521 |
| Rituximab and Combination Chemotherapy in Treating Patients With Primary Central Nervous System Lymphoma |
Terminated |
Lymphoma |
NCT00335140 |
| High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Combination Chemotherapy in Treating Women With High-Risk Breast Cancer |
Completed |
Breast Cancer |
NCT00002784 |
| Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplant (HSCT) For Lymphoma |
Withdrawn |
Lymphoma |
NCT02724904 |
| Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls (BMT CTN 1203) |
Completed |
Acute Leukemia|Chronic Myelogenous Leukemia|Myelodysplasia|Chronic Lymphocytic Leukemia|Small Lymphocytic Lymphoma|Lymphoma, B-Cell|Lymphoma, Follicular|Lymphoma, Large B-Cell, Diffuse|Hodgkin's Lymphoma |
NCT02208037 |
| Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Un-Related Stem Cell Transplantation |
Completed |
Acute Myelogenous Leukemia|Graft Versus Host Disease|Acute Lymphoblastic Leukemia|Chronic Myelogenous Leukemia|Myelodysplastic Syndromes|Non-Hodgkin's Lymphoma|Hodgkin's Disease |
NCT00144677 |
| Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed, Non-metastatic Desmoplastic Medulloblastoma |
Active, not recruiting |
Desmoplastic/Nodular Medulloblastoma|Medulloblastoma|Medulloblastoma With Extensive Nodularity|Nevoid Basal Cell Carcinoma Syndrome|Untreated Childhood Medulloblastoma |
NCT02017964 |
| Phase II, Open Label, International, Multicentre Clinical Trial to Investigate Safety and Efficacy of Oral ITF2357 in Patients With Active Systemic Onset Juvenile Idiopathic Arthritis (SOJIA) |
Completed |
Active Systemic|Onset Juvenile Idiopathic Arthritis |
NCT00570661 |
| Two-Drug Combination Chemotherapy Compared With Four-Drug Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium |
Completed |
Bladder Cancer|Transitional Cell Cancer of the Renal Pelvis and Ureter|Urethral Cancer |
NCT00003376 |
| Crenolanib in Combination With Sorafenib in Patients With Refractory or Relapsed Hematologic Malignancies |
Completed |
Acute Myeloid Leukemia |
NCT02270788 |
| Trial to Evaluate Palifermin in the Reduction of Acute Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Allogeneic Marrow/Peripheral Blood Progenitor Cell (PBPC) Transplantation |
Completed |
Graft Versus Host Disease|Hematologic Malignancies |
NCT00189488 |
| Brentuximab Vedotin or Crizotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II-IV Anaplastic Large Cell Lymphoma |
Suspended |
Anaplastic Large Cell Lymphoma, ALK-Positive|Ann Arbor Stage II Noncutaneous Childhood Anaplastic Large Cell Lymphoma|Ann Arbor Stage III Noncutaneous Childhood Anaplastic Large Cell Lymphoma|Ann Arbor Stage IV Noncutaneous Childhood Anaplastic Large Cell Lymphoma|CD30-Positive Neoplastic Cells Present |
NCT01979536 |
| Evaluation of the Effectiveness and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking an Existing Medication Called a Tumour Necrosis Factor Alpha Inhibitor But Have Active Disease |
Recruiting |
Rheumatoid Arthritis |
NCT02760433 |
| Weight Reduction Alone May Not be Sufficient to Maintain Disease Remission in Obese Patients With Psoriasis |
Unknown status |
Psoriasis |
NCT01439425 |
| A Study of Tocilizumab in Patients With Active Polyarticular Juvenile Idiopathic Arthritis |
Completed |
Juvenile Idiopathic Arthritis |
NCT00988221 |
| Cyclophosphamide and Busulfan Followed by Donor Stem Cell Transplant in Treating Patients With Myelofibrosis, Acute Myeloid Leukemia, or Myelodysplastic Syndrome |
Completed |
Adult Acute Myeloid Leukemia in Remission|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Del(5q)|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)|Childhood Acute Myeloid Leukemia in Remission|Childhood Myelodysplastic Syndromes|de Novo Myelodysplastic Syndromes|Essential Thrombocythemia|Myelodysplastic Syndrome With Isolated Del(5q)|Polycythemia Vera|Previously Treated Myelodysplastic Syndromes|Primary Myelofibrosis|Recurrent Adult Acute Myeloid Leukemia|Recurrent Childhood Acute Myeloid Leukemia|Secondary Acute Myeloid Leukemia|Secondary Myelodysplastic Syndromes|Secondary Myelofibrosis|Untreated Adult Acute Myeloid Leukemia|Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies |
NCT00445744 |
| A Study of RoActemra/Actemra (Tocilizumab) in Patients With Active Systemic Juvenile Idiopathic Arthritis (JIA) |
Completed |
Juvenile Idiopathic Arthritis |
NCT00642460 |
| Re-Induction Therapy for Relapsed Pediatric T-Cell Acute Lymphoblastic Leukemia or Lymphoma |
Terminated |
Acute Lymphoblastic Leukemia|Lymphoma, Non-Hodgkin's|Leukemia, T-Cell|Leukemia, B-Cell |
NCT02518750 |
| Efficacy and Safety Study of ATG for Prophylaxis of aGVHD in Matched Sibling Donor PBSCT |
Unknown status |
aGVHD |
NCT02677181 |
| Gene Expression Profiling in PBMCs as a Tool for Prediction of Anakinra Responsiveness in Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT00213538 |
| Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Central Nervous System Lymphoma |
Completed |
Lymphoma |
NCT00003632 |
| Gene Expression Profiling in PBMCs as a Tool for Prediction of Infliximab Responsiveness in Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT00213564 |
| STep-up and Step-down Therapeutic Strategies in Childhood ARthritiS |
Recruiting |
Oligoarthritis, Juvenile|Polyarthritis, Juvenile, Rheumatoid Factor Negative |
NCT03728478 |
| Fludarabine, Bendamustine, and Rituximab in Treating Participants With Lymphoid Cancers Undergoing Stem Cell Transplant |
Completed |
CD20 Positive|Chronic Lymphocytic Leukemia|Follicular Lymphoma|Mantle Cell Lymphoma|Marginal Zone Lymphoma|Recurrent Diffuse Large B-Cell Lymphoma|T-Cell Non-Hodgkin Lymphoma |
NCT00880815 |
| Doxorubicin Hydrochloride Liposome and Rituximab With Combination Chemotherapy in Treating Patients With Newly Diagnosed Burkitt's Lymphoma or Burkitt-Like Lymphoma |
Completed |
Lymphoma |
NCT00392990 |
| Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia |
Completed |
Leukemia |
NCT00002744 |
| Combination Chemotherapy and Filgrastim Before Surgery in Treating Patients With HER2-Positive Breast Cancer That Can Be Removed By Surgery |
Completed |
Estrogen Receptor-negative Breast Cancer|Estrogen Receptor-positive Breast Cancer|HER2-positive Breast Cancer|Progesterone Receptor-negative Breast Cancer|Progesterone Receptor-positive Breast Cancer|Stage IA Breast Cancer|Stage IB Breast Cancer|Stage II Breast Cancer|Stage IIIA Breast Cancer |
NCT00194779 |
| Videocapillaroscopy Assessment During Systemic Agent Therapy in Psoriasis |
Recruiting |
Psoriasis |
NCT02162472 |
| A Study of Efficacy of Rituximab [Mabthera/Rituxan] in Patients With Rheumatoid Arthritis Using Magnetic Resonance Imaging of the Hand (RESONAR) |
Terminated |
Rheumatoid Arthritis |
NCT01117129 |
| Efficacy of Basiliximab in the Prevention of Acute Graft-versus-host Disease in Unrelated Allogeneic Hematopoietic Stem Cell Transplantation Therapy for Thalassemia Major |
Unknown status |
Beta-Thalassemia Major |
NCT02342145 |
| Myeloid-Derived Suppressor Cells and Checkpoint Immune Regulators' Expression in Allogeneic SCT Using FluBuATG |
Active, not recruiting |
Leukemia, Lymphoid|Leukemia, Myeloid|Myelodysplastic Syndromes|Myelofibrosis|Lymphoma, Malignant|Multiple Myeloma|Waldenstrom Macroglobulinemia |
NCT02916979 |
| Comparison of Different Combination Chemotherapy Regimens in Treating Children With Acute Lymphoblastic Leukemia |
Completed |
Leukemia |
NCT00005945 |
| Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma |
Recruiting |
NK-Cell Lymphoma|NK-Cell Leukemia|Peripheral T Cell Lymphoma |
NCT03719105 |
| High-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin Lymphoma |
Completed |
Accelerated Phase Chronic Myelogenous Leukemia|Adult Acute Lymphoblastic Leukemia in Remission|Adult Acute Megakaryoblastic Leukemia (M7)|Adult Acute Monoblastic Leukemia (M5a)|Adult Acute Monocytic Leukemia (M5b)|Adult Acute Myeloblastic Leukemia With Maturation (M2)|Adult Acute Myeloblastic Leukemia Without Maturation (M1)|Adult Acute Myeloid Leukemia in Remission|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Del(5q)|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With T(15;17)(q22;q12)|Adult Acute Myeloid Leukemia With T(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With T(8;21)(q22;q22)|Adult Acute Myelomonocytic Leukemia (M4)|Adult Acute Promyelocytic Leukemia (M3)|Adult Erythroleukemia (M6a)|Adult Nasal Type Extranodal NK/T-cell Lymphoma|Adult Pure Erythroid Leukemia (M6b)|Anaplastic Large Cell Lymphoma|Angioimmunoblastic T-cell Lymphoma|Burkitt Lymphoma|Childhood Acute Erythroleukemia (M6)|Childhood Acute Lymphoblastic Leukemia in Remission|Childhood Acute Megakaryocytic Leukemia (M7)|Childhood Acute Monoblastic Leukemia (M5a)|Childhood Acute Monocytic Leukemia (M5b)|Childhood Acute Myeloblastic Leukemia With Maturation (M2)|Childhood Acute Myeloblastic Leukemia Without Maturation (M1)|Childhood Acute Myeloid Leukemia in Remission|Childhood Acute Myelomonocytic Leukemia (M4)|Childhood Acute Promyelocytic Leukemia (M3)|Childhood Chronic Myelogenous Leukemia|Childhood Myelodysplastic Syndromes|Chronic Phase Chronic Myelogenous Leukemia|Cutaneous B-cell Non-Hodgkin Lymphoma|De Novo Myelodysplastic Syndromes|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue|Hepatosplenic T-cell Lymphoma|Intraocular Lymphoma|Nodal Marginal Zone B-cell Lymphoma|Peripheral T-Cell Lymphoma|Post-transplant Lymphoproliferative Disorder|Previously Treated Myelodysplastic Syndromes|Recurrent Adult Acute Lymphoblastic Leukemia|Recurrent Adult Acute Myeloid Leukemia|Recurrent Adult Burkitt Lymphoma|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent Adult Diffuse Mixed Cell Lymphoma|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma|Recurrent Adult Grade III Lymphomatoid Granulomatosis|Recurrent Adult Hodgkin Lymphoma|Recurrent Adult Immunoblastic Large Cell Lymphoma|Recurrent Adult Lymphoblastic Lymphoma|Recurrent Adult Non-Hodgkin Lymphoma|Recurrent Adult T-cell Leukemia/Lymphoma|Recurrent Childhood Acute Lymphoblastic Leukemia|Recurrent Childhood Acute Myeloid Leukemia|Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma|Recurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Grade 3 Follicular Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Marginal Zone Lymphoma|Recurrent Mycosis Fungoides/Sezary Syndrome|Recurrent Small Lymphocytic Lymphoma|Refractory Multiple Myeloma|Relapsing Chronic Myelogenous Leukemia|Secondary Myelodysplastic Syndromes|Small Intestine Lymphoma|Splenic Marginal Zone Lymphoma|Testicular Lymphoma|Waldenstrom Macroglobulinemia |
NCT01177371 |
| Draining PLN and Synovial Inflammation in RA Knee Joints Pre and Post Anti-TNF or B Cell Depletion Therapy |
Terminated |
Rheumatoid Arthritis |
NCT01083563 |
| Evaluate if Response to Infliximab or Adalimumab May be Regained With an Immunomodulator |
Terminated |
Inflammatory Bowel Disease|Ulcerative Colitis|Crohn's Disease |
NCT02413047 |
| Mycophenolate Mofetil for the Prophylaxis of Graft-versus-host Disease in High Risk Allogeneic Stem Cell Transplantation |
Unknown status |
Graft vs Host Disease|Hematopoietic Stem Cell Transplantation |
NCT00563589 |
| Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies |
Completed |
Accelerated Phase Chronic Myelogenous Leukemia|Adult Acute Lymphoblastic Leukemia in Remission|Adult Acute Myeloid Leukemia in Remission|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Del(5q)|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)|Adult Grade III Lymphomatoid Granulomatosis|Adult Nasal Type Extranodal NK/T-cell Lymphoma|Anaplastic Large Cell Lymphoma|Angioimmunoblastic T-cell Lymphoma|Aplastic Anemia|Burkitt Lymphoma|Childhood Acute Lymphoblastic Leukemia in Remission|Childhood Acute Myeloid Leukemia in Remission|Childhood Chronic Myelogenous Leukemia|Childhood Diffuse Large Cell Lymphoma|Childhood Grade III Lymphomatoid Granulomatosis|Childhood Immunoblastic Large Cell Lymphoma|Childhood Myelodysplastic Syndromes|Childhood Nasal Type Extranodal NK/T-cell Lymphoma|Chronic Myelomonocytic Leukemia|Chronic Phase Chronic Myelogenous Leukemia|Congenital Amegakaryocytic Thrombocytopenia|Diamond-Blackfan Anemia|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue|Hepatosplenic T-cell Lymphoma|Juvenile Myelomonocytic Leukemia|Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable|Nodal Marginal Zone B-cell Lymphoma|Paroxysmal Nocturnal Hemoglobinuria|Peripheral T-cell Lymphoma|Polycythemia Vera|Post-transplant Lymphoproliferative Disorder|Previously Treated Myelodysplastic Syndromes|Primary Myelofibrosis|Recurrent Adult Acute Lymphoblastic Leukemia|Recurrent Adult Acute Myeloid Leukemia|Recurrent Adult Burkitt Lymphoma|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent Adult Diffuse Mixed Cell Lymphoma|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma|Recurrent Adult Grade III Lymphomatoid Granulomatosis|Recurrent Adult Hodgkin Lymphoma|Recurrent Adult Immunoblastic Large Cell Lymphoma|Recurrent Adult Lymphoblastic Lymphoma|Recurrent Adult T-cell Leukemia/Lymphoma|Recurrent Childhood Acute Lymphoblastic Leukemia|Recurrent Childhood Acute Myeloid Leukemia|Recurrent Childhood Anaplastic Large Cell Lymphoma|Recurrent Childhood Grade III Lymphomatoid Granulomatosis|Recurrent Childhood Large Cell Lymphoma|Recurrent Childhood Lymphoblastic Lymphoma|Recurrent Childhood Small Noncleaved Cell Lymphoma|Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma|Recurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Grade 3 Follicular Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Marginal Zone Lymphoma|Recurrent Mycosis Fungoides/Sezary Syndrome|Recurrent Small Lymphocytic Lymphoma|Recurrent/Refractory Childhood Hodgkin Lymphoma|Refractory Chronic Lymphocytic Leukemia|Refractory Hairy Cell Leukemia|Refractory Multiple Myeloma|Secondary Acute Myeloid Leukemia|Secondary Myelodysplastic Syndromes|Secondary Myelofibrosis|Severe Combined Immunodeficiency|Severe Congenital Neutropenia|Shwachman-Diamond Syndrome|Splenic Marginal Zone Lymphoma|T-cell Large Granular Lymphocyte Leukemia|Waldenstrom Macroglobulinemia|Wiskott-Aldrich Syndrome |
NCT01529827 |
| CTOP/ITE/MTX Compared With CHOP as the First-line Therapy for Newly Diagnosed Young Patients With T Cell Lymphoma |
Unknown status |
ALK-negative Anaplastic Large Cell Lymphoma|Peripherial T Cell Lymphoma,Not Otherwise Specified|Angioimmunoblastic T Cell Lymphoma|Enteropathy Associated T Cell Lymphoma|Hepatosplenic T Cell Lymphoma|Subcutaneous Panniculitis Like T Cell Lymphoma |
NCT01746992 |
| Study of Therapeutic Options for Subjects Discontinuing Efalizumab and Experiencing Disease Recurrence |
Completed |
Psoriasis |
NCT01079988 |
| Weekly Docetaxel and CMF in the Adjuvant Treatment of Elderly Women With High-Risk Breast Cancer |
Completed |
Breast Cancer |
NCT00193011 |
| The Use of Chemotherapy Plus Radiotherapy Plus Azidothymidine in Patients With AIDS-Related Lymph Node Cancer |
Terminated |
Lymphoma, Non-Hodgkin|HIV Infections |
NCT00000723 |
| Psoriatic Oligoarthritis Intervention With Symptomatic thErapy |
Recruiting |
Psoriatic Arthritis |
NCT03797872 |
| Induction of Remission in RA Patients at Low Disease Activity by Additional Infliximab Therapy (Study P04644AM1) (TERMINATED) |
Terminated |
Rheumatoid Arthritis |
NCT00521924 |
| Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia |
Completed |
Accelerated Phase Chronic Myelogenous Leukemia|Adult Acute Lymphoblastic Leukemia in Remission|Adult Acute Myeloid Leukemia in Remission|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Del(5q)|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)|Blastic Phase Chronic Myelogenous Leukemia|Childhood Acute Lymphoblastic Leukemia in Remission|Childhood Acute Myeloid Leukemia in Remission|Childhood Chronic Myelogenous Leukemia|Childhood Myelodysplastic Syndromes|Chronic Myelomonocytic Leukemia|de Novo Myelodysplastic Syndromes|Previously Treated Myelodysplastic Syndromes|Recurrent Adult Acute Lymphoblastic Leukemia|Recurrent Adult Acute Myeloid Leukemia|Recurrent Childhood Acute Lymphoblastic Leukemia|Recurrent Childhood Acute Myeloid Leukemia|Secondary Myelodysplastic Syndromes|Untreated Adult Acute Lymphoblastic Leukemia|Untreated Childhood Acute Lymphoblastic Leukemia |
NCT00860574 |
| Bortezomib, Vorinostat and Dexamethasone for Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) |
Terminated |
Acute Lymphoblastic Leukemia |
NCT01312818 |
| Swiss Dermatology Network of Targeted Therapies (SDNTT) |
Recruiting |
Psoriasis |
NCT01706692 |
| Comparison of Telephone Follow-up With In-person Follow-up After Medical Abortion |
Completed |
Medical; Abortion, Fetus |
NCT01943279 |
| Etanercept in Rheumatoid Arthritis and Vascular Inflammation |
Terminated |
Rheumatoid Arthritis|Vascular Inflammation |
NCT02109289 |
| Donor Stem Cell Transplant in Treating Young Patients With Acute Myeloid Leukemia With Monosomy 7, -5/5q-, High FLT3-ITD AR, or Refractory or Relapsed Acute Myelogenous Leukemia |
Unknown status |
Leukemia |
NCT00553202 |
| Busulfan, Fludarabine Phosphate, and Anti-Thymocyte Globulin Followed By Donor Stem Cell Transplant and Azacitidine in Treating Patients With High-Risk Myelodysplastic Syndrome and Older Patients With Acute Myeloid Leukemia |
Active, not recruiting |
Acute Myeloid Leukemia|Adult Acute Megakaryoblastic Leukemia|Adult Acute Monoblastic Leukemia|Adult Acute Monocytic Leukemia|Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11|Adult Acute Myeloid Leukemia With Maturation|Adult Acute Myeloid Leukemia With Minimal Differentiation|Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11|Adult Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1|Adult Acute Myeloid Leukemia With t(9;11)(p21.3;q23.3); MLLT3-KMT2A|Adult Acute Myeloid Leukemia Without Maturation|Adult Acute Myelomonocytic Leukemia|Adult Erythroleukemia|Adult Pure Erythroid Leukemia|Alkylating Agent-Related Acute Myeloid Leukemia|de Novo Myelodysplastic Syndrome|Myelodysplastic Syndrome|Myelodysplastic Syndrome With Excess Blasts|Recurrent Adult Acute Myeloid Leukemia|Secondary Myelodysplastic Syndrome |
NCT01168219 |
| Alemtuzumab, Fludarabine, and Busulfan Followed By Donor Stem Cell Transplant in Treating Young Patients With Hematologic Disorders |
Completed |
Congenital Amegakaryocytic Thrombocytopenia|Diamond-blackfan Anemia|Leukemia|Myelodysplastic Syndromes|Severe Congenital Neutropenia |
NCT00301834 |
| MESA Treatment for NK/T Cell Lymphoma |
Unknown status |
Lymphoma, Extranodal NK-T-Cell |
NCT01933282 |
| A Study of the Efficacy and Safety of TACI-antibody Fusion Protein Injection (RC18) in Subjects With Inadequate Response to TNF-α Antagonists Due to Treat Moderate and Severe Rheumatoid Arthritis |
Terminated |
Moderate and Severe Rheumatoid Arthritis |
NCT02882087 |
| A Study of Mavrilimumab Versus Anti Tumor Necrosis Factor in Subjects With Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT01715896 |
| A Study Comparing SB5 to Humira® in Subjects With Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy |
Completed |
Rheumatoid Arthritis |
NCT02167139 |
| Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia or Advanced Lymphoblastic Non-Hodgkin's Lymphoma |
Completed |
Cardiac Toxicity|Leukemia|Lymphoma |
NCT01230983 |
| Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Malignancies or Secondary Myelodysplasia Previously Treated With High-Dose Chemotherapy and Autologous Stem Cell Transplant |
Terminated |
Leukemia|Lymphoma|Lymphoproliferative Disorder|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Myelodysplastic/Myeloproliferative Neoplasms |
NCT01118013 |
| A Study to Evaluate the Impact of Apremilast (CC-10004) on MRI Outcomes in Subjects With Psoriatic Arthritis |
Recruiting |
Psoriatic Arthritis |
NCT03783026 |
| Augmented Berlin-Frankfurt-Munster (BFM) Therapy for Adolescent/Young Adults With Acute Lymphoblastic Leukemia or Acute Lymphoblastic Lymphoma |
Completed |
Lymphoblastic Leukemia|Lymphoblastic Lymphoma |
NCT00866749 |
| Phase 2, Multicenter, Open-Label Extension Study With ABT-122 in Rheumatoid Arthritis Subjects Who Have Completed the Preceding M12-963 Study |
Completed |
Rheumatoid Arthritis |
NCT02433340 |
| MRI Evaluation Assessing Synovitis to Address the Unmet Need for Reliable Endpoints in SLE |
Recruiting |
Systemic Lupus Erythematosus Arthritis |
NCT03355482 |
| Efficacy Confirmation Trial of CDP870 as add-on Medication to Methotrexate (MTX) in Japanese Rheumatoid Arthritis (RA) |
Completed |
Rheumatoid Arthritis |
NCT00791999 |
| Comparison of MTX+Anti-TNF to MTX+Conventional DMARDs in Patients With Early Rheumatoid Arthritis (RA) Who Failed MTX Alone (SWEFOT) |
Completed |
Rheumatoid Arthritis |
NCT00764725 |
| Efficacy Confirmation Trial of CDP870 Without Coadministration of Methotrexate (MTX) in Japanese Rheumatoid Arthritis (RA) |
Completed |
Rheumatoid Arthritis |
NCT00791921 |
| Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological Cancer |
Completed |
Chronic Myeloproliferative Disorders|Graft Versus Host Disease|Infection|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Myelodysplastic/Myeloproliferative Neoplasms|Precancerous Condition|Secondary Myelofibrosis|Small Intestine Cancer |
NCT00589563 |
| Characterize Patients With Moderately Active Rheumatoid Arthritis (RA) |
Completed |
Rheumatoid Arthritis |
NCT01557322 |
| Immune Tolerance Induction Study |
Terminated |
Pompe Disease|Glycogen Storage Disease Type II (GSD-II)|Glycogenesis 2 Acid Maltase Deficiency |
NCT00701701 |
| Faecal Analyses in Rheumatoid Arthritis Therapy |
Completed |
Rheumatoid Arthritis |
NCT03775824 |
| LSA4 Protocol for the Treatment of Advanced Pediatric and Adolescent Non-Hodgkins Lymphoma |
Completed |
Non-Hodgkin's Lymphoma |
NCT00610883 |
| Treatment for Patients With Stage III or IV Non-Hodgkin Lymphoma |
Completed |
Lymphoblastic Lymphoma |
NCT00187122 |
| Fludarabine and Busulfan Followed by Allogeneic Stem Cell Transplant in Treating Older Patients With Acute Myeloid Leukemia in First Complete Remission |
Completed |
Adult Acute Myeloid Leukemia in Remission|Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome |
NCT00070135 |
| Substudy - Low Dose of Abatacept in Subjects With Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT00989235 |
| Assessment Of The Safety And Efficacy Of BG9924 In Rheumatoid Arthritis (RA) Participants |
Completed |
Rheumatoid Arthritis |
NCT00664716 |
| The Efficacy and Safety of Fang yi Qing Feng Shi Granules in Subjects With Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT02029599 |
| Efficacy of Fluoroscopic Guided Atlantoaxial Joint Injection on Head and Neck Pain and Sleep Quality in RA Patients |
Recruiting |
Pain, Head|Sleep Disturbance |
NCT03606707 |
| Improvement of Hand Dysfunction by Arthritis in Systemic Sclerosis |
Unknown status |
Systemic Sclerosis|Arthritis |
NCT01834157 |
| Comparison of the Effectiveness of Two Different Dosages of Cortisone Compared to Placebo in Rheumatoid Arthritis |
Active, not recruiting |
Progression of Rheumatoid Arthritis |
NCT02000336 |
| Treatment of Acute Lymphoblastic Leukemia Ph '(BCR / ABL) Positive Patients Aged > 55 Years |
Recruiting |
Acute Lymphoblastic Leukemia Ph Positive |
NCT01376427 |
| A Pilot Trial of Sequential Chemotherapy With Antimetabolite Induction, High-Dose Alkylating Agent Consolidation With Peripheral Blood Progenitor Cell Support, and Intensification With Paclitaxel and Doxorubicin for Patients With High-Risk Breast Cancer |
Completed |
Breast Cancer|Breast Neoplasms |
NCT00001498 |
| Durvalumab and Standard Chemotherapy Before Surgery in Treating Patients With Variant Histology Bladder Cancer |
Recruiting |
Bladder Adenocarcinoma|Bladder Mixed Adenocarcinoma|Bladder Squamous Cell Carcinoma|Bladder Urothelial Carcinoma|Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant|Infiltrating Bladder Urothelial Carcinoma With Giant Cells|Infiltrating Bladder Urothelial Carcinoma With Glandular Differentiation|Infiltrating Bladder Urothelial Carcinoma With Trophoblastic Differentiation|Infiltrating Bladder Urothelial Carcinoma, Clear Cell Variant|Infiltrating Bladder Urothelial Carcinoma, Micropapillary Variant|Infiltrating Bladder Urothelial Carcinoma, Nested Variant|Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant |
NCT03912818 |
| Stem Cell Transplantation for Metastatic Solid Tumors |
Completed |
Neoplasm Metastasis |
NCT00001880 |
| Selinexor in Combination With Fludarabine and Cytarabine in Patients With Refractory or Relapsed Acute Myeloid Leukemia |
Terminated |
Acute Myeloid Leukemia (AML) |
NCT03071276 |
| Treatment of Acute Lymphoblastic Leukemia HIGH RISK BCR / ABL NEGATIVE IN ADULTS |
Completed |
Acute Lymphoblastic Leukemia |
NCT01540812 |
| Selinexor With Fludarabine and Cytarabine for Treatment of Refractory or Relapsed Leukemia or Myelodysplastic Syndrome |
Completed |
Acute Myeloid Leukemia (AML)|Acute Lymphoblastic Leukemia (ALL)|Myelodysplastic Syndrome (MDS)|Mixed Phenotype Acute Leukemia (MPAL) |
NCT02212561 |
| HeadStart4: Newly Diagnosed Children (<10 y/o) With Medulloblastoma and Other CNS Embryonal Tumors |
Recruiting |
Medulloblastoma|Central Nervous System Embryonal Tumors |
NCT02875314 |
| Combined Immunochemotherapy Followed By Reduced Dose Radiation Therapy (RT) for Patients With Newly Diagnosed Primary Central Nervous System Lymphoma |
Completed |
Lymphoma |
NCT00594815 |
| A proSpective Randomized Controlled Trial comParing infliximAb-antimetabolites Combination Therapy to Anti-metabolites monotheRapy and Infliximab monothErapy in Crohn's Disease Patients in Sustained Steroid-free Remission on Combination Therapy |
Active, not recruiting |
Crohn's Disease |
NCT02177071 |
| Feasibility Study of Interval Compressed Regimen Using Four-drugs for Osteosarcoma |
Not yet recruiting |
Osteosarcoma|Feasibility|Treatment Response|Biomarker |
NCT03390946 |
| the Effects and Safety of Idarubicin-strengthened Pretreatment Program and Conventional Busulfan Cyclophosphamide Pretreatment Program on High-risk Acute Myeloid Leukemia Patient |
Unknown status |
Acute Myeloid Leukemia |
NCT01766375 |
| Study to Assess Compliance With Long-Term Mercaptopurine Treatment in Young Patients With Acute Lymphoblastic Leukemia in Remission |
Active, not recruiting |
Childhood Acute Lymphoblastic Leukemia in Remission |
NCT00268528 |
| Augmented Berlin-Frankfurt-Munster Therapy Plus Ofatumumab for Young Adults With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma |
Terminated |
Leukemia|Precursor-B Acute Lymphoblastic Leukemia|Lymphoblastic Lymphoma|Lymphoma |
NCT02419469 |
| Efficacy Study of Leflunomide to Treat Juvenile Idiopathic Arthritis |
Unknown status |
Juvenile Idiopathic Arthritis |
NCT02024334 |
| Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy |
Recruiting |
B Acute Lymphoblastic Leukemia|B Lymphoblastic Lymphoma|Central Nervous System Leukemia|Mixed Phenotype Acute Leukemia|Testicular Leukemia |
NCT03959085 |
| Efficacy and Safety of Traditional Chinese Medicine (TCM) Comprehensive Therapy in Patients With Rheumatoid Arthritis |
Unknown status |
Rheumatoid Arthritis |
NCT02551575 |
| Remicade Safety Line (Study P03236)(COMPLETED) |
Completed |
Arthritis, Rheumatoid |
NCT00748826 |
| Study of Safety and Efficacy of BCD-020 Comparing to MabThera in Patients With Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT01759030 |
| Vaccine Therapy and GM-CSF in Treating Patients With CNS Lymphoma |
Withdrawn |
Brain and Central Nervous System Tumors|Lymphoma|Lymphoproliferative Disorder|Small Intestine Cancer |
NCT00621036 |
| Intergroup Randomized Trial for Children or Adolescents With B-Cell Non Hodgkin Lymphoma or B-Acute Leukemia: Rituximab Evaluation in High Risk Patients |
Active, not recruiting |
B-cell Non Hodgkin Lymphoma|Mature B-cell Leukemia Burkitt-type |
NCT01516580 |
| Acupuncture Study on Rheumatoid Arthritis, Monitoring Microbiome and Blood |
Completed |
Rheumatoid Arthritis |
NCT01619176 |
| TBE-vaccine to Patients With Rheumatoid Arthritis Who Are Using Immunosuppressive Drugs |
Completed |
Rheumatoid Arthritis|Exposed to TBE-virus|Immunosuppression |
NCT01131910 |
| Factors Associated With Biologic DMARD Switching |
Completed |
Rheumatoid Arthritis |
NCT02346942 |
| A Study to Compare Efficacy and Safety of CT-P17 With Humira in Patients With Active Rheumatoid Arthritis |
Active, not recruiting |
Rheumatoid Arthritis |
NCT03789292 |
| Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer |
Completed |
Hematopoietic/Lymphoid Cancer|Accelerated Phase Chronic Myelogenous Leukemia|Adult Acute Lymphoblastic Leukemia in Remission|Adult Acute Myeloid Leukemia in Remission|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)|Atypical Chronic Myeloid Leukemia|Blastic Phase Chronic Myelogenous Leukemia|Childhood Acute Lymphoblastic Leukemia in Remission|Childhood Acute Myeloid Leukemia in Remission|Childhood Chronic Myelogenous Leukemia|Childhood Myelodysplastic Syndromes|Chronic Eosinophilic Leukemia|Chronic Myelomonocytic Leukemia|Chronic Neutrophilic Leukemia|Chronic Phase Chronic Myelogenous Leukemia|Contiguous Stage II Adult Burkitt Lymphoma|Contiguous Stage II Adult Diffuse Large Cell Lymphoma|Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma|Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma|Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma|Contiguous Stage II Adult Lymphoblastic Lymphoma|Contiguous Stage II Grade 1 Follicular Lymphoma|Contiguous Stage II Grade 2 Follicular Lymphoma|Contiguous Stage II Grade 3 Follicular Lymphoma|Contiguous Stage II Mantle Cell Lymphoma|Contiguous Stage II Marginal Zone Lymphoma|Contiguous Stage II Small Lymphocytic Lymphoma|de Novo Myelodysplastic Syndromes|Essential Thrombocythemia|Extramedullary Plasmacytoma|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue|Graft Versus Host Disease|Isolated Plasmacytoma of Bone|Juvenile Myelomonocytic Leukemia|Meningeal Chronic Myelogenous Leukemia|Myelodysplastic/Myeloproliferative Disease, Unclassifiable|Nodal Marginal Zone B-cell Lymphoma|Noncontiguous Stage II Adult Burkitt Lymphoma|Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma|Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma|Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma|Noncontiguous Stage II Adult Lymphoblastic Lymphoma|Noncontiguous Stage II Grade 1 Follicular Lymphoma|Noncontiguous Stage II Grade 2 Follicular Lymphoma|Noncontiguous Stage II Grade 3 Follicular Lymphoma|Noncontiguous Stage II Mantle Cell Lymphoma|Noncontiguous Stage II Marginal Zone Lymphoma|Noncontiguous Stage II Small Lymphocytic Lymphoma|Previously Treated Myelodysplastic Syndromes|Primary Myelofibrosis|Recurrent Adult Acute Lymphoblastic Leukemia|Recurrent Adult Acute Myeloid Leukemia|Recurrent Adult Burkitt Lymphoma|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent Adult Diffuse Mixed Cell Lymphoma|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma|Recurrent Adult Grade III Lymphomatoid Granulomatosis|Recurrent Adult Hodgkin Lymphoma|Recurrent Adult Lymphoblastic Lymphoma|Recurrent Adult T-cell Leukemia/Lymphoma|Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma|Recurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Grade 3 Follicular Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Marginal Zone Lymphoma|Recurrent Mycosis Fungoides/Sezary Syndrome|Recurrent Small Lymphocytic Lymphoma|Recurrent/Refractory Childhood Hodgkin Lymphoma|Refractory Chronic Lymphocytic Leukemia|Refractory Hairy Cell Leukemia|Relapsing Chronic Myelogenous Leukemia|Secondary Myelodysplastic Syndromes|Stage I Adult Burkitt Lymphoma|Stage I Adult Diffuse Large Cell Lymphoma|Stage I Adult Diffuse Mixed Cell Lymphoma|Stage I Adult Diffuse Small Cleaved Cell Lymphoma|Stage I Adult Hodgkin Lymphoma|Stage I Adult Immunoblastic Large Cell Lymphoma|Stage I Adult Lymphoblastic Lymphoma|Stage I Adult T-cell Leukemia/Lymphoma|Stage I Childhood Hodgkin Lymphoma|Stage I Chronic Lymphocytic Leukemia|Stage I Cutaneous T-cell Non-Hodgkin Lymphoma|Stage I Grade 1 Follicular Lymphoma|Stage I Grade 2 Follicular Lymphoma|Stage I Grade 3 Follicular Lymphoma|Stage I Mantle Cell Lymphoma|Stage I Marginal Zone Lymphoma|Stage I Multiple Myeloma|Stage I Mycosis Fungoides/Sezary Syndrome|Stage I Small Lymphocytic Lymphoma|Stage II Adult Hodgkin Lymphoma|Stage II Adult T-cell Leukemia/Lymphoma|Stage II Chronic Lymphocytic Leukemia|Stage II Cutaneous T-cell Non-Hodgkin Lymphoma|Stage II Multiple Myeloma|Stage II Mycosis Fungoides/Sezary Syndrome|Stage III Adult Burkitt Lymphoma|Stage III Adult Diffuse Large Cell Lymphoma|Stage III Adult Diffuse Mixed Cell Lymphoma|Stage III Adult Diffuse Small Cleaved Cell Lymphoma|Stage III Adult Hodgkin Lymphoma|Stage III Adult Immunoblastic Large Cell Lymphoma|Stage III Adult Lymphoblastic Lymphoma|Stage III Adult T-cell Leukemia/Lymphoma|Stage III Chronic Lymphocytic Leukemia|Stage III Cutaneous T-cell Non-Hodgkin Lymphoma|Stage III Grade 1 Follicular Lymphoma|Stage III Grade 2 Follicular Lymphoma|Stage III Grade 3 Follicular Lymphoma|Stage III Mantle Cell Lymphoma|Stage III Marginal Zone Lymphoma|Stage III Multiple Myeloma|Stage III Mycosis Fungoides/Sezary Syndrome|Stage III Small Lymphocytic Lymphoma|Stage IV Adult Burkitt Lymphoma|Stage IV Adult Diffuse Large Cell Lymphoma|Stage IV Adult Diffuse Mixed Cell Lymphoma|Stage IV Adult Diffuse Small Cleaved Cell Lymphoma|Stage IV Adult Hodgkin Lymphoma|Stage IV Adult Immunoblastic Large Cell Lymphoma|Stage IV Adult Lymphoblastic Lymphoma|Stage IV Adult T-cell Leukemia/Lymphoma|Stage IV Chronic Lymphocytic Leukemia|Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma|Stage IV Grade 1 Follicular Lymphoma|Stage IV Grade 2 Follicular Lymphoma|Stage IV Grade 3 Follicular Lymphoma|Stage IV Marginal Zone Lymphoma|Stage IV Mycosis Fungoides/Sezary Syndrome|Stage IV Small Lymphocytic Lymphoma |
NCT00489203 |
| A Study of Ocrelizumab Compared to Placebo in Patients With Active Rheumatoid Arthritis Who Don't Have a Response to Anti-TNF-α Therapy (SCRIPT) |
Terminated |
Rheumatoid Arthritis |
NCT00476996 |
| Neurocognitive Risks in Children With Solid Tumors |
Recruiting |
Solid Tumor in Children |
NCT03609112 |
| A Study of Japanese Rheumatoid Arthritis Participants |
Completed |
Rheumatoid Arthritis |
NCT01253291 |
| A Study to Determine the Efficacy of Taclonex Topical Suspension as a Supplement to Non-biologic Systemic Therapy |
Completed |
Psoriasis |
NCT01761019 |
| Measurement of the Structural Efficacy in Active RA Patients Treated With Sarilumab in Combination With MTX and Naive to Biologics |
Recruiting |
Rheumatoid Arthritis |
NCT03535402 |
| Chemotherapy and Unrelated Donor Stem Cell Transplantation for Patients With Cancers of the Blood and Immune System |
Completed |
Myelodysplastic Syndrome|Hodgkin's Lymphoma|Non-Hodgkin's Disease|Acute Leukemia|Multiple Myeloma |
NCT00520130 |
| A Study to Assess Benefits of Apremilast in Patients With Moderate to Severe Chronic Plaque Psoriasis Followed by Dermatologists Under Real Life Settings in France |
Recruiting |
Psoriasis |
NCT03757013 |
| Treatment of Burkitt Lymphoma/Leukemia and B Large Cell NHL |
Completed |
Non-Hodgkin Lymphoma|Acute Lymphoblastic Leukemia, Mature B-Cell |
NCT00187161 |
| TOLERA: Tolerance Enhancement in RA |
Recruiting |
Rheumatoid Arthritis |
NCT04120831 |
| An Open-label Extension Study of Certolizumab Pegol in Chinese Patients With Rheumatoid Arthritis Who Enrolled in RA0044 |
Completed |
Rheumatoid Arthritis |
NCT02319642 |
| Comparative Analysis of Outcomes Among Patients Initiating Xeljanz in Combination With Oral MTX Who Withdraw MTX Versus Continue MTX |
Completed |
Rheumatoid Arthritis |
NCT03975790 |
| A Study of LY2439821 in Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT01236118 |
| Evaluation of Tabalumab Using Auto-Injector or Prefilled Syringe in Participants With Rheumatoid Arthritis (RA) |
Terminated |
Rheumatoid Arthritis |
NCT01676701 |
| Response to Treatment With Intravenous Abatacept Adults With Rheumatoid Arthritis |
Not yet recruiting |
Rheumatoid Arthritis |
NCT03700021 |
| Treatment Protocol of Children With Philadelphia Chromosome Negative High Risk Acute Lymphoblastic Leukemia |
Unknown status |
Childhood Acute Lymphoblastic Leukemia|Philadelphia Chromosome, Ph^1^, Absent|B-cell Childhood Acute Lymphoblastic Leukemia |
NCT01990807 |
| Coronary Flow Reserve to Assess Cardiovascular Inflammation (CIRT-CFR) |
Completed |
Coronary Heart Disease|Metabolic Syndrome|Diabetes Mellitus |
NCT02786134 |
| A Study for Japanese Participants With Rheumatoid Arthritis (RA) |
Completed |
Rheumatoid Arthritis |
NCT01253226 |
| Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer |
Completed |
Myeloproliferative Disorders|Kidney Cancer|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Myelodysplastic/Myeloproliferative Diseases |
NCT00787761 |
| Observational Study Assessing Outcomes, Treatment Patterns and Related Costs in Patients in Bullous Pemphigoid |
Unknown status |
Bullous Pemphigoid |
NCT02837965 |
| Two Combination Chemotherapy Regimens in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia |
Completed |
Leukemia |
NCT00707083 |
| A Study in Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT01253265 |
| A Phase IIb Study for ALX-0061 Monotherapy in Subjects With Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT02287922 |
| A Study of JHL1101 Versus MabThera® in Subjects With Severe Rheumatoid Arthritis |
Terminated |
Rheumatoid Arthritis|Arthritis, Rheumatoid |
NCT03161457 |
| Concomitant Chemo-radiotherapy Followed by MIDLE Chemotherapy in Stage I/II Extranodal NK/T-cell Lymphoma |
Completed |
Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-Type |
NCT01238159 |
| 506U78 in Treating Patients With Refractory Hematologic Cancer |
Completed |
Recurrent Childhood Acute Lymphoblastic Leukemia|Recurrent Childhood Lymphoblastic Lymphoma|T-cell Childhood Acute Lymphoblastic Leukemia |
NCT00002970 |
| A Study of Herceptin (Trastuzumab) in Combination Chemotherapy in Women With Locally Advanced Breast Cancer |
Completed |
Breast Cancer |
NCT01998906 |
| The Effect of Certolizumab Pegol on MRI Synovitis and Bone Edema in Rheumatoid Arthritis Patients |
Completed |
Rheumatoid Arthritis |
NCT01213017 |
| Modified MRCUKALLâ…«/ECOGE2993 Regimen for ALL |
Unknown status |
Leukaemia,Lymphoblastic |
NCT02660762 |
| Hybrid Immunotherapy for Hemophagocytic LymphoHistiocytosis |
Completed |
Hemophagocytic Lymphohistiocytosis |
NCT01104025 |
| High-dose Chemotherapy With Rituximab for Adults With Aggressive Large B-cell Lymphoma |
Completed |
B-Cell Lymphoma |
NCT00965289 |
| A Phase 2 Study to Evaluate the Efficacy and Safety of 60mg of MM-093 in Patients With Active Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT00458146 |
| Low-dose Chemotherapy Combine With Tyrosine Kinase Inhibitor to Treat ph+ Acute Lymphoblastic Leukemia Patients |
Unknown status |
ph+ Acute Lymphoblastic Leukemia |
NCT02690922 |
| Abatacept Versus Adalimumab Head-to-Head |
Completed |
Rheumatoid Arthritis |
NCT00929864 |
| Chemotherapy Plus Rituximab Combination for Adult Lymphoblastic Leukemia (B-ALL) and Burkitt's Non-Hodgkin Lymphoma |
Completed |
Burkitt Lymphoma|B-ALL |
NCT01290120 |
| Combination Chemotherapy With or Without Surgery and Chemoradiotherapy in Treating Patients With Malignant Pleural Mesothelioma |
Unknown status |
Malignant Mesothelioma |
NCT00354393 |
| Dosing Flexibility Study in Patients With Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT00580840 |
| Rituximab Hyaluronidase in Combination With Chemotherapy in Treating Aggressive B-cell Lymphoma in Uganda |
Suspended |
Burkitt Lymphoma|KSHV-associated Multicentric Castleman Disease|Diffuse Large B-Cell Lymphoma |
NCT03864419 |
| Gelclair at Conditioning or After Oral Mucositis Diagnosed vs. Magic Mouth Wash in Stem Cell Transplant Recipients |
Terminated |
Oral Mucositis |
NCT03490396 |
| A Trial to Evaluate the Safety and Tolerability of Namilumab (MT203) in Patients With Mild to Moderate Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT01317797 |
| The Efficacy of Influenza Vaccine Program in Children With Juvenile Idiopathic Arthritis. A Single Centre Results From Hungary |
Active, not recruiting |
Juvenile Idiopathic Arthritis |
NCT03833271 |
| Intensified Post Remission Therapy Containing PEG-Asparaginase |
Completed |
Acute Lymphoblastic Leukemia |
NCT00184041 |
| Total Marrow and Lymphoid Irradiation and Chemotherapy for High-Risk Acute Leukemia |
Recruiting |
Acute Leukemia |
NCT03408223 |
| Investigating Clinical Efficacy of Ofatumumab in Adult Rheumatoid Arthritis (RA) Patients Who Had an Inadequate Response to MTX Therapy |
Terminated |
Arthritis, Rheumatoid |
NCT00611455 |
| Total Marrow and Lymphoid Irradiation and Chemotherapy for Myelodysplastic Syndrome or Acute Leukemia |
Recruiting |
Myelodysplastic Syndromes|Acute Leukemia |
NCT03408210 |
| Prospective Neurobehavioral Functions in Newly-diagnosed Patients With Primary CNS Lymphoma Treated With Hyperfractionated Conformal Whole-brain Radiation Therapy Plus Simultaneous Integrated Boost |
Recruiting |
Primary CNS Lymphoma|Brain Lymphoma |
NCT04006561 |
| Phase I Study Of The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Multiple Intravenously Administered Doses Of PF-04236921 In Patients With Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT00838565 |
| Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia |
Completed |
Leukemia |
NCT00372619 |
| Treatment of Acute Promyelocytic Leukemia With All-Trans Retinoic Acid (ATRA) and Idarubicin (AIDA) |
Completed |
Acute Promyelocytic Leukemia |
NCT00465933 |
| Dose-Ranging Phase 2b Study of ABX464 in Moderate to Severe Ulcerative Colitis |
Recruiting |
Ulcerative Colitis |
NCT03760003 |
| AC220 for Children With Relapsed/Refractory ALL or AML |
Completed |
Lymphoblastic Leukemia, Acute, Childhood|Myelogenous Leukemia, Acute, Childhood |
NCT01411267 |
| ChangE From Any Systemic psoriasiS therapY to Raptiva |
Terminated |
Chronic Plaque Psoriasis |
NCT00697593 |
| Reduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease |
Completed |
Chronic Myeloproliferative Disorders|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes |
NCT00448201 |
| A Study to Evaluate the Safety of Escalating Doses of Ocrelizumab in Subjects With Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT00077870 |
| High-Dose Chemotherapy in Treating Patients With Advanced Stomach Cancer |
Completed |
Gastric Cancer |
NCT00002722 |
| Study to Assess the Management of Synthetic Disease-modifying Antirheumatic Drug (DMARD) at the Onset of Adverse Events, Intolerance or Lack of Efficacy in Rheumatoid Arthritis (RA) |
Completed |
Rheumatoid Arthritis |
NCT02094326 |
| Combination Chemotherapy Compared With Mitoxantrone in Treating Older Patients With Advanced Breast Cancer |
Unknown status |
Breast Cancer |
NCT00002498 |
| Combination Chemotherapy in Patients With Advanced or Recurrent Mycosis Fungoides |
Unknown status |
Lymphoma |
NCT00002557 |
| Combination Chemotherapy With Trastuzumab in Treating Women With Metastatic Breast Cancer |
Unknown status |
Breast Cancer |
NCT00036868 |
| Comparison of Combination Chemotherapy Regimens in Treating Older Women Who Have Undergone Surgery for Breast Cancer |
Completed |
Breast Cancer |
NCT00024102 |
| A Study of the Safety and Effectiveness of Liquid Certolizumab Pegol in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT00160641 |
| A Study of the Safety and Effectiveness of Lyophilized Certolizumab Pegol in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT00175877 |
| Oral Psoriasis Treatment Adherence and Intervention Study |
Active, not recruiting |
Psoriasis |
NCT02850900 |
| Combination Chemotherapy Following Surgery in Treating Women With Early Stage Breast Cancer |
Completed |
Breast Cancer |
NCT00003012 |
| Cyclophosphamide in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Fanconi's Anemia |
Completed |
Fanconi Anemia |
NCT00317876 |
| Effects of Abatacept on Myocarditis in Rheumatoid Arthritis |
Recruiting |
Rheumatoid Arthritis|Myocardial Inflammation |
NCT03619876 |
| PTCy-ATG vs ATG in Haploidentical HSCT for Acute Graft-versus-host Disease Prophylaxis |
Recruiting |
Hematopoietic Stem Cell Transplantation |
NCT03689465 |
| Alemtuzumab or Tocilizumab in Combination With Etoposide and Dexamethasone for the Treatment of Adult Patients With Hemophagocytic Lymphohistiocytosis |
Recruiting |
Leukemia |
NCT02385110 |
| Adalimumab vs. Conventional Immunosuppression for Uveitis Trial |
Recruiting |
Uveitis |
NCT03828019 |
| Safety and Efficacy Study of Allogenic Mesenchymal Stem Cells to Treat Extensive Chronic Graft Versus Host Disease |
Unknown status |
Graft Versus Host Disease |
NCT00972660 |
| Rituximab for the Treatment of Early Rheumatoid Arthritis (RA) |
Terminated |
Rheumatoid Arthritis |
NCT00396812 |
| Maraviroc in Patients Undergoing Non-Myeloablative Allogeneic Stem-Cell Transplantation |
Active, not recruiting |
Graft-versus-host Disease|Hematopoietic Stem Cell Transplantation |
NCT00948753 |
| Pilot of Abatacept-based Immunosuppression for Prevention of Acute GvHD During Unrelated Donor HCT |
Completed |
AML|ALL|Undifferentiated Leukemia|Biphenotypic Leukemia|Refractory Anemia|Refractory Anemia With Ringed Sideroblasts|Refractory Cytopenia With Multilineage Dysplasia|Ref. Cytopenia w Multilineage Dysplasia & Ringed Sideroblasts|Refractory Anemia With Excess Blasts-1 (5-10% Blasts)|Refractory Anemia With Excess Blasts-2 (10-20% Blasts)|Myelodysplastic Syndrome, Unclassified|MDS Associated With Isolated Del (5q) |
NCT01012492 |
| Adult ALL Treatment at Diagnosis |
Completed |
Leukemia, Lymphocytic, Acute |
NCT00537550 |
| Dexamethasone Compared With Prednisone During Induction Therapy and MTX With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia |
Unknown status |
Leukemia |
NCT00075725 |
| A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia |
Recruiting |
B Acute Lymphoblastic Leukemia|B Lymphoblastic Lymphoma|Down Syndrome |
NCT03914625 |
| A Study of Mavrilimumab in Subjects With Moderate-to-Severe Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT01706926 |
| Photoimmunotherapy (PIT) Study in Recurrent Head/Neck Cancer for Patients Who Have Failed at Least Two Lines of Therapy |
Recruiting |
Head and Neck Cancer |
NCT03769506 |
| Rituximab and Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) for Burkitt's and Burkitt's -Like Leukemia/Lymphoma |
Completed |
Burkitt's Lymphoma|Burkitt'S-like Lymphoma |
NCT00669877 |
| Outcomes With Treatment and Withdraw of Secukinumab in Patients With Plaque Psoriasis |
Not yet recruiting |
Plaque Psoriasis |
NCT04239859 |
| Pentoxifylline In Pediatric Acute Lymphoblastic Leukemia During Induction |
Recruiting |
Acute Lymphoblastic Leukemia |
NCT02451774 |
| Role of [18F]-FDG Brain PET in Newly Diagnosed Primary Cerebral Lymphoma, in Immunocompetent Patient Older Than 60 Years |
Recruiting |
Primary Central Nervous System Lymphoma |
NCT03582254 |
| Dose Reduction for Early Rheumatoid Arthritis Patients With Low Disease Activity |
Recruiting |
Rheumatoid Arthritis |
NCT02466581 |
| A Study in Healthy Adults and Adult Subjects With Rheumatoid Arthritis to Evaluate the Safety, Tolerability and Pharmacokinetics After Multiple Doses of ABT-494 |
Completed |
Rheumatoid Arthritis |
NCT01741493 |
| Is More Than One Dose of Misoprostol Needed to Expedite Vaginal Delivery in a Patient With an Unripe Cervix? |
Unknown status |
Labor; Forced or Induced, Affecting Fetus or Newborn |
NCT02680314 |
| Allogeneic Stem Cell Transplant for Patients With Severe Aplastic Anemia |
Terminated |
Aplastic Anemia |
NCT00578903 |
| RAD001 Study in Treatment of Relapsed or Refractory Acute Lymphocytic Leukemia |
Completed |
Leukemia|Acute Lymphocytic Leukemia |
NCT00968253 |
| A Multiple Dose Study to Evaluate Subcutaneous AMG 108 in Subjects With Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT00293826 |
| LAL-BR/2001: Study Treatment to Low Risk ALL |
Completed |
Acute Lymphoblastic Leukemia |
NCT00526175 |
| Intensive Chemotherapy and Rituximab in the Treatment of Burkitt Lymphoma |
Terminated |
Burkitt Lymphoma|Non-Hodgkins Lymphoma|Atypical Burkitt Lymphoma |
NCT00126191 |
| Modified Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) Program for Acute Lymphoblastic Leukemia |
Completed |
Leukemia|Acute Lymphoblastic Leukemia |
NCT00671658 |
| Peripheral Stem Cell Transplant in Treating Patients With Metastatic Kidney Cancer |
Unknown status |
Kidney Cancer |
NCT00003553 |
| Rituximab Combined With Chemotherapy in Burkitt`s Lymphoma |
Completed |
Acute Lymphoblastic Leukemia|Burkitt's Lymphoma |
NCT00388193 |
| Therapy for Pediatric Relapsed or Refractory Acute Lymphoblastic Leukemia |
Completed |
Acute Lymphoblastic Leukemia|Lymphoma, Lymphoblastic |
NCT00186875 |
| Induction Therapy With Cytarabine, High-Dose Mitoxantrone and Dasatinib for Patients With Philadelphia-Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia |
Completed |
Leukemia|Acute Lymphoblastic Leukemia |
NCT00940524 |
| DepoCyt Therapy in Patients With Neoplastic Meningitis From Lymphoma or a Solid Tumor |
Completed |
Meningeal Neoplasms |
NCT00029523 |
| ASIA Down Syndrome Acute Lymphoblastic Leukemia 2016 |
Recruiting |
Down Syndrome|Acute Lymphoblastic Leukemia|Childhood Cancer |
NCT03286634 |
| Phase II Study to Analyze Sarilumab in Non-Infectious Uveitis |
Completed |
Uveitis |
NCT01900431 |
| Bortezomib and Vorinostat in Younger Patients With Refractory or Relapsed MLL Rearranged Hematologic Malignancies |
Terminated |
Mixed Lineage Acute Leukemia|Acute Myeloid Leukemia|Acute Lymphoid Leukemia |
NCT02419755 |
| Nilotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or Blastic Phase Chronic Myelogenous Leukemia |
Withdrawn |
B-cell Adult Acute Lymphoblastic Leukemia|Blastic Phase Chronic Myelogenous Leukemia|Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia|Untreated Adult Acute Lymphoblastic Leukemia |
NCT01670084 |
| Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement |
Suspended |
Acute Leukemia of Ambiguous Lineage|B Acute Lymphoblastic Leukemia|Mixed Phenotype Acute Leukemia |
NCT02828358 |
| Treatment of Newly Diagnosed Patients With Acute Promyelocytic Leukemia (PETHEMA LPA 2005) |
Completed |
Acute Promyelocytic Leukemia |
NCT00408278 |
| Use of Immunosuppressive Therapy for Sarcoidosis |
Unknown status |
Sarcoidosis |
NCT02356445 |
| Risk Enabled Therapy After Initiating Neoadjuvant Chemotherapy for Bladder Cancer (RETAIN) |
Recruiting |
Urothelial Carcinoma of the Bladder |
NCT02710734 |
| Randomized Study Comparing Pre- and Postoperative Vs. Conventional Adjuvant Treatment in Receptor-Negative Patients |
Completed |
Early Stage Breast Cancer |
NCT00309569 |
| Safety Study of Abatacept in Rheumatoid Arthritis Participants |
Completed |
Rheumatoid Arthritis |
NCT03696173 |
| Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma |
Recruiting |
T Acute Lymphoblastic Leukemia|T Lymphoblastic Lymphoma |
NCT00501826 |
| MMP-3 and 9 in RA and Their Relation to Cardiovascular Affection , Disease Activity and Treatment Response |
Completed |
Rheumatoid Arthritis |
NCT03194204 |
| Chemotherapy Followed by Allogeneic Stem Cell Transplantation for Hematologic Malignancies |
Active, not recruiting |
Hematologic Malignancies |
NCT00741455 |
| Erwinase for Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) (IND 104224) |
Terminated |
Relapsed Acute Lymphoblastic Leukemia|Allergy to PEG e.Coli Asparaginase|Allergy to Native e.Coli Asparaginase |
NCT00928200 |
| NHL16: Study For Newly Diagnosed Patients With Acute Lymphoblastic Lymphoma |
Active, not recruiting |
Lymphoblastic Lymphoma |
NCT01451515 |
| Donor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic Cancer |
Terminated |
Chronic Myeloproliferative Disorders|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Myelodysplastic/Myeloproliferative Neoplasms|Unusual Cancers of Childhood |
NCT00281879 |
| Study Comparing Doses Of An Experimental Glucocorticoid Compound To Prednisone And Placebo In Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT01393639 |
| Combination Chemotherapy and Inotuzumab Ozogamicin in Treating Patients With B Acute Lymphoblastic Leukemia |
Active, not recruiting |
Acute Lymphoblastic Leukemia in Remission|B Acute Lymphoblastic Leukemia|B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative |
NCT03488225 |
| Evaluating Efficacy and Safety of Etanercept 50 mg Twice Weekly (BIW) in Rheumatoid Arthritis (RA) Subjects Who Are Sub-Optimal Responders to Etanercept 50 mg Once Weekly (QW) |
Completed |
Rheumatoid Arthritis |
NCT00115219 |
| Low-Intensity Chemotherapy and Blinatumomab in Treating Patients With Philadelphia Chromosome Negative Relapsed or Refractory Acute Lymphoblastic Leukemia |
Recruiting |
Philadelphia Chromosome Negative|Recurrent B Acute Lymphoblastic Leukemia|Refractory B Acute Lymphoblastic Leukemia |
NCT03518112 |
| Low-Intensity Chemotherapy and Venetoclax in Treating Patients With Relapsed or Refractory B- or T-Cell Acute Lymphoblastic Leukemia |
Recruiting |
Recurrent B Acute Lymphoblastic Leukemia|Recurrent T Acute Lymphoblastic Leukemia|Refractory B Acute Lymphoblastic Leukemia|Refractory T Acute Lymphoblastic Leukemia |
NCT03808610 |
| Study of Intensity Modulated Total Marrow Irradiation (IM-TMI) in Addition to Fludarabine/Busulfan Conditioning for Allogeneic Transplantation in High Risk AML and Myelodysplastic Syndromes |
Recruiting |
Acute Myeloid Leukemia|Myelodysplastic Syndromes |
NCT03121014 |
| Active Conventional Therapy Compared to Three Different Biologic Treatments in Early Rheumatoid Arthritis With Subsequent Dose Reduction |
Active, not recruiting |
Rheumatoid Arthritis |
NCT01491815 |
| A Phase III Randomized Trial of Low-Dose Versus Standard-Dose mBACOD Chemotherapy With rGM-CSF for Treatment of AIDS-Associated Non-Hodgkin's Lymphoma |
Completed |
Lymphoma, Non-Hodgkin|HIV Infections |
NCT00000658 |
| Low-Intensity Chemotherapy, Ponatinib and Blinatumomab in Treating Patients With Philadelphia Chromosome-Positive and/or BCR-ABL Positive Acute Lymphoblastic Leukemia |
Recruiting |
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Acute Lymphoblastic Leukemia|Acute Myeloid Leukemia With BCR-ABL1|Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Philadelphia Chromosome Positive|Recurrent Acute Lymphoblastic Leukemia|Refractory Acute Lymphoblastic Leukemia |
NCT03147612 |
| Blinatumomab and Combination Chemotherapy as Frontline Therapy in Treating Patients With B Acute Lymphoblastic Leukemia |
Recruiting |
B Acute Lymphoblastic Leukemia|B Lymphoblastic Lymphoma |
NCT02877303 |
| Treat-to-target Strategy in Ankylosing Spondylitis Using Etanercept and Conventional Synthetic DMARDs |
Not yet recruiting |
Ankylosing Spondylitis|Spondyloarthritis |
NCT04077957 |
| Combination Chemotherapy in Treating Patients Undergoing Surgery for Newly Diagnosed High-Grade Osteosarcoma |
Completed |
Sarcoma |
NCT00645632 |
| Hormone Therapy and Combination Chemotherapy Before and After Surgery in Treating Patients With Stage I-IIIA Breast Cancer |
Terminated |
Estrogen Receptor-positive Breast Cancer|HER2-negative Breast Cancer|Progesterone Receptor-positive Breast Cancer|Stage I Breast Cancer|Stage II Breast Cancer|Stage IIIA Breast Cancer |
NCT00194792 |
| An Observational Study to Evaluate Impact of CRP-Level on Real World Effectiveness of Upadacitinib as Monotherapy or in Combination With MTX in Adult Participants With Rheumatoid Arthritis |
Recruiting |
Rheumatoid Arthritis (RA) |
NCT04267536 |
| Acthar Gel for Chronic Pulmonary Sarcoidosis (ACPS) |
Unknown status |
Sarcoidosis|Pulmonary Sarcoidosis |
NCT02188017 |
| Bortezomib With Chemotherapy for Relapsed Pediatric Acute Lymphoblastic Leukemia (ALL) |
Completed |
Acute Lymphoblastic Leukemia |
NCT00440726 |
| Combination Chemotherapy and Dasatinib in Treating Participants With Philadelphia Positive or BCR-ABL Positive Acute Lymphoblastic Leukemia. |
Active, not recruiting |
Acute Lymphoblastic Leukemia|BCR-ABL1 Fusion Protein Expression|Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Philadelphia Chromosome Positive|Recurrent Acute Lymphoblastic Leukemia|t(9;22) |
NCT00390793 |
| Study of Augmented Hyper-CVAD in Acute Lymphoblastic Leukemia Salvage |
Completed |
Acute Lymphoblastic Leukemia |
NCT00890656 |
| Observational Trial With Enbrel |
Completed |
Rheumatoid Arthritis |
NCT00488475 |
| Preoperative Epirubicin Paclitaxel Aranesp Study (PREPARE) |
Completed |
Breast Cancer |
NCT00544232 |
| Combination Chemotherapy in Treating Women With Stage III Breast Cancer |
Suspended |
Breast Cancer |
NCT00002696 |
| Donor Stem Cell Transplant After Busulfan, Fludarabine, and Antithymocyte Globulin in Treating Patients With Hematological Cancer |
Completed |
Leukemia|Myelodysplastic Syndromes|Myelodysplastic/Myeloproliferative Neoplasms |
NCT00627666 |
| Bortezomib and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia |
Completed |
B-cell Adult Acute Lymphoblastic Leukemia (ALL)|Ph-positive Adult Acute Lymphoblastic Leukemia (ALL)|Recurrent Adult Acute Lymphoblastic Leukemia (ALL)|T-cell Adult Acute Lymphoblastic Leukemia (ALL) |
NCT01769209 |
| Benefits of Injectable Abatacept Using Magnetic Resonance Imaging (MRI) in Rheumatoid Arthritis (RA) Patients |
Completed |
Rheumatoid Arthritis |
NCT01351480 |
| Inotuzumab Ozogamicin for Children With MRD Positive CD22+ Lymphoblastic Leukemia |
Recruiting |
Acute Lymphoblastic Leukemia |
NCT03913559 |
| R-CHOP Combined With Lenalidomide in the First-line Treatment for Patients With Diffuse Large B Cell Lymphoma |
Recruiting |
Diffuse Large B Cell Lymphoma |
NCT04214626 |
| An Efficacy Study Comparing Ponatinib Versus Imatinib, Administered in Combination With Reduced-Intensity Chemotherapy, in Participants With Newly Diagnosed Ph+ ALL |
Recruiting |
Lymphoblastic Leukemia, Acute, Adult|Acute Lymphoid Leukemia|Leukemia, Acute Lymphoblastic|Leukemia, Lymphoblastic|Ph1 Chromosome|Leukemia, Lymphoblastic, Acute, Philadelphia-Positive |
NCT03589326 |
| S0535, Gemtuzumab and Combination Chemotherapy in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia |
Completed |
Leukemia |
NCT00551460 |
| Alemtuzumab, Busulfan, and Cyclophosphamide Followed By a Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer |
Terminated |
Graft Versus Host Disease|Leukemia|Myelodysplastic Syndromes|Myelodysplastic/Myeloproliferative Diseases |
NCT00555048 |
| Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia (Closed to Accrual 4-22-2011) |
Unknown status |
B-cell Adult Acute Lymphoblastic Leukemia|B-cell Childhood Acute Lymphoblastic Leukemia|Untreated Adult Acute Lymphoblastic Leukemia|Untreated Childhood Acute Lymphoblastic Leukemia |
NCT00866307 |
| Combination Chemotherapy in Treating Pediatric Patients With Advanced-Stage Large Cell Lymphoma |
Completed |
Lymphoma |
NCT00002618 |
| Total Therapy for Infants With Acute Lymphoblastic Leukemia (ALL) I |
Recruiting |
Acute Lymphoblastic Leukemia |
NCT02553460 |
| Bortezomib and Chemotherapy in Treating Participants With Lymphoid Malignancies Undergoing Stem Cell Transplant |
Completed |
CD20 Positive|Hematopoietic and Lymphoid Cell Neoplasm|Lymphocytic Neoplasm|Lymphoma |
NCT00439556 |
| Planned Donor Lymphocyte Infusion (DLI) After Allogeneic Stem Cell Transplantation (SCT) |
Terminated |
Leukemia|Lymphoma|Myeloma|Myeloproliferative Diseases |
NCT01518153 |
| Treatment Outcome of Uveitis in Autoimmune Diseases |
Not yet recruiting |
Autoimmune Uveitis |
NCT03886233 |
| Itacitinib for the Prevention of Graft Versus Host Disease in Patients Undergoing Donor Stem Cell Transplantation |
Not yet recruiting |
Allogeneic Stem Cell Transplant Recipient|Hematologic and Lymphocytic Disorder|Hematopoietic and Lymphoid Cell Neoplasm |
NCT04127721 |
| Etanercept to Treat Wegener's Granulomatosis |
Completed |
Vasculitis|Wegener's Granulomatosis |
NCT00001901 |
| Timing of Surgery in Nonmetastatic Osteosarcoma of the Pelvis and Sacrum |
Recruiting |
Osteosarcoma of Pelvis |
NCT03360760 |
| Assessment of Rituximab's Immunomodulatory Synovial Effects (The ARISE Study) |
Completed |
Rheumatoid Arthritis |
NCT00147966 |
| Treatment of Older Adults With Acute Lymphoblastic Leukemia |
Completed |
Acute Lymphoblastic Leukemia |
NCT00973752 |
| Organ-Sparing Marrow-Targeted Irradiation Before Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies |
Recruiting |
Adult Acute Lymphoblastic Leukemia in Remission|Adult Acute Myeloid Leukemia in Remission|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Del(5q)|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)|de Novo Myelodysplastic Syndromes|Previously Treated Myelodysplastic Syndromes|Recurrent Adult Acute Lymphoblastic Leukemia|Recurrent Adult Acute Myeloid Leukemia|Secondary Myelodysplastic Syndromes|Untreated Adult Acute Lymphoblastic Leukemia|Untreated Adult Acute Myeloid Leukemia |
NCT02122081 |
| 4 x Epirubicin, Cyclophosphamide, Followed by 4 x Docetaxel Versus 6 x CMF / 6 x CEF |
Completed |
Breast Cancer |
NCT02115204 |
| Reduced-Intensity Regimen Before Allogeneic Transplant for Patients With Relapsed Non-Hodgkin's or Hodgkin's Lymphoma |
Terminated |
Lymphoma |
NCT00057954 |
| Efficacy of the HCVIDDOXIL Regimen in Patients With Newly Diagnosed Peripheral T-Cell Lymphoma |
Completed |
Lymphoma |
NCT00290433 |
| Total Therapy Study XIV for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia |
Terminated |
Acute Lymphoblastic Leukemia |
NCT00187005 |
| Busulfan and Fludarabine Before Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer |
Withdrawn |
Anemia|Chronic Myeloproliferative Disorders|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Myelodysplastic/Myeloproliferative Diseases |
NCT00301912 |
| Safety and Efficacy of an Adult Acute Lymphoblastic Leukemia Chemotherapy for Adult Lymphoblastic Lymphoma |
Unknown status |
Lymphoblastic Lymphoma |
NCT00195871 |
| Clinical Prognosis and Progression of Myasthenia Gravis Patients |
Recruiting |
Myasthenia Gravis |
NCT04101578 |
| Alloreactive NK Cells for Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) |
Completed |
Myelodysplastic Syndrome|Leukemia |
NCT00402558 |
| S0333 Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia |
Completed |
Leukemia |
NCT00109837 |
| Donor Stem Cell Transplant in Treating Older or Frail Patients With Hematologic Cancer |
Completed |
Chronic Myeloproliferative Disorders|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes |
NCT00296023 |
| Novel Imaging Markers for Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT01773681 |
| Phase I Trial of mBACOD and Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in AIDS-Associated Large Cell, Immunoblastic, and Small Non-cleaved Lymphoma |
Completed |
Lymphoma, Non-Hodgkin|HIV Infections |
NCT00000689 |
| Donor Stem Cell Transplant or Bone Marrow Transplant in Treating Patients With Acute Myeloid Leukemia in Remission |
Completed |
Leukemia |
NCT01020734 |
| Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult ETP-ALL |
Recruiting |
Leukemia, Acute|Leukemia, T Cell|Leukemia, Lymphoblastic |
NCT03553238 |
| Treatment of Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplasia |
Completed |
Leukemia, Myelocytic, Acute |
NCT00136084 |
| Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Cancer |
Terminated |
Leukemia|Lymphoma|Myelodysplastic Syndromes|Myelodysplastic/Myeloproliferative Diseases |
NCT00818961 |
| Donor Stem Cell Transplant in Treating Patients With High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma |
Active, not recruiting |
Leukemia|Lymphoma |
NCT01027000 |
| Ponatinib With Chemotherapy for Young Adults Ph Positive Acute Lymphoblastic Leukemia |
Recruiting |
ALL |
NCT02776605 |
| Immunogenicity of Influenza, Pneumococcal and Hepatitis B Vaccines in IBD Patients Treated With Vedolizumab |
Completed |
Inflammatory Bowel Diseases |
NCT03056924 |
| Donor Stem Cell Transplant in Treating Young Patients With Relapsed or Refractory Solid Tumors |
Completed |
Neuroblastoma|Sarcoma|Unspecified Childhood Solid Tumor, Protocol Specific |
NCT00112645 |
| Cyclophosphamide vs. Infliximab for Refractory Idiopathic Scleritis (CIRIS) |
Not yet recruiting |
Idiopathic Refractory Scleritis |
NCT03088293 |
| Donor Stem Cell Transplant After Conditioning Therapy in Treating Patients With Hematologic Cancer, Recurrent or Metastatic Solid Tumor, or Other Disease |
Completed |
Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Nonmalignant Neoplasm|Unspecified Adult Solid Tumor, Protocol Specific |
NCT00521430 |
| Cytosine Arabinoside and Mitoxantrone for Patients With Juvenile Myelomonocytic Leukemia Receiving Repeat Stem Cell Transplantation |
Terminated |
Leukemia |
NCT00609739 |
| Study of Hyper-CVAD Plus Imatinib Mesylate for Philadelphia-Positive Acute Lymphocytic Leukemia |
Completed |
Leukemia |
NCT00038610 |
| Study of Different Therapeutic Strategies in Hydatidiform Mole With Lung Nodule |
Recruiting |
Hydatidiform Mole|Gestational Trophoblastic Neoplasia |
NCT03785574 |
| Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations |
Active, not recruiting |
B Acute Lymphoblastic Leukemia|Central Nervous System Leukemia|Ph-Like Acute Lymphoblastic Leukemia|Testicular Leukemia |
NCT02883049 |
| Standard Chemotherapy Compared With High-Dose Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer |
Completed |
Breast Cancer |
NCT00002755 |
| Combination Chemotherapy Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or High-Risk Primary Refractory Hodgkin Lymphoma |
Active, not recruiting |
Lymphoma |
NCT00574496 |
| Haploidentical Hematopoietic Stem Cell Transplantation for Patients With Thalassemia Major |
Recruiting |
Thalassemia Major |
NCT03171831 |
| To Evaluate The Effect Of SAR153191 (REGN88) Added To Other RA Drugs In Patients With RA Who Are Not Responding To Or Intolerant Of Anti-TNF Therapy (SARIL-RA-TARGET) |
Completed |
Rheumatoid Arthritis |
NCT01709578 |
| Combination Chemotherapy, Rituximab, and Ixazomib Citrate in Treating Patients With Non-Hodgkin Lymphoma |
Active, not recruiting |
Adult Burkitt Lymphoma|B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma|Diffuse Large B-Cell Lymphoma|MYC Gene Mutation|Plasmablastic Lymphoma |
NCT02481310 |
| Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders |
Active, not recruiting |
Chronic Myeloproliferative Disorders|Graft Versus Host Disease|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Myelodysplastic/Myeloproliferative Diseases|Precancerous/Nonmalignant Condition |
NCT00544115 |
| Different Therapies in Treating Infants With Newly Diagnosed Acute Leukemia |
Recruiting |
Leukemia |
NCT00550992 |
| Enbrel Liquid Immunogenicity Protocol |
Completed |
Rheumatoid Arthritis |
NCT00249041 |
| Combination Chemotherapy Followed By Donor Stem Cell Transplant in Treating Patients With Hemophagocytic Lymphohistiocytosis |
Unknown status |
Nonneoplastic Condition |
NCT00334672 |
| GVAX vs. Placebo for MDS/AML After Allo HSCT |
Recruiting |
Myelodysplastic Syndrome|Acute Myeloid Leukemia|Chronic Myelomonocytic Leukemia |
NCT01773395 |
| Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Related Stem Cell Transplantation |
Completed |
Hematologic Malignancies|Myelogenous Leukemia|Acute Lymphoblastic Leukemia|Myelodysplastic Syndrome|Non-Hodgkin's Lymphoma|Hodgkin's Disease |
NCT00144703 |
| Donor Stem Cell Transplant Followed By Donor White Blood Cell Infusions in Treating Young Patients With Hematologic Cancer |
Terminated |
Leukemia|Lymphoma |
NCT00301860 |
| Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Primary CNS Lymphoma |
Completed |
Lymphoma |
NCT00098774 |
| Allogeneic Hematopoietic Cell Transplantation for Patients With Busulfex-based Regimen |
Completed |
Chronic Myeloproliferative Disorders|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes |
NCT00448357 |
| Comparison of Two Combination Chemotherapy Regimens With Either Vincristine or Vinblastine in Treating Patients With Advanced Anaplastic Large Cell Lymphoma |
Completed |
Lymphoma |
NCT00059839 |
| Predictability Studies on the Efficacy of TNF-α Inhibitors in Chinese RA From "Real World" |
Unknown status |
Rheumatoid Arthritis |
NCT02878161 |
| Study Of Two Non-Myeloablative Stem Cell Transplant Strategies For Low-Grade Lymphoma And CLL |
Active, not recruiting |
Leukemia|Lymphoma |
NCT00041288 |
| Therapy for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia |
Completed |
Lymphoblastic Leukemia, Acute |
NCT00137111 |
| An Efficacy and Safety Study of Tocilizumab (RoActemra/Actemra) in Participants With Giant Cell Arteritis (GCA) |
Completed |
Giant Cell Arteritis |
NCT01791153 |
| Pevonedistat, Azacitidine, Fludarabine Phosphate, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome |
Recruiting |
Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome|Recurrent Acute Myeloid Leukemia|Recurrent Myelodysplastic Syndrome|Refractory Acute Myeloid Leukemia|Refractory Myelodysplastic Syndrome |
NCT03813147 |
| Allogeneic Stem Cell Transplant After ATG, High-Dose Melphalan, and Fludarabine for Patients With Metastatic Breast Cancer |
Terminated |
Breast Cancer |
NCT00074269 |
| Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed Burkitt's Lymphoma or Leukemia |
Completed |
Leukemia|Lymphoma |
NCT00133991 |
| PsoBest - The German Psoriasis Registry |
Recruiting |
Psoriasis|Psoriatic-arthritis |
NCT01848028 |
| Long-term Follow-up Study of GLPG0634 in Active Rheumatoid Arthritis Patients |
Active, not recruiting |
Rheumatoid Arthritis |
NCT02065700 |
| Study of Paclitaxel Plus Cisplatin as the First-line Chemotherapy in High Risk Gestational Trophoblastic Tumor |
Recruiting |
Gestational Trophoblastic Neoplasms |
NCT02639650 |
| Fludarabine and Cyclophosphamide in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Chronic Lymphocytic Leukemia or Waldenstrom's Macroglobulinemia |
Completed |
Chronic Lymphocytic Leukemia |
NCT00281983 |
| Pevonedistat With VXLD Chemotherapy for Adolescent/Young Adults With Relapsed/Refractory Acute Lymphoblastic Leukemia |
Recruiting |
Refractory Acute Lymphoblastic Leukemia|Relapsed Acute Lymphoblastic Leukemia |
NCT03349281 |
| BNHL-2015 for Children or Adolescents in China |
Recruiting |
Mature B-cell Non-Hodgkin Lymphoma |
NCT02405676 |
| Chemotherapy Resistance in Osteogenic Sarcoma and Other Solid Tumors |
Active, not recruiting |
Osteosarcoma |
NCT00580385 |
| Pegaspargase and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia |
Terminated |
Leukemia |
NCT01005914 |
| Rituximab Plus Chemotherapy for CD20+ Adult Acute Lymphoblastic Leukemia |
Completed |
Acute Lymphoblastic Leukemia |
NCT01358253 |
| Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts in Preventing GVHD in Children |
Active, not recruiting |
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Acute Biphenotypic Leukemia|Acute Leukemia of Ambiguous Lineage|Acute Undifferentiated Leukemia|Adult Acute Lymphoblastic Leukemia in Remission|Adult Acute Myeloid Leukemia in Remission|Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Childhood Acute Lymphoblastic Leukemia in Remission|Childhood Acute Myeloid Leukemia in Remission|Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Myelodysplastic Syndrome With Excess Blasts-1|Myelodysplastic Syndrome With Excess Blasts-2|Recurrent Adult Acute Lymphoblastic Leukemia|Recurrent Adult Acute Myeloid Leukemia|Recurrent Childhood Acute Lymphoblastic Leukemia|Recurrent Childhood Acute Myeloid Leukemia|Refractory Adult Acute Lymphoblastic Leukemia|Refractory Childhood Acute Lymphoblastic Leukemia |
NCT01858740 |
| Infliximab for the Prevention of Graft-versus-Host Disease Following Allogenic Hematopoietic Stem Cell Transplantation |
Completed |
Graft-Versus-Host Disease |
NCT00201799 |
| EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) |
Terminated |
Lymphoblastic Leukemia, Acute|Lymphoblastic Leukemia, Acute, Childhood|Leukemia, Lymphoblastic, Acute, T Cell|Leukemia, Lymphoblastic, Acute |
NCT01186328 |
| Temsirolimus, Dexamethasone, Mitoxantrone Hydrochloride, Vincristine Sulfate, and Pegaspargase in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma |
Completed |
Childhood B Acute Lymphoblastic Leukemia|Childhood T Acute Lymphoblastic Leukemia|Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma|Recurrent Childhood Acute Lymphoblastic Leukemia|Recurrent Childhood Lymphoblastic Lymphoma |
NCT01403415 |
| Study of Low-Intensity Conditioning for Allogeneic Stem Cell Transplant |
Completed |
Multiple Myeloma|Lymphocytic Leukemia, Chronic|Lymphoma, Low-Grade |
NCT00143845 |
| Phase I Study of Inotuzumab With Augmented BFM Re-Induction for Younger Adults With Relapsed/Refractory B-cell ALL |
Recruiting |
B-cell Acute Lymphoblastic Leukemia |
NCT03962465 |
| N-PhenoGENICS: Neurocognitive-Phenome, Genome, Epigenome and Nutriome In Childhood Leukemia Survivors |
Active, not recruiting |
Childhood Leukemia Survivors |
NCT01913093 |
| Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed, HIV-Associated Burkitt's Lymphoma |
Completed |
Lymphoma |
NCT00392834 |
| Unrelated Donor Transplant Versus Immune Therapy in Pediatric Severe Aplastic Anemia |
Recruiting |
Severe Aplastic Anemia |
NCT02845596 |
| Four Drug Reinduction With Bortezomib for Relapsed or Refractory ALL or LL in Children and Young Adults |
Terminated |
Acute Lymphoblastic Leukemia|Lymphoblastic Lymphoma |
NCT02535806 |
| SWOG-9320 Combination Chemotherapy, Radiation Therapy, and Antiviral Therapy in Treating Patients With AIDS-Related Lymphoma |
Completed |
Lymphoma |
NCT00002571 |
| Lupus Immunosuppressive/Immunomodulatory Therapy or Stem Cell Transplant (LIST) |
Withdrawn |
Systemic Lupus Erythematosus |
NCT00230035 |
| Filgrastim-Treated Donor Peripheral Stem Cell Transplantation in Treating Patients With Acute Leukemia</p> |
Completed |
Leukemia |
NCT00025545 |
| Combination Chemotherapy Plus Dexrazoxane in Treating Patients With Newly Diagnosed Nonmetastatic Osteosarcoma |
Completed |
Cardiac Toxicity|Sarcoma |
NCT00003937 |
| Targeted Marrow Irradiation, Fludarabine Phosphate, and Busulfan Before Donor Progenitor Cell Transplant in Treating Patients With Hematologic Malignancies |
Active, not recruiting |
Acute Myeloid Leukemia|Hematologic Malignancies|Acute Lymphocytic Leukemia|Non Hodgkin Lymphoma|Hodgkin Lymphoma|Multiple Myeloma|Myelodysplastic Syndrome|Chronic Lymphocytic Leukemia|Chronic Myeloid Leukemia|Myelofibrosis|Myeloproliferative Syndrome |
NCT02129582 |
| To Evaluate The Safety of SAR153191 (REGN88) and Tocilizumab Added to Other RA Drugs in Patients With RA Who Are Not Responding to or Intolerant of Anti-TNF Therapy (SARIL-RA-ASCERTAIN) |
Completed |
Rheumatoid Arthritis |
NCT01768572 |
| Chemoimmunotherapy With Epratuzumab in Relapsed Acute Lymphoblastic Leukemia (ALL) |
Completed |
Recurrent Childhood Acute Lymphoblastic Leukemia |
NCT00098839 |
| On the Impact of Therapeutic Tumor Necrosis Factor-alpha Inhibition on Anogenital Human Papillomavirus Infection |
Completed |
Psoriasis|Inflammatory Bowel Diseases |
NCT02376478 |
| Reduced-Intensity Regimen Before Donor Bone Marrow Transplant in Treating Patients With Myelodysplastic Syndromes |
Completed |
Leukemia|Myelodysplastic Syndromes|Myelodysplastic/Myeloproliferative Neoplasms |
NCT00045305 |
| Phase I Study of MLN 9708 in Addition to Chemotherapy for the Treatment of Acute Lymphoblastic Leukemia in Older Adults |
Completed |
Acute Lymphoblastic Leukemia|Lymphoblastic Lymphoma|B-cell Adult Acute Lymphoblastic Leukemia|T-cell Adult Acute Lymphoblastic Leukemia |
NCT02228772 |
| Biomarkers to Classify Young Patients With Acute Lymphoblastic Leukemia (ALL) and Remission Induction Therapy in Young Patients With B-Precursor ALL |
Completed |
Leukemia |
NCT01225874 |
| Brentuximab Vedotin Prevention of (GVHD) After Unrelated Allogeneic Stem Cell Transplantation |
Completed |
Leukemia, Acute Myeloid|Leukemia, Lymphoblastic,Acute|Myelodysplastic Syndromes |
NCT01700751 |
| An Observational Study on Fatigue in Patients With Rheumatoid Arthritis Treated With RoActemra/Actemra (Tocilizumab) |
Completed |
Rheumatoid Arthritis |
NCT01667458 |
| Combination Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia |
Completed |
Leukemia |
NCT00967057 |
| Chemotherapy, Stem Cell Transplantation and Donor and Patient Vaccination for Treatment of Multiple Myeloma |
Completed |
Multiple Myeloma |
NCT00006184 |
| Carfilzomib and Hyper-CVAD in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoma |
Unknown status |
Contiguous Stage II Adult Lymphoblastic Lymphoma|Noncontiguous Stage II Adult Lymphoblastic Lymphoma|Stage I Adult Lymphoblastic Lymphoma|Stage III Adult Lymphoblastic Lymphoma|Stage IV Adult Lymphoblastic Lymphoma|Untreated Adult Acute Lymphoblastic Leukemia |
NCT02293109 |
| Imatinib Mesylate, Busulfan, Fludarabine, and Antithymocyte Globulin for CML Patients |
Terminated |
Leukemia |
NCT00499889 |
| Decidua Stroma Cells for Steroid Resistent Acute Graft-versus-host Disease (GvHD) After Allogenic Stem-cell Transplantation (HSCT) |
Not yet recruiting |
GVHD, Acute |
NCT04118556 |
| Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant |
Recruiting |
Acute Biphenotypic Leukemia|Acute Leukemia|Acute Leukemia of Ambiguous Lineage|Acute Lymphoblastic Leukemia|Acute Undifferentiated Leukemia|Allogeneic Hematopoietic Stem Cell Transplantation Recipient|Blastic Plasmacytoid Dendritic Cell Neoplasm|Blasts Under 25 Percent of Bone Marrow Nucleated Cells|Blasts Under 5 Percent of Bone Marrow Nucleated Cells|Mixed Phenotype Acute Leukemia|Myelodysplastic Syndrome With Excess Blasts-1|Myelodysplastic Syndrome With Excess Blasts-2 |
NCT03779854 |
| A Study of Pre-Operative Treatment of Newly-Diagnosed, Surgically-Resectable Osteosarcoma With Doxorubicin, Ifosfamide, Etoposide, and Cisplatin With Early Metabolic Assessment of Response |
Terminated |
Osteosarcoma|Lung Metastases |
NCT01258634 |
| Combination Chemotherapy, Radiation Therapy, and an Autologous Peripheral Blood Stem Cell Transplant in Treating Young Patients With Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System |
Active, not recruiting |
Childhood Atypical Teratoid/Rhabdoid Tumor |
NCT00653068 |
| Therapy for Pediatric Relapsed or Refractory Precursor B-Cell Acute Lymphoblastic Leukemia and Lymphoma |
Active, not recruiting |
Recurrent B-Cell Childhood Acute Lymphoblastic Leukemia|Recurrent Childhood B-Lymphoblastic Lymphoma |
NCT01700946 |
| Haplo-identical HSCT Versus Chemotherapy for Adult Acute Lymphoblastic Leukemia Patients |
Completed |
Acute Lymphoblastic Leukemia |
NCT02042690 |
| Combination Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia |
Completed |
Leukemia |
NCT00002816 |
| APL93: Timing of CxT and Role of Maintenance |
Completed |
Leukemia, Promyelocytic, Acute |
NCT00599937 |
| Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma |
Recruiting |
Acute Lymphoblastic Leukemia|Acute Lymphoblastic Lymphoma |
NCT03117751 |
| Combination Chemotherapy and Donor Stem Cell Transplant Followed by Ixazomib Citrate Maintenance Therapy in Treating Patients With Relapsed High-Risk Multiple Myeloma |
Active, not recruiting |
Plasma Cell Leukemia|Recurrent Plasma Cell Myeloma |
NCT02504359 |
| CMC-544 and Allogeneic Transplantation for CD22 Positive-Lymphoid Malignancies |
Active, not recruiting |
Hematopoietic and Lymphoid Cell Neoplasm |
NCT01664910 |
| Allogeneic Stem Cell Transplant for CLL |
Terminated |
Allogeneic Hematopoietic Stem Cell Transplantation Recipient|Chronic Lymphocytic Leukemia|Prolymphocytic Leukemia|Richter Syndrome |
NCT01629511 |
| A Study to Evaluate the Efficacy and Safety of Daratumumab in Pediatric and Young Adult Participants Greater Than or Equal to (>=)1 and Less Than or Equal to (<=) 30 Years of Age With Relapsed/Refractory Precursor B-cell or T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma |
Recruiting |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
NCT03384654 |
| A Study Of PF-04171327 In The Treatment Of The Signs And Symptoms Of Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT00938587 |
| Radiolabeled BC8 Antibody, Busulfan, Cyclophosphamide Followed by Donor Stem Cell Transplant in Treating Patients With Acute Myelogenous Leukemia in First Remission |
Completed |
Adult Acute Myeloid Leukemia in Remission|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Del(5q)|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) |
NCT00005940 |
| Effects of Different Antirheumatic Treatments of Arthritis on Antibody Response Following Vaccination Using Prevenar® |
Completed |
Rheumatoid Arthritis|Spondylarthropathy |
NCT00828997 |
| Ifosfamide, Carboplatin, Etoposide, and SGN-30 in Treating Young Patients With Recurrent Anaplastic Large Cell Lymphoma |
Terminated |
Anaplastic Large Cell Lymphoma|Recurrent Childhood Anaplastic Large Cell Lymphoma |
NCT00354107 |
| Study of Pralatrexate With Vitamin B12 and Folic Acid Supplementation for Previously Treated Recurrent or Metastatic Head and Neck Squamous Cell Cancer (HNSCC) |
Completed |
Head and Neck Cancer |
NCT01183065 |
| Combination Chemotherapy and Ofatumumab in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma |
Active, not recruiting |
Acute Lymphoblastic Leukemia|Adult Acute Lymphoblastic Leukemia in Complete Remission|Burkitt Leukemia|Burkitt Lymphoma|CD20 Positive|Childhood Acute Lymphoblastic Leukemia in Complete Remission|Lymphoblastic Lymphoma |
NCT01363128 |
| TORPEDO Study: A Study on Rapid Effect of Tocilizumab in Patients With Rheumatoid Arthritis With an Inadequate Response to Disease-Modifying Antirheumatic Drugs (DMARDs) or Anti-TNF |
Completed |
Rheumatoid Arthritis |
NCT00977106 |
| Intrathecal Pemetrexed for Recurrent Leptomeningeal Metastases From Non-small Cell Lung Cancer |
Completed |
Leptomeningeal Metastases |
NCT03101579 |
| Spanish Registry of Systemic Treatments in Psoriasis |
Recruiting |
Psoriasis |
NCT02075697 |
| Chemotherapy Followed by Surgery in Treating Women With Stage II or Stage III Breast Cancer |
Completed |
Breast Cancer |
NCT00003953 |
| PEG-ASP+Gemox Regimen and Thalidomide for NK/T Lymphoma |
Active, not recruiting |
Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-Type |
NCT02085655 |
| Association Between Proton Pump Inhibitors and Hematologic Toxicity of Pemetrexed |
Recruiting |
Patients With Non-small Cell Lung Cancer (NSCLC) and Pleural Mesothelioma and Treated With a Pemetrexed-based Chemotherapy |
NCT03537833 |
| Liposomal Doxorubicin Plus Combination Chemotherapy in Treating Patients With AIDS-Associated Non-Hodgkin's Lymphoma |
Completed |
Lymphoma |
NCT00004162 |
| Rituximab, Chemotherapy, and Filgrastim in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia |
Completed |
Leukemia|Lymphoma |
NCT00039130 |
| A Study to Assess the Safety, Tolerability and Pharmacokinetics of Multiple Subcutaneous Injections of ABBV-257 in Subjects With Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT02531178 |
| The Impact of Chemotherapy on Memory Function and the Development of Traumatic Symptoms in Children With Cancer |
Unknown status |
Oncology|Trauma|Pediatric |
NCT01108952 |
| Peginterferon Alfa-2a to Enhance Anti-leukemic Responses After Allogeneic Transplantation in Acute Myeloid Leukemia |
Completed |
Acute Myeloid Leukemia |
NCT02328755 |
| Intrathecal Rituximab With Standard Intrathecal Prophylaxis to Prevent CNS Relapse for CD 20+ Non Hodgkin Lymphoma |
Recruiting |
Non Hodgkin Lymphoma |
NCT03688451 |
| A Phase II Study of CODOX-M/ IVAC in Relapsed/Refractory ALL |
Unknown status |
Acute Lymphoblastic Leukemia |
NCT00774332 |
| Safety, Tolerability, PK and PD of Biosimilar Drug Ritumax® Compared to Original Drug MabThera® |
Terminated |
Rheumatoid Arthritis |
NCT03061838 |
| Chemotherapy in Treating Children With Down Syndrome and Myeloproliferative Disorder, Acute Myelogenous Leukemia, or Myelodysplastic Syndrome |
Completed |
Leukemia|Myelodysplastic Syndromes|Myelodysplastic/Myeloproliferative Neoplasms |
NCT00003593 |
| Study of Refractory and/or Relapsing TAkayasu aRTeritis |
Recruiting |
Systemic Vasculitis|Arteritis, Takayasu|Arteritis |
NCT03543527 |
| Combination Chemotherapy in Treating Young Patients With Langerhans Cell Histiocytosis |
Completed |
Childhood Langerhans Cell Histiocytosis |
NCT00276757 |
| RCHOP Chemoimmunotherapy Preceded BY BBB Permeabilization by t-NGR Necrosis Factor |
Recruiting |
Lymphoma, Large B-Cell, Diffuse |
NCT03536039 |
| Palbociclib in Combination With Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LL) |
Recruiting |
Leukemia, Lymphocytic|Lymphoblastic Lymphoma|T-cell Lymphoma|T-cell Leukemia|Recurrent Disease|Acute Leukemia |
NCT03792256 |
| Comparative Efficacy and Safety Study of GP2015 and Enbrel® in Patients With Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT02638259 |
| Phase II Study Evaluating the Safety and Efficacy of GSK315234A in Patients With Rheumatoid Arthritis |
Completed |
Arthritis, Rheumatoid |
NCT00674635 |
| A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT01927263 |
| Rituximab, Rasburicase, and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Advanced B-Cell Leukemia or Lymphoma |
Completed |
Childhood Burkitt Lymphoma|Childhood Diffuse Large Cell Lymphoma|Childhood Immunoblastic Large Cell Lymphoma|Stage I Childhood Large Cell Lymphoma|Stage I Childhood Small Noncleaved Cell Lymphoma|Stage II Childhood Large Cell Lymphoma|Stage II Childhood Small Noncleaved Cell Lymphoma|Stage III Childhood Large Cell Lymphoma|Stage III Childhood Small Noncleaved Cell Lymphoma|Stage IV Childhood Large Cell Lymphoma|Stage IV Childhood Small Noncleaved Cell Lymphoma|Untreated Childhood Acute Lymphoblastic Leukemia |
NCT00057811 |
| A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE) |
Completed |
Rheumatoid Arthritis (RA) |
NCT02990806 |
| TNF and IL23 Blocking Agents Gene Expression Ratios in the Psoriatic Arthritis Synovium_(TIGERS) Study |
Recruiting |
Psoriatic Arthritis |
NCT04261010 |
| Efficacy and Safety Study of ABP 501 Compared to Adalimumab in Subjects With Moderate to Severe Rheumatoid Arthritis |
Completed |
Arthritis, Rheumatoid |
NCT01970475 |
| Intensive Treatment to Reach the Target With Golimumab in ulcErative coliTis - In-TARGET |
Recruiting |
ULCERATIVE COLITIS |
NCT02425865 |
| The BCD-089 (aIL6R) in Patients With Active Rheumatoid Arthritis |
Completed |
Seropositive RA |
NCT03455842 |
| Strength Training on Pancreatic Cancer |
Withdrawn |
Pancreatic Neoplasms|Cachexia|Myopathy |
NCT01395563 |
| CD73+ Th1.17 in Rheumatoid Arthritis and Psoriatic Arthritis |
Completed |
Rheumatoid Arthritis|Psoriatic Arthritis |
NCT03953378 |
| Gallium Nitrate in Treating Patients With AIDS-Related Non-Hodgkin's Lymphoma |
Completed |
Lymphoma |
NCT00002578 |
| A Phase II, Multicenter, Open-Label, Long-Term Study of the Safety, Tolerability, and Efficacy of Intravenous Natalizumab in Subjects With Rheumatoid Arthritis Who Have Previously Participated in Study ELN100226-RA201 |
Terminated |
Rheumatoid Arthritis |
NCT00831649 |
| Allogeneic Blood Stem Cell Transplantation and Adoptive Immunotherapy for Hodgkin's Disease |
Completed |
Hodgkin's Disease |
NCT00385788 |
| Serum Protein Research Substudy |
Unknown status |
Breast Cancer |
NCT02393833 |
| Long Term Neurotoxic Effects of Chemotherapy in Survivors of Bone and Soft Tissue Sarcomas. A Retrospective Study |
Unknown status |
Sarcoma, Soft Tissue|Osteosarcoma Tumor |
NCT02309242 |
| A Multicenter Phase I Study Evaluating the Addition of Bortezomib to an Established Acute Graft Versus Host Disease Prophylaxis Regimen in Pediatric Allogeneic Hematopoietic Stem Cell Transplant Patients |
Completed |
Hematopoetic Stem Cell Transplant |
NCT01926899 |
| Study to Evaluate Safety and Efficacy of CCX 354-C in Subjects With Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT01027728 |
| Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year |
Active, not recruiting |
Crohn Disease |
NCT03464136 |
| Concurrent Intrathecal-pemetrexed and Involved-field Radiotherapy for Leptomeningeal Metastasis From Solid Tumors |
Completed |
Leptomeningeal Metastasis |
NCT03507244 |
| Comparative Effectiveness of Psoriasis Treatments on Systemic Inflammation |
Completed |
Psoriasis|Inflammation |
NCT02330380 |
| Open Label Clinical Trial With Rituximab (MabThera ®) in Ankylosing Spondylitis |
Unknown status |
Ankylosing Spondylitis |
NCT00432653 |
| Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Unresectable Kidney Cancer |
Completed |
Kidney Cancer |
NCT00027573 |
| A Study Comparing Sirukumab (CNTO 136) Monotherapy With Adalimumab (HUMIRA®) Monotherapy in the Treatment of Active Rheumatoid Arthritis |
Completed |
Arthritis, Rheumatoid |
NCT02019472 |
| RESTART C0168Z05 Rheumatoid Arthritis Study |
Completed |
Rheumatoid Arthritis |
NCT00714493 |
| Safety of Intravenous Infusion of Human Placenta-Derived Cells (PDA001) for the Treatment of Adults With Stage II or III Pulmonary Sarcoidosis |
Terminated |
Stage 2 Pulmonary Sarcoidosis|Stage 3 Pulmonary Sarcoidosis |
NCT01440192 |
| Comparative Study (Double-Blind) of MRA for Rheumatoid Arthritis (RA) |
Completed |
Rheumatoid Arthritis |
NCT00144521 |
| Dose-Escalation Study of TH-302 in Combination With A) Gemcitabine or B) Docetaxel or C) Pemetrexed to Treat Advanced Solid Tumors |
Completed |
Non-Small Cell Lung Cancer|Prostate Cancer|Pancreatic Cancer |
NCT00743379 |
| Program evaLuating the Autoimmune Disease iNvEstigational Drug cT-p13 in RA Patients(PLANETRA) |
Completed |
Rheumatoid Arthritis |
NCT01217086 |
| An Observational Study of Infliximab in Participants Suffering From Ankylosing Spondylitis With Hip Involvement |
Terminated |
Spondylitis, Ankylosing |
NCT02293681 |
| Efficacy and Safety of Increased Dose of TA-650(Infliximab) in Patients With Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT00691028 |
| Safety and Efficacy Study of Eculizumab in Patients With Refractory Generalized Myasthenia Gravis |
Terminated |
Myasthenia Gravis |
NCT00727194 |
| Infliximab for the Treatment of Early Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT00006292 |
| Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Mantle Cell Lymphoma |
Completed |
Graft Versus Host Disease|Lymphoma |
NCT00006747 |
| Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia |
Completed |
Leukemia |
NCT00005585 |
| Safety and Efficacy of Abatacept Versus Placebo in Participants With Psoriatic Arthritis |
Terminated |
Psoriatic Arthritis |
NCT00534313 |
| Zoledronic Acid and Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma |
Completed |
Sarcoma |
NCT00742924 |
| Efficacy and Safety of Tocilizumab in Adult's Still Disease |
Unknown status |
Adult's Still Disease |
NCT01002781 |
| Study of Human Anti-TNF Monoclonal Antibody Adalimumab in Children With Polyarticular Juvenile Idiopathic Arthritis (JIA) |
Completed |
Arthritis, Juvenile Idiopathic |
NCT00048542 |
| Combination Chemotherapy and Rituximab in Treating Young Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Acute Lymphoblastic Leukemia |
Terminated |
B-cell Childhood Acute Lymphoblastic Leukemia|Childhood Burkitt Lymphoma|Childhood Diffuse Large Cell Lymphoma|Childhood Immunoblastic Large Cell Lymphoma|L3 Childhood Acute Lymphoblastic Leukemia|Recurrent Childhood Acute Lymphoblastic Leukemia|Recurrent Childhood Large Cell Lymphoma|Recurrent Childhood Lymphoblastic Lymphoma|Recurrent Childhood Small Noncleaved Cell Lymphoma |
NCT00058461 |
| Personalized Kinase Inhibitor Therapy Combined With Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia |
Recruiting |
Acute Lymphoblastic Leukemia|Acute Myeloid Leukemia |
NCT02779283 |
| "AIDA" Protocol (LAP 0493) |
Recruiting |
Leukemia |
NCT01064557 |
| Chemotherapy Combined With Radiation Therapy for Newly Diagnosed CNS AT/RT |
Completed |
Central Nervous System Tumor, Pediatric |
NCT00084838 |
| TRUST Study: Raptiva ® in Hand & Foot Psoriasis |
Terminated |
Chronic Plaque Psoriasis |
NCT00739882 |
| Daclizumab to Treat Wegener's Granulomatosis |
Completed |
Wegener's Granulomatosis |
NCT00040248 |
| Aflibercept and Standard Chemotherapy (R-CHOP) in First Line of Non Hodgkin B-cell Lymphoma |
Completed |
Lymphoma, Non-Hodgkin |
NCT00644124 |
| A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT01225393 |
| SWOG-9239 Reduction of Immunosuppression Plus Interferon Alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ Transplant |
Completed |
Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm |
NCT00002657 |
| Assessment of Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Plaque Psoriasis, Crohn's Disease and Ulcerative Colitis Patients´ Adherence Attitudes to Maintenance Therapy With a Scheduled Adalimumab Treatment in Routine Clinical Practice |
Completed |
Rheumatoid Arthritis|Ankylosing Spondylitis|Psoriatic Arthritis|Crohn´s Disease|Ulcerative Colitis|Plaque Psoriasis |
NCT01768858 |
| BIOTIPRA: BIOmarker-guided Treatment Decisions In Psoriatic and Rheumatoid Arthritis |
Recruiting |
Arthritis, Rheumatoid|Arthritis, Psoriatic |
NCT03853395 |
| Treatment of Necrotizing Vasculitides for Patients Older Than 65 Years |
Completed |
Vasculitis|Wegener's Granulomatosis|Microscopic Polyangiitis|Churg-Strauss Syndrome|Polyarteritis Nodosa |
NCT00307671 |
| To Evaluate Sarilumab - SAR153191 (REGN88) - Auto-injector Device In Patients With Rheumatoid Arthritis |
Completed |
RA |
NCT02057250 |
| A Placebo-Controlled Double-Blind Study on the Safety and Efficacy of Etanercept in Palmoplantar Pustulosis |
Completed |
Palmoplantaris Pustulosis |
NCT00353119 |
| Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL |
Terminated |
Relapsed T-Cell Acute Lymphoblastic Leukemia|Relapsed T-Cell Lymphoblastic Lymphoma |
NCT00981799 |
| Hematopoietic Stem Cell Transplantation for Malignant Infantile Osteopetrosis |
Unknown status |
Osteopetrosis |
NCT01087398 |
| T&B Depletion Non Malignant |
Unknown status |
Graft Versus Host Disease |
NCT01810926 |
| An Observational Study of RoActemra/Actemra (Tocilizumab) in Monotherapy in Patients With Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT01669902 |
| Mycophenolate Mofetil to Treat Wegener's Granulomatosis and Related Vascular Inflammatory Conditions |
Completed |
Vasculitis|Wegener's Granulomatosis |
NCT00001764 |
| Clinical Study to Evaluate the Efficacy of Anakinra in Patients With Rheumatoid Arthritis and Diabetes |
Terminated |
Diabetes Mellitus, Type 2|Arthritis, Rheumatoid |
NCT02236481 |
| An Open Label Pilot Study Examining the Use of Rituximab in Patients With Wegener's Granulomatosis Who Have Experienced Disease Relapse on Standard Therapies |
Completed |
Wegener's Granulomatosis |
NCT00072592 |
| UACE Followed by Uterine Suction Curettage for the Treatment of Caesarean Scar Pregnancy |
Completed |
Caesarean Scar Pregnancy |
NCT02357095 |
| Temozolomide, Nedaplatin, Vincristine, and Radiotherapy as First-line Treatment in Newly Diagnosed Primary CNS Lymphoma |
Unknown status |
Central Nervous System Tumors |
NCT01735747 |
| Double Blind, Placebo-controlled, Study of the Safety, Tolerability and Pharmacokinetics of AIN457 in Rheumatoid Arthritis Patients |
Completed |
Rheumatoid Arthritis |
NCT00669942 |
| PETHEMA LAL-07FRAIL: All Treatment In Fragile Patients Ph' Negative Over 55 Years |
Recruiting |
Acute Lymphoblastic Leukemia |
NCT01358201 |
| A Protocol Based Treatment for Debilitating Fibrosing Skin Disorders With (Anti-CD 20), Rituximab, Evaluating Safety and Efficacy |
Unknown status |
Debilitating Fibrosing Skin Disorders (Localised Scleroderma, Eosinophilic Fasciitis) |
NCT00936546 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of ABBV-3373 in Participants With Moderate to Severe Rheumatoid Arthritis |
Active, not recruiting |
Rheumatoid Arthritis (RA) |
NCT03823391 |
| To Determine the Role of Adding Campath-1H or ATG Given In-vivo in Addition to Fludarabine and Low Dose Busulfex on Outcome in Patients Treated With Reduced Intensity Conditioning |
Withdrawn |
Acute Myeloid Leukemia|Myelodysplastic Syndrome |
NCT00226512 |
| Hyper-CVAD With Liposomal Vincristine in Acute Lymphoblastic Leukemia |
Active, not recruiting |
Leukemia |
NCT01319981 |
| A Study of the Safety, Tolerability and Efficacy of Treatment With AP1189 in Early RA Patients With Active Joint Disease |
Recruiting |
Rheumatoid Arthritis |
NCT04004429 |
| Tocilizumab for Relapsing Polychondritis |
Withdrawn |
Relapsing Polychondritis |
NCT01104480 |
| SAFIR02_Breast - Efficacy of Genome Analysis as a Therapeutic Decision Tool for Patients With Metastatic Breast Cancer |
Active, not recruiting |
Metastatic Breast Cancer |
NCT02299999 |
| Study Evaluating the Influence of LV5FU2 Bevacizumab Plus Anakinra Association on Metastatic Colorectal Cancer |
Completed |
Metastatic Colorectal Cancer |
NCT02090101 |
| Low-Dose or High-Dose Conditioning Followed by Peripheral Blood Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia |
Completed |
Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome|Acute Myeloid Leukemia/Transient Myeloproliferative Disorder|Adult Acute Myeloid Leukemia in Remission|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Del(5q)|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)|Childhood Acute Myeloid Leukemia in Remission|Childhood Myelodysplastic Syndromes|de Novo Myelodysplastic Syndromes|Myelodysplastic Syndrome With Isolated Del(5q)|Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable|Previously Treated Myelodysplastic Syndromes|Recurrent Adult Acute Myeloid Leukemia|Recurrent Childhood Acute Myeloid Leukemia|Secondary Acute Myeloid Leukemia|Secondary Myelodysplastic Syndromes |
NCT00322101 |
| A Study of AK106-001616 in Patients With Rheumatoid Arthritis (RA) |
Completed |
Rheumatoid Arthritis |
NCT00902369 |
| First Human Dose Trial of NNC0215-0384 in Subjects With Rheumatoid Arthritis |
Completed |
Inflammation|Rheumatoid Arthritis |
NCT01611688 |
| Treosulfan and Fludarabine Phosphate Before Donor Stem Cell Transplant in Treating Patients With Nonmalignant Inherited Disorders |
Suspended |
Non-Neoplastic Hematologic and Lymphocytic Disorder |
NCT00919503 |
| A Study of the Efficacy and Safety of Tocilizumab in Adults With Rheumatoid Arthritis. |
Completed |
Rheumatoid Arthritis |
NCT01988012 |
| A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Assess Clinical Efficacy of NNC0114-0006 in Subjects With Active Rheumatoid Arthritis |
Completed |
Inflammation|Rheumatoid Arthritis |
NCT01647451 |
| ELDA: Elderly Breast Cancer - Docetaxel in Adjuvant Treatment |
Completed |
Breast Cancer |
NCT00331097 |
| A Study of ARRY-371797 in Patients With Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT00729209 |
| Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells |
Recruiting |
Severe Aplastic Anemia|MDS (Myelodysplastic Syndrome) |
NCT01174108 |
| Study of High-Dose Rituximab With Temozolomide as Treatment for Primary Central Nervous System (CNS) Lymphoma |
Terminated |
Primary Central Nervous System Lymphoma |
NCT02113007 |
| A Study of ARRY-438162 in Patients With Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT00650767 |
| A Trial to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NNC0215-0384 Administered to Subjects With Moderate to Severe Rheumatoid Arthritis |
Completed |
Inflammation|Rheumatoid Arthritis |
NCT01955603 |
| Corrona Japan Rheumatoid Arthritis (RA) Registry |
Enrolling by invitation |
Rheumatoid Arthritis |
NCT02737449 |
| A Study of LY3090106 in Healthy Participants and Participants With Rheumatoid Arthritis (RA) |
Completed |
Rheumatoid Arthritis |
NCT01925157 |
| Phase 2 Study of Alisertib Therapy for Rhabdoid Tumors |
Recruiting |
Malignant Rhabdoid Tumor|Atypical Teratoid Rhabdoid Tumor |
NCT02114229 |
| Universal Granulocyte Macrophage-colony Stimulating Factor (GM-CSF)-Producing and GM.CD40L for Autologous Tumor Vaccine in Mantle Cell Lymphoma |
Active, not recruiting |
Lymphoma |
NCT00101101 |
| An Observational Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to DMARDs |
Completed |
Rheumatoid Arthritis |
NCT01388309 |
| A Study of LY2127399 in Rheumatoid Arthritis |
Terminated |
Rheumatoid Arthritis |
NCT01576549 |
| PsA Treatment With hOKT3Îł1 (Ala-Ala) |
Terminated |
Arthritis, Psoriatic |
NCT00239720 |
| A Study of Two Doses of MRC375 in Moderate to Severe Rheumatoid Arthritis Patients |
Unknown status |
Rheumatoid Arthritis |
NCT01408602 |
| Low Dose Rituximab as a First Line Biologic Therapy for the Treatment of DMARD Resistant Patients With Rheumatoid Arthritis |
Completed |
DMARD Resistant Rheumatoid Arthritis |
NCT01593332 |
| DUrvalumab (MEDI4736) and TREmelimumab in NEOadjuvant Bladder Cancer Patients (DUTRENEO) |
Recruiting |
Bladder Cancer |
NCT03472274 |
| Effects of Antirheumatic Treatment on Levels of Survivin in Rheumatoid Arthritis Patients |
Recruiting |
Rheumatoid Arthritis |
NCT03440892 |
| Human Umbilical Cord-Mesenchymal Stem Cells for Rheumatoid Arthritis |
Unknown status |
Rheumatoid Arthritis |
NCT02643823 |
| Large Cell Lymphoma Pilot Study III |
Completed |
Lymphoma, Large Cell|Lymphoma, Non-Hodgkin |
NCT00187070 |
| ATG in HLA-matched Sibling HSCT as GVHD Prophylaxis |
Recruiting |
Hematopoietic Stem Cell Transplantation |
NCT04203108 |
| De-escalated Treatment Approach for Adult Ph-negative Acute Lymphoblastic Leukemia (ALL) |
Recruiting |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
NCT03462095 |
| TOSCARA Study: A Study of Subcutaneous Tocilizumab (RoActemra/Actemra) in Participants With Active Rheumatoid Arthritis NaĂŻve to RoActemra/Actemra Treatment |
Completed |
Rheumatoid Arthritis |
NCT02031471 |
| Bruton's Tyrosine Kinase Inhibitor Ibrutinib as Maintenance Treatment in Elderly Patients With Primary CNS Lymphoma |
Recruiting |
Central Nervous System Lymphoma |
NCT02623010 |
| Allogeneic Stem Cell Transplantation Followed By Targeted Immune Therapy In Average Risk Leukemia |
Active, not recruiting |
Acute Myelogenous Leukemia|Myelodysplastic Syndrome|Juvenile Myelomonocytic Leukemia |
NCT01020539 |
| Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma |
Active, not recruiting |
Acute Lymphoblastic Leukemia|Adult B Lymphoblastic Lymphoma|Ann Arbor Stage I B Lymphoblastic Lymphoma|Ann Arbor Stage II B Lymphoblastic Lymphoma|Childhood B Acute Lymphoblastic Leukemia|Childhood B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1|Childhood B Lymphoblastic Lymphoma|Down Syndrome|Hypodiploid B Acute Lymphoblastic Leukemia|Philadelphia Chromosome Positive |
NCT01190930 |
| Combination Chemotherapy With or Without Etoposide Followed By an Autologous Stem Cell Transplant in Treating Young Patients With Previously Untreated Malignant Brain Tumors |
Unknown status |
Brain and Central Nervous System Tumors |
NCT00392886 |
| A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on One Prior Anti-TNF Therapy (RESET) |
Completed |
Rheumatoid Arthritis |
NCT01272908 |
| A Golimumab Phase 3b, Multicenter, Assessment of Intravenous Efficacy in Rheumatoid Arthritis Subjects Who Have Diminished Disease Control Despite Treatment With Infliximab (REMICADE®) |
Terminated |
Arthritis, Rheumatoid |
NCT01962974 |
| S1106 Rituximab With Combination Chemotherapy or Bendamustine Hydrochloride Followed by Consolidation Chemotherapy and Stem Cell Transplantation in Older Patients With Previously Untreated Mantle Cell Lymphoma |
Active, not recruiting |
Lymphoma |
NCT01412879 |
| Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia |
Completed |
Leukemia |
NCT00005596 |
| A Trial of NNC0109-0012, an Anti-IL-20 Biologic, in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to Anti-TNFa Biologics |
Terminated |
Inflammation|Rheumatoid Arthritis |
NCT01636817 |
| Certolizumab and Lower Extremity Lymph Flow in Rheumatoid Arthritis (RA) |
Completed |
Rheumatoid Arthritis |
NCT01098201 |
| Safety and Effectiveness of Quizartinib in Children and Young Adults With Acute Myeloid Leukemia (AML), a Cancer of the Blood |
Recruiting |
Acute Myeloid Leukemia |
NCT03793478 |
| An Open-label Study With Tocilizumab in Patients With Rheumatoid Arthritis in a Local Environment |
Completed |
Rheumatoid Arthritis |
NCT01254331 |
| Venetoclax and Chemotherapy as Frontline Therapy in Older Patients and Patients With Relapsed/Refractory ALL |
Active, not recruiting |
Leukemia |
NCT03319901 |
| Dose Dense Chemotherapy and Rituximab for Young High Risk Diffuse Large B-Cell Lymphoma Patients (CRY-04) |
Completed |
Diffuse Large B-Cell Lymphoma |
NCT01502982 |
| Comparative Efficacy, Safety and Immunogenicity Study of Etanercept and Enbrel |
Recruiting |
Rheumatoid Arthritis |
NCT04079374 |
| Cognitive Function and Patient-Reported Quality of Life Outcomes Investigation in Patients Taking Vorinostat |
Completed |
Quality of Life|Graft-vs-Host Disease |
NCT02409134 |
| Temsirolimus in Recurrent Primary Central Nervous System (CNS) Lymphoma |
Unknown status |
Recurrent or Refractory Primary CNS Lymphoma |
NCT00942747 |
| Monitoring Epstein-Barr Virus (EBV) Load in Rheumatoid Arthritis Patients Treated With New Immunosuppressive Drugs |
Unknown status |
Rheumatoid Arthritis |
NCT00947492 |
| Mathematic Modeling at Micro and Macroscopic Level of Primary Central Nervous System Lymphomas (PCNSL) |
Not yet recruiting |
Primary Central Nervous System Lymphoma (PCNSL) |
NCT04253496 |
| Concurrent Involved-field Radiotherapy and Intrathecal Chemotherapy for Leptomeningeal Metastases From Solid Tumors |
Completed |
Leptomeningeal Metastasis |
NCT03082144 |
| Feasibility of Neo-adjuvant Versus Adjuvant Chemotherapy in Upper Tract Urothelial Carcinoma |
Recruiting |
Upper Tract Urothelial Carcinoma |
NCT02969083 |
| A Study of Tocilizumab (RoActemra/Actemra) Versus Adalimumab in Patients With Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT01119859 |
| Efficacy and Safety of CDP6038 in Patients With Rheumatoid Arthritis With an Unsuccessful Response to Anti-Tumor Necrosis Factor (Anti-TNF) Therapy |
Completed |
Rheumatoid Arthritis |
NCT01242488 |
| A Study to Assess the Effect of Tocilizumab on Signs and Symptoms in Patients With Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT00848120 |
| Nonmyeloablative Allo SCT for the Treatment of Hematologic Disorders |
Completed |
AML|ALL|CML Chronic Phase, Accelerated Phase, or Blast Crisis|CLL|MDS|RELAPSED NON-HODGKIN'S OR HODGKIN'S LYMPHOMA|APLASTIC ANEMIA|MULTIPLE MYELOMA|MYELOPROLIFERATIVE DISORDER (P Vera, CMML, ET) |
NCT00636909 |
| Use of Thalidomide in Chronic Uveitis |
Terminated |
Uveitis |
NCT00314665 |
| EPANOVA in Crohn's Disease, Study 1 |
Completed |
Crohn's Disease |
NCT00613197 |
| A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to a Single Anti-TNF Inhibitor |
Completed |
Rheumatoid Arthritis |
NCT02079532 |
| DC-STAMP: Regulators of Osteoclastogenesis and Response Marker in PsA |
Recruiting |
Psoriatic Arthritis |
NCT03011242 |
| A Phase 2, Multicenter Open-Label Extension (OLE) Study With ABT-122 in Active Psoriatic Arthritis Subjects Who Have Completed a Preceding Study M14-197 |
Terminated |
Psoriatic Arthritis |
NCT02429895 |
| Allogeneic Donor Lymphocyte Infusions Combined With Blinatumomab |
Recruiting |
B Cell Precursor Acute Lymphoblastic Leukemia With Mixed Chimerism or Minimal Residual Disease After Allogeneic Stem Cell Transplantation|B-Cell Acute Lymphoblastic Leukemia|Acute Lymphoblastic Leukemia|Acute Lymphoblastic Leukemia in Remission|Acute Lymphoblastic Leukemia, Adult |
NCT03982992 |
| Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma |
Completed |
B-cell Adult Acute Lymphoblastic Leukemia|B-cell Childhood Acute Lymphoblastic Leukemia|Recurrent Adult Acute Lymphoblastic Leukemia|Recurrent Adult Lymphoblastic Lymphoma|Recurrent Childhood Acute Lymphoblastic Leukemia|Recurrent Childhood Lymphoblastic Lymphoma|T-cell Adult Acute Lymphoblastic Leukemia|T-cell Childhood Acute Lymphoblastic Leukemia |
NCT00873093 |
| Serum Concentration of Adalimumab as a Predictive Factor of Clinical Outcomes in Rheumatoid Arthritis (AFORA) |
Completed |
Rheumatoid Arthritis |
NCT01382160 |
| Electronic Database for the Follow up of the ATG_FamilyStudy |
Completed |
GVHD, Chronic|Acute Leukemia|Stem Cell Transplant Complications |
NCT03042676 |
| A Trial COmparing staNdard of Care Versus Treat to Target With telemonitoRing and Patient Education in Patients With Ulcerative cOlitis Initiating Adalimumab |
Recruiting |
Ulcerative Colitis |
NCT04183608 |
| Outcome in Patients With Recent Onset Polymyositis and Dermatomyositis |
Completed |
Polymyositis|Dermatomyositis |
NCT01813617 |
| Gemcitabine-Carboplatin Versus Gemcitabine-Oxaliplatin in Cisplatin-unfit Urothelial Carcinoma |
Unknown status |
Advanced Urothelial Carcinoma |
NCT01487915 |
| Papillomavirus Load in Rheumatic Inflammatory Diseases |
Not yet recruiting |
Spondyloarthritis|Rhumatoid Arthisis |
NCT03713736 |
| C.O.R.P.U.S.: Observational Cohort of Adult and Child Inflammatory Arthritis in France |
Completed |
Arthritis, Rheumatoid|Spondylitis, Ankylosing|Arthritis, Psoriatic|Arthitis, Juvenile Idiopathic |
NCT02886689 |
| Efficacy and Safety of Sarilumab and Adalimumab Monotherapy in Patients With Rheumatoid Arthritis (SARIL-RA-MONARCH) |
Active, not recruiting |
Rheumatoid Arthritis |
NCT02332590 |
| Assessment of the Clinical and Medico-economic Impact of SinnoTest® in Patients With Rheumatoid Arthritis |
Not yet recruiting |
Arthritis, Rheumatoid|Biological Therapy |
NCT04117165 |
| Neoadjuvant Dose Dense MVAC in MIBC and Locally Advanced Urothelial Carcinoma |
Recruiting |
Muscle Invasive Bladder Cancer|Urothelial Carcinoma|Neoadjuvant Chemotherapy |
NCT04047693 |
| Use of Optune TTF With Radiation as an Alternative for Elderly Patients With Primary CNS Lymphoma |
Not yet recruiting |
Central Nervous System Neoplasms, Primary |
NCT03530605 |
| Pemetrexed and Cisplatin in Advanced Urothelial Carcinoma |
Completed |
Urothelial Carcinoma |
NCT01490437 |
| Serum VEGF as a Tubal Pregnancy Marker |
Completed |
Pregnancy, Ectopic |
NCT02973230 |
| CHemoImmunotherapy With Early Central Nervous System (CNS) Prophylaxis |
Completed |
Primary Disease |
NCT01325194 |
| Representation and Medication Use in Juvenile Idiopathic Arthritis |
Completed |
Juvenile Idiopathic Arthritis |
NCT03892135 |
| Ibrutinib, Rituximab, Venetoclax, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma |
Recruiting |
Mantle Cell Lymphoma |
NCT03710772 |
| Preemptive Therapy of GVHD |
Active, not recruiting |
Graft-vs-host Disease |
NCT01994824 |
| Avelumab in Chemo-resistant Gestational Trophoblastic Neoplasias |
Recruiting |
Gestational Trophoblastic Neoplasias (GTN) |
NCT03135769 |
| 70% Ethanol for Decontamination of CVL Exposed to Calcineurine Inhibitors Version 1.0, 1/9/2014 |
Completed |
Hematopoietic Stem Cell Transplant|GVHD |
NCT02441075 |
| A Study of the Safety of Rituximab in Combination With Other Anti-Rheumatic Drugs in Subjects With Active Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT00443651 |
| Osteosarcoma1999-A Study Of Intensive Chemotherapy for Osteosarcoma |
Completed |
Osteosarcoma |
NCT00145639 |
| AIDA2000 - Risk-Adapted Therapy for Patients With Acute Promyelocytic Leukemia |
Unknown status |
Leukemia, Promyelocytic, Acute |
NCT00180128 |
| CNS Sarcoidosis and Acthar Gel |
Completed |
CNS Sarcoidosis |
NCT02298491 |
| High-dose Chemotherapy and Stem Cell Transplantation for Central Nervous System (CNS) Relapse of Aggressive Lymphomas |
Unknown status |
Lymphoma, Non-Hodgkin |
NCT01148173 |
| Fertility After Diagnosis and Management of Acquired Uterine Arteriovenous Malformation |
Completed |
Arteriovenous Malformations |
NCT03656211 |
| Prediction Medical Device for Rheumatoid Arthritis (PREDIRA) |
Recruiting |
Arthritis, Rheumatoid |
NCT04147026 |
| Bone Marrow Transplantation in Young Adults With Severe Sickle Cell Disease |
Completed |
Sickle Cell Disease |
NCT01565616 |
| Dose-Dense Therapy in Aggressive Lymphoma |
No longer available |
Lymphoma |
NCT00517894 |
| Selecting Chemotherapy With High-throughput Drug Screen Assay Using Patient Derived Organoids in Patients With Refractory Solid Tumours (SCORE) |
Recruiting |
Organoids|HNSCC|Epithelial Ovarian Cancer|Colorectal Cancer |
NCT04279509 |
| Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors in Preventing GVHD |
Suspended |
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Acute Biphenotypic Leukemia|Acute Leukemia of Ambiguous Lineage|Acute Undifferentiated Leukemia|Allogeneic Hematopoietic Stem Cell Transplant Recipient|Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Blastic Plasmacytoid Dendritic Cell Neoplasm|Childhood Acute Lymphoblastic Leukemia in Remission|Childhood Acute Myeloid Leukemia in Remission|Donor|Lymphoblastic Lymphoma|Myelodysplastic Syndrome With Excess Blasts|Myelodysplastic Syndrome With Excess Blasts-1|Myelodysplastic Syndrome With Excess Blasts-2|Recurrent Acute Lymphoblastic Leukemia|Recurrent Acute Myeloid Leukemia|Recurrent Childhood Acute Lymphoblastic Leukemia|Recurrent Childhood Acute Myeloid Leukemia|Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Refractory Acute Lymphoblastic Leukemia|Refractory Acute Myeloid Leukemia|Acute Lymphoblastic Leukemia in Remission|Acute Myeloid Leukemia in Remission |
NCT02220985 |
| RFC and MTHFR SNPs & hENT1- dCK Expression as Prognostic Factors in ALL & hENT1- dCK Expression as Prognostic Factors in AML |
Unknown status |
Acute Lymphoblastic Leukemia.|Acute Myeloblastic Leukemia |
NCT01307241 |
| Treatment Protocol for Hemophagocytic Lymphohistiocytosis 2004 |
Completed |
Hemophagocytic Lymphohistiocytosis |
NCT00426101 |
| Study Of 90mg Of GW274150 In Subjects Over 50 Years, Who Have Rheumatoid Arthritis (RA) |
Completed |
Arthritis, Rheumatoid |
NCT00370435 |
| Immune Modulation Therapy for Pompe Disease |
Recruiting |
Pompe Disease |
NCT02525172 |
| A Study Comparing CRx-102 Plus Disease-modifying Anti-rheumatic Drug (DMARD) Therapy to Placebo Plus DMARD Therapy in RA |
Completed |
Rheumatoid Arthritis |
NCT00747214 |
| Identification of Inflammatory and Fibrotic Biomarkers in PBC and NAFLD Patients |
Completed |
Primary Biliary Cirrhosis |
NCT02477462 |
| Treatment of Philadelphia-Positive Acute Lymphocytic Leukemia (Ph+ ALL) in the Elderly With Imatinib Mesylate (STI571) and Chemotherapy. |
Unknown status |
Acute Lymphocytic Leukemia |
NCT00149136 |
| Addition of H.P. Acthar Gel to Treatment Regimen of Patients With Rheumatoid Arthritis |
Unknown status |
Rheumatoid Arthritis |
NCT02434757 |
| Formulation and Clinical Evaluation of Ethosomal and Liposomal Preparations of Anthralin in Psoriasis |
Completed |
Psoriasis Vulgaris |
NCT03348462 |
| Study of AMG 531 to Evaluate the Safety & Efficacy in Patients With Non-Hodgkin's Lymphoma |
Completed |
Lymphoma |
NCT00299182 |
| Mechanistic Studies of B- and T-Cell Function in RA Patients Treated With TNF Antagonists, Tocilizumab, or Abatacept |
Active, not recruiting |
Rheumatoid Arthritis (RA) |
NCT02353780 |
| Study on Two Different Formulations of 6-mercaptopurine. Tablet Versus Oral Liquid |
Unknown status |
Acute Lymphoblastic Leukemia|6-mercaptopurine Therapy |
NCT01906671 |
| Phase I Trial of Recombinant Human Interleukin-10 (SCH 52000) in Patients With Wegener's Granulomatosis |
Completed |
Vasculitis|Wegener's Granulomatosis |
NCT00001761 |
| Donor Stem Cell Transplant in Treating Patients With Previously Treated Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia |
Completed |
Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm |
NCT00612716 |
| Interleukin-1 Blockade for Treatment of Cardiac Sarcoidosis |
Not yet recruiting |
Cardiac Sarcoidosis |
NCT04017936 |
| Filling Bone Erosions: a Longitudinal Multicentric HR-pQCT Study of Subcutaneous Tocilizumab in Rheumatoid Arthritis |
Recruiting |
Rheumatoid Arthritis |
NCT02765074 |
| Safety and Efficacy of Infliximab in Palmoplantar Psoriasis |
Completed |
Palmoplantar Psoriasis |
NCT00629772 |
| Long-Term Effects of Infliximab in the Treatment of Moderate to Severe Psoriasis [Extension of Study P04271, NCT00251641] (P04563) |
Terminated |
Psoriasis |
NCT00358670 |
| Proteomics Research of Osteosarcoma |
Recruiting |
Osteosarcoma|Proteomics |
NCT03932058 |
| Treatment With Leflunomide in Patients With Polymyalgia Rheumatica |
Recruiting |
Polymyalgia Rheumatica |
NCT03576794 |
| Anti-TNF Agents for the Treatment of Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT00837434 |
| Multicenter Study to Evaluate CRx-102 vs. Each of Its Components to Treat Active Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT00551707 |
| Donor Bone Marrow Transplant With or Without G-CSF in Treating Young Patients With Hematologic Cancer or Other Diseases |
Terminated |
Childhood Acute Lymphoblastic Leukemia in Remission|Childhood Acute Myeloid Leukemia in Remission|Childhood Chronic Myelogenous Leukemia|Childhood Myelodysplastic Syndromes|Chronic Phase Chronic Myelogenous Leukemia|de Novo Myelodysplastic Syndromes|Juvenile Myelomonocytic Leukemia|Previously Treated Myelodysplastic Syndromes|Recurrent Childhood Acute Lymphoblastic Leukemia|Secondary Myelodysplastic Syndromes |
NCT00450450 |
| Lenalidomide Combined With Modified DA-EPOCH and Rituximab (EPOCH-R2) in Primary Effusion Lymphoma or KSHV-associated Large Cell Lymphoma |
Recruiting |
Primary Effusion Lymphoma|B-Cell Lymphoma |
NCT02911142 |
| Trial of High Dose vs. Standard Dose Influenza Vaccine in Inflammatory Bowel Disease Patients |
Completed |
Inflammatory Bowel Disease (IBD) |
NCT02461758 |
| Efficacy of Levocetirizine Fourfold Dosage in Chronic Spontaneous Urticaria |
Completed |
Chronic Spontaneous Urticaria |
NCT02372604 |
| A Study of RoActemra/Actemra (Tocilizumab) in Combination With DMARDs Versus Current Best Practice DMARD Therapy in Patients With Rheumatoid Arthritis |
Terminated |
Rheumatoid Arthritis |
NCT01251120 |
| Allogeneic Stem Cell Transplantation in Chronic Myeloid Leukemia Failing TKIs Therapy |
Unknown status |
Leukemia|Myelogenous|Chronic|BCR-ABL Positive |
NCT02638467 |
| Phase 1 Study of Ibrutinib and Immuno-Chemotherapy Using Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib,Rituximab (TEDDI-R) in Primary CNS Lymphoma |
Recruiting |
Primary Central Nervous System Lymphoma |
NCT02203526 |
| Sequential Trial on Reduced Intensity Conditioning (RIC) Allogeneic Transplantation |
Completed |
Hematologic Malignancies|Multiple Myeloma |
NCT01460420 |
| Biomarkers of Remission in Rheumatoid Arthritis (BioRRA) |
Completed |
Rheumatoid Arthritis |
NCT02219347 |
| Prospective Multicentric Evaluation of a Bladder Preservation Strategy |
Active, not recruiting |
Urothelial Carcinoma |
NCT01093066 |
| Myeloablative Hematopoietic Progenitor Cell Transplantation (HPCT) for Pediatric Malignancies |
Unknown status |
Leukemia, Myelogenous, Chronic|Leukemia, Lymphoblastic, Acute|Leukemia, Myelogenous, Acute|Myeloproliferative-Myelodysplastic Diseases|Lymphoma, Malignant |
NCT00619879 |
| A 6-Months Infliximab Or Placebo Study In UA At High Risk Of RA:Clinical,Radiological And Synovial Benefit |
Completed |
Undifferentiated Arthritis |
NCT01245361 |
| Four Cycles Versus Six Cycles of Cisplatin-based Chemotherapy in Metastatic Urothelial Carcinoma |
Recruiting |
Bladder Cancer|Ureter Cancer|Urethral Cancer|Transitional Cell Carcinoma |
NCT03296306 |
| Pilot Study of Ranibizumab (Lucentis) for Uveitic Cystoid Macular Edema |
Completed |
Uveitic Cystoid Macular Edema |
NCT00826618 |
| Efficacy, Safety and Tolerability of Denosumab in the Treatment of Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT00095498 |
| Exploratory Study of Changes in Disease Activity and Biomarkers With ABR-215757 in Patients With Mild Active Systemic Lupus Erythematosus (SLE) |
Completed |
Systemic Lupus Erythematosus |
NCT00997100 |
| Personalized Therapy of Precursor Lymphoid Neoplasms |
Unknown status |
Precursor Lymphoid Neoplasms |
NCT01665001 |
| Granulocyte Colony Stimulating Factor (G-CSF) for Bone Marrow Transplant (BMT) |
Completed |
Hematologic Diseases|Hematologic Malignancies |
NCT00231309 |
| The Use of Anti-CD4 Monoclonal Antibody (mAb)-Fragment for the Imaging of Chronic Inflammation in Patients With Active Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis|Polyarthritis|Rheumatism|Autoimmune Disease|Inflammation |
NCT00372177 |
| Treatment of Myeloma in Patients <= 65 Years Old With Response >= 50% After HSC Autotransplant by Allogenic Transplant Genoidentical or Phenoidentical After Reduced Intensity Conditioning |
Completed |
Myeloma |
NCT00466674 |
| Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Diseases |
Completed |
Chronic Myeloproliferative Disorders|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes |
NCT00453206 |
| Autologous Stem Cell Transplant for Refractory Crohn's Disease |
Withdrawn |
Crohn's Disease |
NCT02676622 |
| Study With Pazopanib and Weekly Paclitaxel in Penile Carcinoma (PAZOPEN-SOGUG) |
Terminated |
Penile Squamous Cell Carcinoma Stage IV |
NCT02279576 |
| Study of Pomalidomide Combined With Modified DA-EPOCH and Rituximab in KSHV-Associated Lymphomas |
Withdrawn |
Large Cell Lymphoma Arising in KSHV-associated Multicentric Castleman Disease|Primary Effusion Lymphoma |
NCT02228512 |
| Autologous Stem Cell Transplant for Crohn's Disease |
Suspended |
Crohn Disease |
NCT03219359 |
| Sibling Donor Peripheral Stem Cell Transplant or Sibling Donor Bone Marrow Transplant in Treating Patients With Hematologic Cancers or Other Diseases |
Completed |
Chronic Myeloproliferative Disorders|Graft Versus Host Disease|Leukemia|Lymphoma|Myelodysplastic Syndromes|Secondary Myelofibrosis |
NCT00438958 |
| A Multimodality Treatment Approach to Patients With Inflammatory Cancer of the Breast and Locally Advanced Non-Inflammatory Stage III Breast Cancer and Stage IV Breast Cancer |
Completed |
Breast Neoplasms|Neoplasm Metastasis |
NCT00001193 |
| Phase II Study on Gusperimus in Patients With Refractory Wegener's Granulomatosis |
Completed |
Wegener's Granulomatosis |
NCT00530075 |
| TREATgermany: German National Clinical Registry for Patients With Moderate-to-severe Atopic Dermatitis |
Recruiting |
Moderate-to-severe Atopic Dermatitis |
NCT03057860 |
| Rituximab Vasculitis Maintenance Study |
Completed |
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis|Microscopic Polyangiitis|Wegener Granulomatosis |
NCT01697267 |
| Ustekinumab for the Treatment of Relapse of Refractory Giant Cell Arteritis |
Recruiting |
Patients Relapsing Refractory Giant Cell Arteritis |
NCT03711448 |
| Exposure of Taxi Drivers to Ultrafine Particles and Black Carbon Within Their Vehicles |
Recruiting |
Pulmonary Ventilation |
NCT03839537 |
| Centocor Microarray Study of Patients |
Completed |
Rheumatoid Arthritis|Psoriatic Arthritis|Psoriasis|Crohn's Disease |
NCT00462072 |
| Clofarabine or High-Dose Cytarabine and Pegaspargase in Children With ALL |
Active, not recruiting |
Leukemia |
NCT01228331 |
| Pneumococcal Vaccination in Patients With Inflammatory Bowel Disease |
Completed |
Inflammatory Bowel Disease|Crohn Disease|Ulcerative Colitis |
NCT00829595 |
| Evaluate the Hematological Remission Rates and Survival Among Chinese Adult Patients With B-precursor ALL |
Completed |
B-precursor Acute Lymphoblastic Leukemia |
NCT03123887 |
| Prospective Neurobehavioral Outcomes Follow-up in Primary CNS Lymphoma Patients Treated With Cranial Radiotherapy Combined With or Without MTX-based Chemotherapy According to the Multidisciplinary Treatment Guidelines Implemented at a Single Institute |
Recruiting |
Primary Central Nervous System Lymphoma |
NCT02655744 |
| An Open-Label Trial of Tocilizumab in Schizophrenia |
Completed |
Schizophrenia |
NCT01696929 |
| Raptiva in Palm and Sole Psoriasis |
Terminated |
Chronic Plaque Psoriasis |
NCT00972543 |
| Pediatric Research on Improving Speed, Memory and Attention |
Unknown status |
Brain Tumors |
NCT00961922 |
| Effect of Andosan in Patients With Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT01815411 |
| Brentuximab Vedotin in Early Diffuse Cutaneous Systemic Sclerosis |
Recruiting |
Diffuse Cutaneous Systemic Sclerosis |
NCT03198689 |
| A Pilot Study to Determine the Safety and Tolerability of Sirolimus Given With Hyper-CVAD Chemotherapy |
Completed |
Lymphoid Malignancies (New or Relapsed)|Acute Lymphoblastic Leukemia|Burkitt Lymphoma|Lymphoblastic Lymphoma|Mantle Cell Lymphoma|Adult T-cell Leukemia/Lymphoma |
NCT01184885 |
| Trial of Adalimumab in Progressive Sarcoidosis |
Terminated |
Sarcoidosis |
NCT00311246 |
| Active Immunization of Sibling Bone Marrow Transplant Donors Against Purified Myeloma Protein of the Recipient Undergoing Allogeneic Bone Marrow Transplantation |
Completed |
Graft vs Host Disease|Multiple Myeloma |
NCT00001561 |
| Stem Cell Support in Patients With Rheumatoid Arthritis |
Terminated |
RHEUMATOID ARTHRITIS |
NCT00278551 |
| Assessing the Efficacy and Safety of Metformin in Treatment of Moderate Psoriasis |
Unknown status |
Psoriasis |
NCT02644954 |
| Alefacept for Prevention of Graft Versus Host Disease (GVHD) |
Terminated |
Graft Versus Host Disease |
NCT00361413 |
| Combination Chemotherapy in Treating Children With Acute Lymphocytic Leukemia |
Completed |
Leukemia |
NCT00002812 |
| RHYTHM (Formerly Escape II Myocardium) |
Active, not recruiting |
Rheumatoid Arthritis |
NCT01548768 |
| Zevalin-Containing Nonmyeloablative Conditioning for Stem Cell Transplantation (SCT) |
Completed |
Leukemia|Lymphoma |
NCT01490723 |
| Alefacept for Chronic Graft Versus Host Disease |
Completed |
Resistant Chronic GVHD |
NCT00397332 |
| Intensive Combo Chemo With Autologous BM Rescue for Metastatic Breast Cancer |
Completed |
Metastatic Breast Cancer |
NCT00584766 |
| High Dose Cyclophosphamide for Treatment of Scleroderma |
Completed |
Scleroderma |
NCT00501995 |
| HAT in Eye Complications of Behcet's Disease |
Completed |
Behcet's Syndrome|Retinal Disease|Uveitis |
NCT00001865 |
| Thiotepa-Clofarabine-Busulfan With Allogeneic Stem Cell Transplant for High Risk Malignancies |
Completed |
Stem Cell Transplantation|Leukemia|Lymphoma |
NCT00857389 |
| Efalizumab to Treat Uveitis |
Completed |
Uveitis|Macular Edema |
NCT00280826 |
| Safety and Efficacy Study of Umbilical Cord/Placenta-Derived Mesenchymal Stem Cells to Treat Ankylosing Spondylitis (AS) |
Unknown status |
Ankylosing Spondylitis |
NCT01420432 |
| Clinically Important Changes in Rheumatoid Arthritis |
Completed |
Rheumatoid Arthritis |
NCT00056602 |
| LBL-2016 for Children or Adolescents in China |
Recruiting |
Lymphoblastic Lymphoma |
NCT02845882 |
| Study of Recombinant Human B Lymphocyte(RC18) Administered Subcutaneously to Subjects With Systemic Lupus Erythematosus(SLE) |
Recruiting |
Systemic Lupus Erythematosus |
NCT04082416 |
| Systemic Therapies for Pediatric Atopic Dermatitis |
Recruiting |
Dermatitis, Atopic |
NCT01447381 |
| TNRF:Fc to Treat Eye Inflammation in Juvenile Rheumatoid Arthritis |
Completed |
Juvenile Rheumatoid Arthritis|Uveitis |
NCT00001862 |
| Safety and Efficacy Study of Humira in Treatment of Pyoderma Gangrenosum |
Withdrawn |
Pyoderma Gangrenosum |
NCT00730717 |
| The Impact of Targeted Therapy on Microorganism in Patients With Psoriasis |
Unknown status |
Psoriasis |
NCT01504113 |
| Thymoglobulin to Prevent Acute Graft vs. Host Disease (GvHD) in Patients With Acute Lymphocytic Leukemia (ALL) or Acute Myelogenous Leukemia (AML) Receiving a Stem Cell Transplant |
Completed |
Acute Myelogenous Leukemia (AML)|Acute Lymphocytic Leukemia (ALL)|Graft vs. Host Disease (GvHD) |
NCT00088543 |
| Effectiveness and Safety of Tofacitinib in Korean Patients With Rheumatoid Arthritis |
Recruiting |
Rheumatoid Arthritis |
NCT03011281 |
| Rituximab+mVPDL for CD20(+) Adult Acute Lymphoblastic Leukemia |
Active, not recruiting |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
NCT01429610 |
| Nurses Internal Contamination by Antineoplastic Drugs. |
Active, not recruiting |
Antineoplastic Drugs Contamination Prevalence |
NCT03137641 |
| An Open Label Study of Multiple Doses of Cannabidiol in the Prevention of Acute Graft-Versus-Host Disease (GVHD) |
Recruiting |
Prevention aGVHD |
NCT03840512 |
| Cyclosporin Implant to Treat Uveitis |
Completed |
Eye Disease|Inflammation|Uveitis |
NCT00001737 |
| Leflunomide to Treat Uveitis |
Completed |
Uveitis |
NCT00001863 |
| Infliximab to Treat Children With Juvenile Rheumatoid Arthritis |
